
<html lang="en"     class="pb-page"  data-request-id="cb7c1919-2baf-4535-a60e-f9f4e044b470"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm400459m;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes" /></meta><meta name="dc.Creator" content="Yulin  Wu" /></meta><meta name="dc.Creator" content="Christopher J.  Aquino" /></meta><meta name="dc.Creator" content="David J.  Cowan" /></meta><meta name="dc.Creator" content="Don L.  Anderson" /></meta><meta name="dc.Creator" content="Jeff L.  Ambroso" /></meta><meta name="dc.Creator" content="Michael J.  Bishop" /></meta><meta name="dc.Creator" content="Eric E.  Boros" /></meta><meta name="dc.Creator" content="Lihong  Chen" /></meta><meta name="dc.Creator" content="Alan  Cunningham" /></meta><meta name="dc.Creator" content="Robert L.  Dobbins" /></meta><meta name="dc.Creator" content="Paul L.  Feldman" /></meta><meta name="dc.Creator" content="Lindsey T.  Harston" /></meta><meta name="dc.Creator" content="Istvan W.  Kaldor" /></meta><meta name="dc.Creator" content="Ryan  Klein" /></meta><meta name="dc.Creator" content="Xi  Liang" /></meta><meta name="dc.Creator" content="Maggie S.  McIntyre" /></meta><meta name="dc.Creator" content="Christine L.  Merrill" /></meta><meta name="dc.Creator" content="Kristin M.  Patterson" /></meta><meta name="dc.Creator" content="Judith S.  Prescott" /></meta><meta name="dc.Creator" content="John S.  Ray" /></meta><meta name="dc.Creator" content="Shane G.  Roller" /></meta><meta name="dc.Creator" content="Xiaozhou  Yao" /></meta><meta name="dc.Creator" content="Andrew  Young" /></meta><meta name="dc.Creator" content="Josephine  Yuen" /></meta><meta name="dc.Creator" content="Jon L.  Collins" /></meta><meta name="dc.Description" content="The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein. Multiple pharmaceutical companies ..." /></meta><meta name="Description" content="The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein. Multiple pharmaceutical companies ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 6, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400459m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400459m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400459m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400459m" /></link>
        
    
    

<title>Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400459m" /></meta><meta property="og:title" content="Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0014.jpeg" /></meta><meta property="og:description" content="The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein. Multiple pharmaceutical companies have exploited the physiological link between ASBT and hepatic cholesterol metabolism, which led to the clinical investigation of ASBT inhibitors as lipid-lowering agents. While modest lipid effects were demonstrated, the potential utility of ASBT inhibitors for treatment of type 2 diabetes has been relatively unexplored. We initiated a lead optimization effort that focused on the identification of a potent, nonabsorbable ASBT inhibitor starting from the first-generation inhibitor 264W94 (1). Extensive SAR studies culminated in the discovery of GSK2330672 (56) as a highly potent, nonabsorbable ASBT inhibitor which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400459m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400459m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400459m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400459m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400459m&amp;href=/doi/10.1021/jm400459m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5094-5114</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400416u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400511s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yulin++Wu">Yulin Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Aquino">Christopher J. Aquino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Cowan">David J. Cowan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Don+L.++Anderson">Don L. Anderson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+L.++Ambroso">Jeff L. Ambroso</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Bishop">Michael J. Bishop</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+E.++Boros">Eric E. Boros</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lihong++Chen">Lihong Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Cunningham">Alan Cunningham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+L.++Dobbins">Robert L. Dobbins</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+L.++Feldman">Paul L. Feldman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lindsey+T.++Harston">Lindsey T. Harston</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Istvan+W.++Kaldor">Istvan W. Kaldor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan++Klein">Ryan Klein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xi++Liang">Xi Liang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maggie+S.++McIntyre">Maggie S. McIntyre</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+L.++Merrill">Christine L. Merrill</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin+M.++Patterson">Kristin M. Patterson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judith+S.++Prescott">Judith S. Prescott</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+S.++Ray">John S. Ray</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shane+G.++Roller">Shane G. Roller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaozhou++Yao">Xiaozhou Yao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Young">Andrew Young</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josephine++Yuen">Josephine Yuen</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+L.++Collins">Jon L. Collins</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">GlaxoSmithKline Research & Development, Five Moore Drive, Research Triangle Park, North Carolina 27709, United States</span></div><div class="corresp-info"><strong>*</strong>email: <a href="/cdn-cgi/l/email-protection#642e0b0a4a284a270b08080d0a172403170f4a070b09"><span class="__cf_email__" data-cfemail="c882a7a6e684e68ba7a4a4a1a6bb88afbba3e6aba7a5">[email protected]</span></a>, tel 919-483-5694.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400459m&amp;href=/doi/10.1021%2Fjm400459m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5094–5114</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 March 2013</li><li><span class="item_label"><b>Published</b> online</span>6 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400459m" title="DOI URL">https://doi.org/10.1021/jm400459m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5094%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYulin%2BWu%252C%2BChristopher%2BJ.%2BAquino%252C%2BDavid%2BJ.%2BCowan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D12%26contentID%3Djm400459m%26title%3DDiscovery%2Bof%2Ba%2BHighly%2BPotent%252C%2BNonabsorbable%2BApical%2BSodium-Dependent%2BBile%2BAcid%2BTransporter%2BInhibitor%2B%2528GSK2330672%2529%2Bfor%2BTreatment%2Bof%2BType%2B2%2BDiabetes%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5114%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400459m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3272</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400459m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yulin&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Aquino&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Cowan&quot;},{&quot;first_name&quot;:&quot;Don&quot;,&quot;last_name&quot;:&quot;L. Anderson&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;L. Ambroso&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Bishop&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;E. Boros&quot;},{&quot;first_name&quot;:&quot;Lihong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Cunningham&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;L. Dobbins&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;L. Feldman&quot;},{&quot;first_name&quot;:&quot;Lindsey&quot;,&quot;last_name&quot;:&quot;T. Harston&quot;},{&quot;first_name&quot;:&quot;Istvan&quot;,&quot;last_name&quot;:&quot;W. Kaldor&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;Klein&quot;},{&quot;first_name&quot;:&quot;Xi&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Maggie&quot;,&quot;last_name&quot;:&quot;S. McIntyre&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;L. Merrill&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;M. Patterson&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;S. Prescott&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;S. Ray&quot;},{&quot;first_name&quot;:&quot;Shane&quot;,&quot;last_name&quot;:&quot;G. Roller&quot;},{&quot;first_name&quot;:&quot;Xiaozhou&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Young&quot;},{&quot;first_name&quot;:&quot;Josephine&quot;,&quot;last_name&quot;:&quot;Yuen&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;L. Collins&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;5094-5114&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400459m&quot;},&quot;abstract&quot;:&quot;The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein. Multiple pharmaceutical companies have exploited the physiological link between ASBT and hepatic cholesterol metabolism, which led to the clinical investigation of ASBT inhibitors as lipid-lowering agents. While modest lipid effects were demonstrated, the potential utility of ASBT inhibitors for treatment of type 2 diabetes has been relatively unexplored. We initiated a lead optimization effort that focused on the identification of a potent, nonabsorbable ASBT inhibitor starting from the first-generation inhibitor 264W94 (1). Extensive SAR studies culminated in the discovery of GSK2330672 (56) as a highly potent, nonabsorbable ASBT inhibitor which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patien&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400459m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400459m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400459m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400459m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400459m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400459m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400459m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400459m&amp;href=/doi/10.1021/jm400459m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400459m" /></input><a href="/doi/pdf/10.1021/jm400459m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400459m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400459m%26sid%3Dliteratum%253Aachs%26pmid%3D23678871%26genre%3Darticle%26aulast%3DWu%26date%3D2013%26atitle%3DDiscovery%2Bof%2Ba%2BHighly%2BPotent%252C%2BNonabsorbable%2BApical%2BSodium-Dependent%2BBile%2BAcid%2BTransporter%2BInhibitor%2B%2528GSK2330672%2529%2Bfor%2BTreatment%2Bof%2BType%2B2%2BDiabetes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D12%26spage%3D5094%26epage%3D5114%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jmcmar.2013.56.issue-12/production/jmcmar.2013.56.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0014.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein. Multiple pharmaceutical companies have exploited the physiological link between ASBT and hepatic cholesterol metabolism, which led to the clinical investigation of ASBT inhibitors as lipid-lowering agents. While modest lipid effects were demonstrated, the potential utility of ASBT inhibitors for treatment of type 2 diabetes has been relatively unexplored. We initiated a lead optimization effort that focused on the identification of a potent, nonabsorbable ASBT inhibitor starting from the first-generation inhibitor 264W94 (<b>1</b>). Extensive SAR studies culminated in the discovery of GSK2330672 (<b>56</b>) as a highly potent, nonabsorbable ASBT inhibitor which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The World Health Organization estimates that 3.4 million people died from diabetes in 2004 and projects that worldwide deaths from this debilitating disease will increase by two-thirds between 2008 and 2030. Approximately 90% of all cases of diabetes are classified as type 2 diabetes, a condition that arises when the pancreas produces insufficient insulin and/or tissues become insulin resistant, resulting in excessively high blood sugar levels which can eventually lead to severe microvascular and macrovascular complications as well as death.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Current guidelines for treatment of type 2 diabetes outline lifestyle modification including weight loss and increased physical activity as an initial approach.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, this approach predominantly fails, and patients will require pharmacological therapies that can include metformin, sulfonylureas, thiazolidinediones, insulin, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon-like-1 (GLP-1) analogues. While effective in subsets of patients with type 2 diabetes, these agents have limitations and side effects. Clearly, type 2 diabetes remains a significant unmet medical need.</div><div class="NLM_p">The incretin peptides GLP-1 and glucose dependent insulinotropic peptide (GIP) are secreted by L and K enteroendocrine cells, respectively, from the gastrointestinal tract into the bloodstream following ingestion of nutrients. This important physiological response serves as the primary signaling mechanism between nutrients in the gastrointestinal tract and peripheral organs. Upon secretion, one of the effects of both circulating peptides is to initiate signals in beta cells of the pancreas to enhance glucose-stimulated insulin secretion, which, in turn, controls glucose concentrations in the bloodstream.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">Bile salts have been shown to enhance secretion of peptides from the gastrointestinal tract that enhance glucose-stimulated insulin secretion from the pancreatic beta cells. In particular, bile salts have been shown to promote secretion of GLP-1 from colonic L cells in a vascularly perfused rat colon model as well as GLP-1, peptide YY (PYY), and neurotensin in a vascularly perfused rat ileum model.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> In humans, infusion of deoxycholate into the sigmoid colon produces a rapid and marked dose responsive increase in plasma PYY and enteroglucagon concentrations.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Novel mechanisms that can increase ileal and colonic bile salt concentrations would be expected to induce secretion of GLP-1 and other peptides from the distal gastrointestinal tract, providing a means to elicit an antidiabetic effect.</div><div class="NLM_p">Bile acids are synthesized from cholesterol in the liver then, upon conjugation, released from the gallbladder into the proximal small intestine after each meal to facilitate digestion of nutrients, in particular fat, lipids, and lipid-soluble vitamins.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Conjugated bile acids then descend down the small intestine to the distal ileum, where 90% are reabsorbed into enterocytes via the apical sodium-dependent bile acid transporter (ASBT; also known as the ileal bile acid transporter, iBAT). Pharmacological disruption of bile acid reabsorption with an inhibitor of ASBT has been shown to increase the conversion of hepatic cholesterol to bile acids to compensate for fecal loss of bile acids.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> While ASBT inhibitors have been explored in humans as lipid-lowering agents (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the physiological consequences of increasing the concentrations of bile salts in the colon with an ASBT inhibitor on glucose homeostasis has not been extensively explored. Data from exploratory studies in preclinical animal models of type 2 diabetes with the ASBT inhibitor 264W94 (<b>1</b>) or other inhibitors supports this strategy as a potential target for treatment of this debilitating disease.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Unfortunately, <b>1</b> is not an ideal clinical tool for testing this hypothesis in humans because the compound is extensively metabolized following oral administration, an undesirable profile which did not lead to maximal concentrations of <b>1</b> at the primary site of action in the distal ileum. Thus, we set out to identify a potent, highly soluble, nonabsorbable inhibitor of ASBT for evaluation in a preclinical animal model of type 2 diabetes and ultimately humans.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Select ASBT Inhibitors That Have Advanced to Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> served as the key starting material for the lead optimization program because kilogram quantities of the compound were available in our chemical stores (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Not surprisingly, regioselective demethylation of the C8-methoxy (see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, compound <b>1</b> for numbering) proved to be very challenging; however, highly reproducible, scalable conditions were ultimately identified to affect clean demethylation of <b>1</b>. Pretreatment of <b>1</b> with HCl gas followed by addition of AlCl<sub>3</sub> provided a 1:1 mixture of phenol <b>2</b> and the regioisomeric C7-phenol in 96% yield. Separation of the regioisomers by chiral column chromatography provided intermediate phenol <b>2</b> in approximately 40% overall yield.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Key Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCl(<i>g</i>), AlCl<sub>3</sub>, DCE; (b) Tf<sub>2</sub>O, pyridine, DCM; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, CO, MeOH, 70 °C; (d) LiOH, THF, MeOH, H<sub>2</sub>O; (e) ZnCN<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, Zn<sup>o</sup>, DMF, 80 °C; (f) DiBAL-H, toluene, DCM; (g) H<sub>2</sub>, 10% Pd/C, EtOH, 40 psi.</p></p></figure><div class="NLM_p">Several key synthetic intermediates were prepared from <b>2</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Conversion of <b>2</b> to the corresponding triflate <b>3</b> was uneventful. Pd-catalyzed carbonylation in the presence of methanol provided methyl ester <b>4</b>, which was subjected to basic hydrolysis using LiOH to give the corresponding C8-carboxylic acid. Triflate <b>3</b> was also converted to C8-nitrile following subjection to ZnCN<sub>2</sub> in the presence of Pd<sub>2</sub>(dba)<sub>3</sub>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> DiBAL-H mediated reduction of <b>6</b> followed by hydrolysis of the intermediate imine generated aldehyde <b>7</b>. Nitrile <b>6</b> was also reduced to aminomethyl intermediate <b>8</b> upon exposure to H<sub>2</sub> atmosphere at 40 psi in the presence of 10% Pd/C.</div><div class="NLM_p">A small number of C8-phenolic ethers were prepared via base-catalyzed alkylation of <b>2</b> with haloalkyl esters, haloalkyl sulfonic acids, haloalkyl phosphonates, dimethyl α-(4-chlorobenzenesulfonyl)methylphosphonate,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> or 1,2-dibromoethane followed by bromide displacement with sulfite or trialkylphosphonate (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Subsequent LiOH or TMSBr-mediated deprotection of the alkyl esters or alkyl phosphonates, respectively, provided compounds <b>9</b>–<b>12</b> and <b>14</b>–<b>15</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route to Oxygen-Linked Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RX, K<sub>2</sub>CO<sub>3</sub>, DMSO, 70–100 °C; (b) 1,2-dibromoethane, 1 M KOH, Bu<sub>4</sub>NBr, DMSO, 100 °C; (c) Na<sub>2</sub>SO<sub>3</sub>, EtOH, 100 °C; (d) 4 N HCl, 1,4-dioxane, DCM or LiOH, THF, MeOH, H<sub>2</sub>O; (e) TMSBr, DCM; (f) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>OSO<sub>2</sub>-(4-Cl-Ph), NaHMDS, THF, DMSO.</p></p></figure><div class="NLM_p">Triflate intermediate <b>3</b> proved to be a key intermediate for preparation of analogues containing alkyl and amide-linked acidic functionalities at C8 (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Heck reaction of <b>3</b> with ethyl acrylate in the presence of palladium catalyst at elevated temperature followed by hydrogenation of the intermediate ethyl cinnamate and saponification with LiOH provided compound <b>16</b>. Subjection of carboxylic acids <b>5</b> and <b>16</b> to substituted amines and HATU with base or EDC with DMAP led directly to amide analogues <b>24</b>–<b>25</b> and <b>27</b>. Amide analogues possessing an ester moiety were saponified with LiOH to give derivatives containing a terminal carboxylic acid (compounds <b>23</b>, <b>26</b>, and <b>32</b>–<b>35</b>). Reduction of <b>16</b> with BH<sub>3</sub>-THF provided alcohol <b>16a</b>, which was converted to compound <b>19</b> upon bromination then reaction with Na<sub>2</sub>SO<sub>3</sub>. Mesylate <b>16b</b>, derived from <b>16a</b> using standard conditions, was reacted with NaCN then subjected to acidic hydrolysis to give carboxylic acid <b>17</b>. In a similar fashion, the corresponding phosphonic acid <b>22</b> was also prepared from <b>16b</b> upon conversion to a phosphonate ester followed by deprotection.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl acrylate, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> Et<sub>3</sub>N, DMF, 120 °C; (b) H<sub>2</sub>, 10% Pd/C, EtOH; (c) LiOH, THF, MeOH, H<sub>2</sub>O; (d) RNH<sub>2</sub>, HATU, DIPEA, DCM or EDC, DMAP, DCM; (e) BH<sub>3</sub>-THF, THF; (f) PPh<sub>3</sub>, CBr<sub>4</sub>, THF; (g) Na<sub>2</sub>SO<sub>3</sub>, EtOH, H<sub>2</sub>O, Δ; (h) MsCl, Et<sub>3</sub>N, DCM; (i) NaCN, DMSO, 60 °C; (j) 37% aq HCl, 100 °C; (k) HP(O)(OEt)<sub>2</sub>, NaH, THF; (l) TMSBr, DCM.</p></p></figure><div class="NLM_p">Additional amide and amine-linked analogues containing acidic functionalities were readily prepared from benzylamine intermediate <b>8</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>28</b> was prepared from <b>8</b> upon exposure to methyl chlorooxoacetate and Et<sub>3</sub>N followed by saponification of the methyl ester. Acylation of <b>8</b> with haloalkyl acid chlorides in the presence of base led to intermediate <b>8b</b>, which was subsequently treated with Na<sub>2</sub>SO<sub>3</sub> at elevated temperature to give sulfonic acid analogues <b>29</b>–<b>30</b>. Phosphonic acid analogue <b>31</b> was synthesized in a similar fashion using P(OEt)<sub>3</sub> as nucleophile followed by deprotection with TMSBr. Intermediate <b>8b</b> was also treated with KI and a substituted amine to give, following base-catalyzed saponification, dicarboxylic acid analogue <b>36</b>. Amine-linked analogues containing one (<b>47</b>) or two (<b>54</b>) terminal sulfonic acid moieties were generated upon heating in the presence of bromoethylsulfonic acid sodium salt, and similarly, the corresponding analogues containing one (<b>48</b>) or two (<b>55</b>) phosphonic acids were synthesized following condensation with formaldehyde in the presence of diethyl phosphate, then TMSBr-catalyzed deprotection.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ROCOCOCl, Et<sub>3</sub>N, DCM; (b) LiOH, THF, H<sub>2</sub>O; (c) Cl(CH<sub>2</sub>)<sub><i>x</i></sub>COCl, pyridine, DCM; (d) Na<sub>2</sub>SO<sub>3</sub>, EtOH, H<sub>2</sub>O; (e) P(OEt)<sub>3</sub>, 135 °C; (f) TMSBr, DCM; (g) R<sup>1</sup>NH<sub>2</sub>, KI, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (h) Na<sup>+–</sup>O<sub>3</sub>SCH<sub>2</sub>CH<sub>2</sub>Br, DMF, 70 °C; (i) paraformaldehyde, HP(O)(OEt)<sub>2</sub>, THF or toluene, 70 °C.</p></p></figure><div class="NLM_p">Reductive amination of aldehyde <b>7</b> using several substituted aminocarboxylic and aminophosphonic acid starting materials under standard reaction conditions followed by deprotection (LiOH, HCl, or TMSBr as appropriate) provided compounds <b>37</b>–<b>46</b>, <b>49</b>–<b>51</b>, and <b>56</b> in a highly efficient manner (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Mannich reaction of <b>7</b> with diethyl malonate in the presence of piperidine followed by base-catalyzed Michael addition of diethyl malonate then acidic hydrolysis led to the formation of compound <b>52</b>. Condensation of <b>7</b> with tetraethyl methanediylbis(phosphonate) in the presence of NaH followed by Pd<sup>0</sup>-catalyzed olefin hydrogenation then deprotection provided compound <b>21</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RNH<sub>2</sub>, NaHB(OAc)<sub>3</sub>, AcOH, DCE; (b) LiOH, THF, MeOH, H<sub>2</sub>O; (c) 4 N HCl, 1,4-dioxane; (d) TMSBr, DCM; (e) piperidine, diethylmalonate, toluene, 100 °C; (f) diethyl malonate, NaOEt, EtOH; (g) 37% HCl, Δ; (h) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>P(O)(OEt)<sub>2</sub>, NaH, THF; (i) H<sub>2</sub>, 10% Pd/C, EtOH.</p></p></figure><div class="NLM_p">Two-step conversion of methyl ester intermediate <b>4</b> to bromomethyl moiety (<b>4a</b>) was achieved upon reduction with DiBAL-H to the alcohol followed by conversion to the bromide upon addition to a premixed solution of PPh<sub>3</sub>, Br<sub>2</sub>, and imidazole at 0 °C (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Importantly, use of low temperature was critical for minimizing degradation of the sensitive benzyl bromide. Bromide <b>4a</b> was aminated upon heating in the presence of diethyl iminodiacetate then saponified to give compound <b>53</b>. Compounds <b>18</b> and <b>20</b> were readily synthesized from <b>4a</b> upon exposure to Na<sub>2</sub>SO<sub>3</sub> and P(OEt)<sub>3</sub>, respectively, with deprotection of the phosphonate ester being achieved via acidic hydrolysis.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DiBAL-H, toluene; (b) PPh<sub>3</sub>, Br<sub>2</sub>, imidazole, DCM, 0 °C; (c) diethyl iminodiacetate, CH<sub>3</sub>CN, 65 °C; (d) LiOH, THF, H<sub>2</sub>O; (e) Na<sub>2</sub>SO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O; (f) P(OEt)<sub>3</sub>, toluene; (g) 6 N HCl, EtOH, Δ.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were initially evaluated in a series of assays beginning with a <sup>3</sup>H-taurocholate uptake assay in HEK293 cells expressing human ASBT. In general, compounds showing potencies comparable to or better than <b>1</b> were evaluated for cellular permeability using a MDR1-MDCK assay. Compounds with low to medium permeability (<i>P</i><sub>app</sub> < 15 nm/s) were subsequently evaluated in vivo in fed male SD rats for determination of maximum portal vein and systemic blood parent drug concentrations (<i>C</i><sub>max</sub>) following a single oral dose at 10 mg/kg. The data from profiling of potential ASBT inhibitors in these assays are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Consistent with previous data, <b>1</b> was a modestly potent ASBT inhibitor with good cellular permeability but showed unexpectedly low portal vein drug levels (<i>C</i><sub>max</sub> = 100 ng/mL) in vivo, which may be due to extensive intestinal and hepatic first pass metabolism (unpublished data). These results and other unpublished data led us to initiate a lead optimization effort to identify a nonabsorbable derivative of <b>1</b> with improved ASBT potency, decreased cellular permeability, improved metabolic stability in the gastrointestinal tract, and low (<50 ng/mL) portal vein parent drug levels when dosed orally at 10 mg/kg.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. C(8) Oxygen-Linked and Carbon-Linked ASBT Inhibitor Potency and Rat Portal Vein Drug Concentrations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">hASBT IC<sub>50</sub>(nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MDCK <i>P</i><sub>app</sub>(nm/s)</th><th class="colsep0 rowsep0" align="center">portal <i>C</i><sub>max</sub>(ng/mL)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">systemic <i>C</i><sub>max</sub>(ng/mL)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">180 ± 55</td><td class="colsep0 rowsep0" align="center">107</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 5</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">1458</td><td class="colsep0 rowsep0" align="center">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>C(CH<sub>2</sub>)<sub>3</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 1</td><td class="colsep0 rowsep0" align="center">303</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">4 ± 3</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">220</td><td class="colsep0 rowsep0" align="center">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>3</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 25</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">289</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">900 ± 150</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>P(CH<sub>2</sub>)CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 28</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>P(CH<sub>2</sub>)<sub>3</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">133 ± 60</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">260</td><td class="colsep0 rowsep0" align="center">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">17 ± 19</td><td class="colsep0 rowsep0" align="center">383</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>C(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">2 ± 2</td><td class="colsep0 rowsep0" align="center">342</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S–</td><td class="colsep0 rowsep0" align="char" char="±">4 ± 1</td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">170</td><td class="colsep0 rowsep0" align="center">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">4 ± 1</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>P–</td><td class="colsep0 rowsep0" align="char" char="±">23 ± 1</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 4</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>P(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 14</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are expressed as the mean ± standard error of ≥2 replicates.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">dosed via oral gavage at 10 mg/kg.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">NT or – means not tested.</p></div></div></div><div class="NLM_p">We initiated our optimization efforts by exploring the SAR of the 5-aryl and 7,8-dimethoxy moieties, however, our focus quickly shifted to modifications of the 7- and 8-methoxy substituents because highly potent compounds with low cellular permeability were rapidly identified. While a full description of the SAR of the 7 and 8-dimethoxy substituents is beyond the scope of this article, data with analogues containing structural modifications of the 8 position clearly revealed that this position was more tolerant of structural modifications and led to compounds with superior ASBT inhibitory activity. Numerous 8-substituted derivatives of <b>1</b> were synthesized containing a range of functional groups to explore whether basicity, acidity, lipophilicity, ionization state, and conformational rigidity impacted ASBT potency and cellular permeability. However, compounds with acidic moieties consistently showed potent ASBT inhibition and, in general, low to moderate cellular permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Substitution of the 8-methoxy carbon with a carboxylic acid (<b>9</b>) led to a 6-fold improvement in ASBT inhibition potency and low cellular permeability. Further evaluation of <b>9</b> in a rat portal vein study revealed the compound to be highly absorbed into the portal vein as parent or the corresponding glucuronide with drug levels surpassing 1 μM. Insertion of two additional methylene groups between the acid and methoxy carbon as in <b>10</b> led to further improvement in potency, however, the additional lipophilicity led to a significant increase in cellular permeability in the MDCK assay. Analogues containing more acidic sulfonic and phosphonic acid moieties were targeted because these modifications would lead to a higher percentage of sulfonate or phosphonate anion in the intestine, which would be predicted to decrease passive cellular permeability. While the direct phosphonic acid analogue (<b>13</b>) of <b>9</b> showed significantly reduced ASBT potency, analogues with extended alkyl chains containing terminal sulfonic or phosphonic acids (compounds <b>11</b>–<b>12</b>, <b>14</b>–<b>15</b>) showed improved ASBT potency and decreased cellular permeability relative to <b>1</b> but did not show significantly reduced portal vein drug concentrations. Overall, while improved potencies were observed with several analogues, almost all of the analogues were highly absorbed from the GI tract into the portal vein.</div><div class="NLM_p">Early in the course of our optimization effort, data emerged from exploratory intestinal stability studies with several C8 oxygen-linked compounds showing the presence of the corresponding 8-phenol (compound <b>2</b>) as a metabolite. As a result, the optimization effort shifted focus to evaluation of terminal acid analogues containing a methylene instead of the 8-oxygen. With carboxylic acid analogues, this modification led to a 2–6-fold improvement in ASBT potency (compounds <b>16</b> vs <b>9</b> and <b>17</b> vs <b>10</b>) but did not decrease cellular permeability. In contrast, two sulfonic acid analogues (<b>18</b>, <b>19</b>) were highly potent and showed low permeability, however, portal vein drug levels for <b>18</b> were higher than the targeted threshold of 50 ng/mL. Structurally similar phosphonic acid compounds (<b>20</b>, <b>21</b>, <b>22</b>) showed equivalent or better ASBT potency and cellular penetration as compared to the oxygen-containing analogues (<b>21</b> vs <b>13</b>, <b>22</b> vs <b>14</b>), and of these, compound <b>20</b> showed low oral absorption (portal <i>C</i><sub>max</sub> = 14 ng/mL) when tested in a rat portal vein study. Of all of the 8-oxygen and carbon analogues, compound <b>20</b> had the best overall profile and was selected for further evaluation in more advanced in vitro and in vivo assays (vide infra).</div><div class="NLM_p">Compounds containing a lipophilic linker between the aryl ring and a terminal acid moiety were highly potent ASBT inhibitors with highly variable cellular permeability; however, portal vein drug levels for the majority of these derivatives were higher than the targeted threshold. Our strategy for maintaining potency while decreasing cellular permeability was to conserve the terminal acid group but incorporate more polar atoms within the 8-linker region. Toward this end, a limited number of compounds containing terminal carboxylic, sulfonic, and phosphonic acids with benzamide, benzylamide, and propanamide linkers were synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). ASBT potency was above 100 nM for compounds containing propanamide (<b>26</b>, <b>27</b>) or benylamide (<b>30</b>, <b>31</b>) linkers. In contrast, compounds with a decreased overall linker length such as benzamides (<b>23</b>–<b>25</b>) and benzylamides (<b>28</b>, <b>29</b>) were highly potent ASBT inhibitors with low to moderate cellular permeability. Unfortunately, exemplars (<b>24</b>, <b>25</b>, <b>28</b>, <b>29</b>) with good ASBT potency and low cellular permeability showed high oral absorption in the rat portal vein assay. In an attempt to decrease portal vein drug levels, a small set of amide analogues (<b>32</b>–<b>36</b>) with more polar dicarboxylic acids were evaluated, however, the majority were very weak ASBT inhibitors, leading us to abandon this approach.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. C(8) Carbon-Linked ASBT Inhibitor Potency, Permeability, And Rat Portal Vein Drug Concentrations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0012.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">hASBT IC<sub>50</sub>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MDCK <i>P</i><sub>app</sub> (nm/s)</th><th class="colsep0 rowsep0" align="center">portal <i>C</i><sub>max</sub>(ng/mL)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">systemic <i>C</i><sub>max</sub>(ng/mL)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CC(Me)<sub>2</sub>CH<sub>2</sub>NHCO–</td><td class="colsep0 rowsep0" align="center">32 ± 21</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>SCH<sub>2</sub>NHCO–</td><td class="colsep0 rowsep0" align="center">11 ± 1</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">92</td><td class="colsep0 rowsep0" align="center">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>NHCO-</td><td class="colsep0 rowsep0" align="center">2 ± 1</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">132</td><td class="colsep0 rowsep0" align="center">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">276 ± 39</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>SCH<sub>2</sub>NHCO(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">167 ± 25</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">6 ± 1</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">87</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>SCH<sub>2</sub>CONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">9 ± 1</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">122</td><td class="colsep0 rowsep0" align="center">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>CONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">128 ± 102</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub>CONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">249 ± 29</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>NCO–</td><td class="colsep0 rowsep0" align="center">2540</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CHNHCO–</td><td class="colsep0 rowsep0" align="center">97 ± 61</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CHNHCO(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>NCO(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">728 ± 44</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CHNHCH<sub>2</sub>CONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>C(CH<sub>2</sub>)<sub>3</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">1287</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>C(CH<sub>2</sub>)<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">367 ± 25</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CC(Me)<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">190 ± 8</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Pro-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">d</span>)-<i>N</i>-Pro-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">751</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-α-<i>N</i>-Lys-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">1458</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Thr-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">425 ± 248</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Ser-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">59 ± 34</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">4 ± 1</td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>N(Me)CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">41 ± 33</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">224</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">54 ± 6</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>P(CH<sub>2</sub>)<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">2698 ± 2225</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">d</span>)-<i>N</i>-Asp-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">55 ± 11</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Asp-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">47 ± 6</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CH–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">333</td><td class="colsep0 rowsep0" align="center">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>NCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">245 ± 21</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">56</td><td class="colsep0 rowsep0" align="center">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>3</sub>SCH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">365 ± 79</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">(H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub>)<sub>2</sub>NCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">>3000</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CHNHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">42 ± 3</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are expressed as the mean ± standard error of ≥2 replicates.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Dosed via oral gavage at 10 mg/kg.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">NT or – means not tested.</p></div></div></div><div class="NLM_p">The cumulative data suggested the distance between the terminal acidic functionality and the aryl ring was critical for potent inhibition of ASBT, as compounds with a total of 6 or more contiguous atoms (<b>26</b>, <b>27</b>, <b>34</b>–<b>36</b>) at the 8 position led to weak inhibition of ASBT whereas compounds with 4 or 5 (for example compounds <b>24</b>, <b>28</b>, <b>33</b>) contiguous atoms were potent ASBT inhibitors. Recognizing this general trend, our strategy shifted toward synthesis and evaluation of several substituted amino acid-derived analogues containing 4–5 contiguous atoms with an amine as one of these atoms. Our rationale for insertion of an amine was to explore whether this basic atom would impact ASBT activity and, more importantly, decrease cellular permeability and oral absorption (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>38</b>–<b>49</b>). β-Aminoglycine (<b>38</b>) and α-aminoisobutyryl derivatives (<b>39</b>) showed moderate to weak inhibition of ASBT while proline-derived analogues with reduced conformational flexibility (<b>40</b>, <b>41</b>) were very weakly active. Consistent with SAR from our initial exploratory studies, substitution with a basic lysine (<b>42</b>) led to very weak ASBT inhibition whereas neutral threonine (<b>43</b>) and serine (<b>44</b>) analogues were active, with the latter being a potent ASBT inhibitor with low cellular permeability and portal vein drug levels. Removal of the α-amino acid side chain to give a glycine analogue (<b>45</b>) resulted in a highly potent analogue with very low portal vein and systemic drug levels despite showing moderate permeability in the MDCK assay. Not surprisingly, we did not observe a linear correlation between the in vitro MDCK permeability and in vivo portal vein drug level assays. While the MDCK assay did effectively identify compounds with moderate to high cellular permeability, data from the in vivo assay was viewed as more physiologically relevant for making decisions about compound progression. <i>N</i>-Methylation of <b>45</b> to give compound <b>46</b> led to a potent ASBT inhibitor, however, portal vein drug levels increased substantially despite low cellular permeability in the MDCK assay. A β-aminosulfonic acid analogue (<b>47</b>) showed potent ASBT inhibitory activity as well as low cellular permeability and oral absorption, whereas structurally related α and β-aminophosphonic acid derivatives (<b>48</b>, <b>49</b>) were significantly less potent than the corresponding sulfonic acid analogue (<b>47</b>), a trend that was also observed with amide-linked analogues <b>29</b> versus <b>31</b>. Two diastereomeric aspartic acid-derived analogues (<b>50</b>, <b>51</b>) potently inhibited ASBT and showed low cellular permeability, however, only the <span class="smallcaps smallerCapital">d</span>-diastereomer showed low oral absorption when tested in vivo. The data with diacids <b>50</b> and <b>51</b> prompted us to explore other diacid-containing analogues <b>52</b>–<b>56</b>. Not surprisingly, diacid <b>52</b> lacking an amine did not inhibit ASBT. The addition of an acetic acid moiety to glycine analogue <b>45</b> to give aminodicarboxylic acid <b>53</b> resulted in a weakly potent ASBT inhibitor. Similar data was also observed with a structurally related aminodisulfonic analogue (<b>54</b>), whereas the respective aminodiphosphonic analogue (<b>55</b>) was inactive. Speculating that the weak activities were due to the presence of a tertiary amine (see <b>46</b>), a methylene was inserted adjacent to the amine to give compound <b>56</b>, resulting in potent inhibition of ASBT and very low oral absorption in vivo in the rat. Of all the analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compounds <b>44</b>, <b>45</b>, <b>47</b>, <b>50</b>, and <b>56</b>, along with compound <b>20</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, met our key criteria of potent ASBT inhibitory activity and low oral absorption in vivo to warrant further evaluation as potential development compounds.</div><div class="NLM_p">Prior to evaluation in a rodent model of type 2 diabetes, the lead compounds were evaluated for mouse and rat ASBT activity, stability in the gastrointestinal tract as measured by GI-tract luminal contents and fecal parent drug recovery assays, and efficacy in a mouse fecal bile acid excretion assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compound <b>1</b> more potently inhibited mouse and rat versus human ASBT but was unstable when tested in the rat fecal drug recovery and intestinal contents stability assays. Despite this instability, <b>1</b> did increase fecal bile acid excretion in mice with an ED<sub>50</sub> of 0.13 mg/kg, which can be attributed to extensive first pass metabolism generating active metabolites that undergo enterohepatic recirculation. Compound <b>20</b> potently inhibited mouse and rat ASBT and was very stable in the GI luminal contents and fecal parent drug recovery assays. Consistent with blocking bile acid reuptake in the ileum, <b>20</b> increased fecal bile acid excretion in mice with an EC<sub>50</sub> of 0.12 mg/kg. In contrast, compound <b>44</b> was relatively unstable in the GI tract, with only 63% of parent drug being recovered in the fecal recovery assay. While potent in the mouse fecal bile acid excretion assay, this reduced intestinal stability led to an approximately 50% reduction in total amount of excreted fecal bile acids as compared to <b>20</b> and <b>1</b>. Compound <b>45</b> potently inhibited mouse and rat ASBT and showed excellent stability in the rat GI luminal contents stability and fecal parent drug recovery assays. When tested in mice, <b>45</b> potently (ED<sub>50</sub> = 0.012 mg/kg) increased fecal bile acid excretion and showed equal or greater percent maximum efficacy as compared to <b>20</b> and <b>1</b>. Despite good mouse and rat ASBT potency and GI stability, compound <b>47</b> was significantly less potent in the mouse fecal bile acid excretion assay as compared to compounds <b>20</b> and <b>45</b>. While rodent ASBT activity and stability data in the GI luminal contents assay were not collected with compound <b>50</b>, significantly weaker mouse fecal bile excretion activity prompted us to abandon this compound as well as compound <b>47</b>. The dicarboxylic acid derivative <b>56</b> showed potent mouse and rat ASBT activity and was stable in the in vitro and in vivo GI stability assays. Moreover, <b>56</b> potently increased fecal bile acid excretion in mice with activity comparable to compounds <b>20</b> and <b>45</b>. Overall, these data indicated that compounds <b>20</b>, <b>45</b>, and <b>56</b> were stable in the rodent GI tract and potently induced fecal bile acid excretion in vivo in mice, leading us to select these three compounds for mechanistic and efficacy studies in vivo in lean rats and Zucker Diabetic Fatty (ZDF) rats, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Nonabsorbable ASBT Inhibitors in Rodent ASBT Inhibition, Intestinal Stability, and Fecal Bile Acid Excretion Assays</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0013.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">mouse/rat ASBT IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">rat fecal drug recovery (%)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rat intestinal contents stability (h)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">mFBA excretion ED<sub>50</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">3/22</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center">h<a class="ref internalNav" href="#tbl3-fn1" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.13 (100)<a class="ref internalNav" href="#t3fn5" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>O<sub>3</sub>PCH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">0.5/0.9</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="center">>12</td><td class="colsep0 rowsep0" align="center">0.12 (92)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Ser-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t3fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">0.012 (47)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">HO<sub>2</sub>CCH<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">0.3/0.2</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="center">>12</td><td class="colsep0 rowsep0" align="center">0.017 (98)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">HO<sub>3</sub>S(CH<sub>2</sub>)<sub>2</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">0.9/2.3</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">>12</td><td class="colsep0 rowsep0" align="center">2.7 (73)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">(<span class="smallcaps smallerCapital">d</span>)-<i>N</i>-Asp-CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">>1 (70)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">(HO<sub>2</sub>CCH<sub>2</sub>)<sub>2</sub>CHNHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="center">2.1/1.9</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="center">>12</td><td class="colsep0 rowsep0" align="center">0.022 (94)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are in nM and are expressed as the mean of ≥2 replicates (variation <25%).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Percentage of parent compound in rat feces following a 10 mg/kg oral dose.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Data are expressed as <i>t</i><sub>1/2</sub> of parent compound.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Mouse fecal bile acid excretion (mFBA) data are in mg/kg, numbers in parentheses are relative efficacy versus compound <b>1</b>.</p></div><div class="footnote" id="tbl3-fn1"><sup>e</sup><p class="last">The corresponding phenol metabolite (R = OH) was detected at increasing concentrations at 2, 4, and 24 h.</p></div><div class="footnote" id="t3fn5"><sup>f</sup><p class="last">Active metabolites of compound <b>1</b> undergo enterohepatic recirculation in mice.</p></div><div class="footnote" id="t3fn6"><sup>g</sup><p class="last">NT means not tested.</p></div></div></div><div class="NLM_p">Prior to in vivo efficacy studies, compound <b>20</b> was selected as an exemplar of a potent, selective, nonabsorbable ASBT inhibitor for proof of mechanism studies to test our hypothesis that inhibition of bile acid reuptake in the distal small intestine would increase portal vein concentrations of GLP-1 and PYY. Oral dosing of <b>20</b> at 10 mg/kg to portal vein cannulated lean SD rats was followed by sampling of portal vein blood for bile acids, total GLP-1, PYY, and GIP concentrations at specified time points. As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, inhibition of ASBT led to a decrease in portal vein concentration of bile acids from 1 to 2 h postdosing relative to vehicle treated animals. Interestingly, this time frame is consistent with published transit times of small molecules through the small intestine in rats.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In contrast to portal vein bile acid concentrations, portal vein total GLP-1 and PYY concentrations increased with ASBT inhibitor-treated animals from 3 to 8 h postdosing whereas the concentrations of a separate upper GI-secreted peptide, GIP, did not change relative to vehicle treated animals. Agonists of the G-protein coupled receptor TGR5 have been linked to GLP-1 secretion,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> which could be an alternative mechanism for increasing portal vein GLP-1 concentrations. However, 52 exemplars from the 1,4-benzothiazepine series did not show activity when tested in a TGR5 assay up to 10 μM, suggesting that direct TGR5 activation is not the primary mechanism of action for this chemical series of ASBT inhibitors. These data are consistent with our hypothesis that inhibition of ASBT with a nonabsorbable compound could stimulate GLP-1 and PYY secretion from the distal intestines.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of compound <b>20</b> on portal vein plasma bile acids (BA), total GLP-1 (tGLP-1), PYY, and GIP. Compound <b>20</b> (○, 1 mg/kg) or vehicle (●) was administered orally in portal vein cannulated male SD rats at 0800 (time 0) without fasting. Portal vein blood samples were collected at indicated time points up to 8 h. Plasma BA, tGLP-1, PYY, and GIP were measured as described in methods. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by the results from the proof of mechanism studies, we next set out to compare the effects of compounds <b>20</b>, <b>45</b>, and <b>56</b> on fecal bile acid secretion and glucose homeostasis in the Zucker Diabetic Fatty (ZDF) rat, an established preclinical animal model of type 2 diabetes. Treatment of 8-week-old male ZDF rats with the three compounds at the indicated doses twice daily for 14 days and determination of fecal bile acid concentration over the last 24 h of the dosing period provided the data that is summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. As expected, all three compounds stimulated bile acid excretion to a maximum of ∼7–10 fold, however, in general, compounds <b>45</b> and <b>56</b> showed a higher fold increase in fecal bile acid secretion at the lowest dose (0.05 mg/kg) as compared to <b>20</b>, a trend that was also observed at the next three higher doses (0.10, 0.50, 1.0 mg/kg). The effects of the three compounds on glucose homeostasis in ZDF rats were determined in two separate in vivo studies in which each compound was given orally at doses ranging from 0.05 to 10 mg/kg (compounds <b>20</b> and <b>45</b>) or 0.001 to 10 mg/kg (compound <b>56</b>) twice daily for 14 days. Plasma glucose, hemoglobin A1c (HbA1c), insulin, and total GLP-1 concentrations were determined at the end of the study (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Treatment with the three nonabsorbable ASBT inhibitors led to a 1.30–1.64% reduction in HbA1c, a greater than 50% reduction in nonfasted plasma glucose to below 200 mg/dL, and statistically significant higher plasma insulin, and, importantly, greater total GLP-1 relative to vehicle treated animals. While all three compounds showed a significant improvement in glucose homeostasis, maximum efficacy was comparable with each compound at identical doses which did not permit the identification of a clearly superior compound.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of ASBT inhibitors at the indicated doses on fecal bile acid concentrations in ZDF rats. Male ZDF rats were treated orally twice a day with vehicle, compound <b>20</b> (open bar), compound <b>56</b> (gray bar), or compound <b>45</b> (black bar) for two weeks. Twenty-four h fecal samples were collected on day 14 and extracted for fecal bile acid (BA) measurement. Data are presented as relative fold change from vehicle groups (dashed line). All treatment groups were statistically different from vehicle groups (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of ASBT inhibitors on blood HbA1c, plasma glucose, insulin, and total GLP-1 in 8-week-old male ZDF rats. Rats were treated orally twice a day with compound <b>20</b> (○), <b>45</b> (▲), or <b>56</b> (△) at the indicated doses for two weeks in two separate studies. Blood samples were collected on day 14 from tail vein. Blood HbA1c, plasma glucose, insulin, and total GLP-1 were measured as described in methods. *<i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cumulative data with compounds <b>20</b>, <b>45</b>, and <b>56</b> suggested that each compound was a viable clinical candidate; however, data from preclinical development assays would be required for selection of a development candidate. The three compounds were tested in a battery of preclinical development assays including equilibrium aqueous solubility, in vitro biotransformation, general selectivity, salt selection, crystallinity, stability, hygroscopicity, and reactive metabolite assays. All three compounds showed acceptable aqueous solubility (≥200 μg/mL) and were highly selective when screened against a broad panel of unrelated targets. However, a reactive metabolite was observed with compound <b>20</b> when tested in a glutathione trapping assay and a crystalline salt derivative of <b>45</b> proved to be thermally unstable and extremely hygroscopic, properties that would slow or possibly preclude further development of these two compounds. In contrast, the zwitterionic, nonhygroscopic, crystalline salt form of <b>56</b> showed good aqueous solubility at pH 7.4 (>7 mg/mL), excellent thermal stability, and did not generate reactive or human-specific metabolite, characteristics that suggested <b>56</b> was a superior development compound versus <b>20</b> and <b>45</b>.</div><div class="NLM_p last">In preparation for safety assessment studies, compound <b>56</b> was profiled in rat, dog, and monkey PK studies to determine if low oral absorption translated across multiple preclinical species. Consistent with our previous data, oral dosing of a solution of <b>56</b> at 10 mg/kg to fed SD rats did not lead to any detectable (LLQ = 1 ng/mL) levels of parent compound in the systemic circulation. Similarly, very low systemic levels (<i>C</i><sub>max</sub> = 6 ng/mL) of <b>56</b> were observed following oral dosing to male beagle dogs at 10 mg/kg, and importantly, <b>56</b> could not be detected in the systemic circulation following oral dosing of cynomolgous monkeys at a very high oral dose (3 mg/kg). The data from these PK studies suggested that <b>56</b> would show very low or no oral absorption in humans at pharmacologically relevant oral doses.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, numerous analogues were designed to probe the effects of molecular size, polarity, lipophilicity, and ionization state on ASBT inhibition, cellular permeability, and oral absorption. Compounds containing acidic moieties at C8 of the 1,1-dioxido-1,4-benzothiazepine core structure emerged as highly potent ASBT inhibitors but showed highly variable cellular permeability and oral absorption, the latter being determined by measuring portal vein parent drug concentrations after oral dosing. Three lead compounds (<b>20</b>, <b>45</b>, <b>56</b>) were identified from this optimization effort which displayed potent ASBT inhibition and very low oral absorption in rats as well as robust efficacy in an animal model of type 2 diabetes. Further characterization of the three compounds in developability assays culminated in the identification of compound <b>56</b> as a highly potent, nonabsorbable ASBT inhibitor with excellent aqueous solubility, selectivity, and developability properties for evaluation in safety studies and ultimately humans. Compound <b>56</b> will be a valuable clinical tool for exploring the therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Protocols</h3><div class="NLM_p">All chemical reagents were purchased and used as received. <sup>1</sup>H NMR spectra were recorded on a Varian Unity-300 or Varian Unity Plus-400. Chemical shifts are expressed in parts per million (ppm, δ units). Coupling constants are in units of hertz (Hz). Splitting patterns describe apparent multiplicities and are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br (broad).</div><div class="NLM_p">Unless otherwise noted, the LCMS system used to determine purity was a UPLC analysis was conducted on a Waters Acquity system with BEH C18, 2 mm × 50 mm, 1.7 μm column at 40 °C 95% H<sub>2</sub>O, 5% MeCN to 99% MeCN in 1.1 min, holding at 100% MeCN for 40 s. Water contained 0.2% v/v formic acid. MeCN contained 0.15% v/v formic acid. The flow rate was 1 mL/min with 5 μL of solution injected. Mass spectra were recorded utilizing electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI) switching between positive and negative modes with DAD scanning from 210 to 350 nm. All compounds tested were of ≥95% purity.</div><div class="NLM_p">Normal phase chromatography was accomplished using Teledyne Isco equipment using prepacked silica columns.</div><div class="NLM_p last">Reverse phase HPLC for purification of final compounds was accomplished on a Gilson 845Z series prep HPLC system using a C18 Sunfire 30 mm × 50 mm or 30 mm × 150 mm, 5 μm column using the gradient described with 0.05% TFA in H<sub>2</sub>O. The flow rate was 60 or 45 mL/min and the product was collected based on UV detection at 220 or 254 nm. In some cases, basic conditions were established using the same Gilson system and a C18 XBridge 30 mm × 50 mm or 30 mm × 150 mm, 5 μm column using the gradient described with 0.2% NH<sub>4</sub>OH in the H<sub>2</sub>O. The flow rate was 60 or 45 mL/min and again the product was collected on UV detection at 220 or 254 nm.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> HRMS</h3><div class="NLM_p last">High resolution LC-MS (top) and MS-MS spectra. Spectra were acquired on a Waters qTOF Premiere mass spectrometer operating in W mode (resolving power ∼15000). A sample volume of 0.2 μL was introduced by flow injection from a Waters nanoAcquity UPLC. Mobile phase A: H<sub>2</sub>O + 0.1% formic acid. Mobile phase B: MeOH + 0.1% formic acid. Wash: 50:50 H<sub>2</sub>O:MeOH + 0.1% formic acid. Flow: 0.02 mL/min, 40% A, 60% B. Lock mass: 0.7 mg leucine enkephalin in 500 mL MeOH. Collision gas: argon.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-ol-1,1-dioxide (<b>2</b>)</h3><div class="NLM_p last">A solution of <b>1</b> (200 g, 479 mmol) (see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>) in DCE (1 L) was saturated with gaseous HCl then treated with AlCl<sub>3</sub> (200 g, 1.5 mol) in one portion. The reaction mixture was stirred while slowly cooling to 25 °C then stirred for 2.5 h. The reaction mixture was added to an ice–H<sub>2</sub>O mixture with vigorous stirring. The biphasic mixture was treated with 1 N HCl (∼200 mL) then the phases were separated after stirring for 30 min. The organic phase was isolated, washed twice with dilute HCl (1.5 L H<sub>2</sub>O/∼200 mL 1 N HCl), dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give a regioisomeric mix of 7-OH and 8-OH products (185 g, 458 mmol, 96% yield) as a white foam. <sup>1</sup>H NMR indicated a 47:53 mix of 7/8-phenols, respectively. The regioisomers were separated by chiral chromatography [stationary phase (CSP)-cellulose tris(3,5-dichlorophenylcarbamate) polymer immobilized on silica (CHIRALPAK IC), DCM and 2-propanol (98/2 v/v) as mobile phase] to give 72.5 g of <b>2</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.1 Hz, 3 H), 0.79 (t, <i>J</i> = 7.5 Hz, 3 H), 0.95–1.28 (m, 4 H), 1.31–1.53 (m, 2 H), 1.64–1.76 (m, 1 H), 1.98–2.10 (m, 1 H), 2.43 (d, <i>J</i> = 9.8 Hz, 1 H), 3.06 (d, <i>J</i> = 14.8 Hz, 1 H), 3.42 (s, 3 H), 3.49 (d, <i>J</i> = 14.8 Hz, 1 H), 5.85 (d, <i>J</i> = 9.8 Hz, 1 H), 6.04 (s, 1 H), 7.24–7.35 (m, 1 H), 7.35–7.48 (m, 5 H), 9.72 (s, 1 H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl trifluoromethanesulfonate (<b>3</b>)</h3><div class="NLM_p last">To a DCM solution of <b>2</b> (105 g, 26 mmol) and pyridine (27.3 mL, 34 mmol) cooled to 0 °C under nitrogen was added Tf<sub>2</sub>O (57.1 mL, 34 mmol) slowly over 30 min while maintaining an internal temperature between 5 and 10 °C. Upon complete addition, the reaction was stirred until TLC and LCMS indicated complete conversion to product. H<sub>2</sub>O (250 mL) was slowly added to the mixture, and the mixture stirred for 10 min, after which the layers separated. The aqueous layer was extracted an additional time with DCM, and the combined organics washed with 10% HCl and brine, then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to half volume. Hexanes was added until the solution became turbid, and crystallization began to occur. The solids were then filtered from the solution to give <b>3</b> (134.6 g, 95%) as a white solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.76–0.96 (m, 6 H), 1.03–1.40 (m, 4 H), 1.40–1.67 (m, 4 H), 1.77–1.97 (m, 1 H), 2.10–2.28 (m, 1 H), 3.07 (d, <i>J</i> = 14.8 Hz, 1 H), 3.48 (d, <i>J</i> = 14.9 Hz, 1 H), 3.62 (s, 3 H), 6.09 (s, 1 H), 6.34 (s, 1 H), 7.32–7.50 (m, 5 H), 7.96 (s, 1 H). ES-LCMS <i>m</i>/<i>z</i> 536 (M + H)<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Methyl (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine-8-carboxylate 1,1-Dioxide (<b>4</b>)</h3><div class="NLM_p last">To a reaction tube containing <b>3</b> (0.103 g, 0.192 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.011 g, 0.012 mmol), dppf (0.013 g, 0.024 mmol), and NEt<sub>3</sub> (0.040 mL, 0.288 mmol) in DMF (1 mL) was bubbled in carbon monoxide gas for a period of 15 min. Anhydrous MeOH (0.039 mL, 0.962 mmol) was added, and the reaction vessel was sealed under a carbon monoxide atmosphere then heated at 70 °C overnight. The reaction was cooled to room temperature, and the contents diluted with Et<sub>2</sub>O then poured into H<sub>2</sub>O. The layers were separated, the aqueous extracted one additional time with Et<sub>2</sub>O, and the combined organics washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude material was chromatographed on silica gel using hexanes/EtOAc to give <b>4</b> (0.080 g, 91%) as a a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.75–0.96 (m, 6 H), 0.99–1.36 (m, 4 H), 1.36–1.59 (m, 5 H), 1.86 (ddd, <i>J</i> = 14.4, 12.0, 4.4 Hz, 1 H), 2.07–2.23 (m, 1 H), 3.02 (d, <i>J</i> = 14.8 Hz, 1 H), 3.45 (d, <i>J</i> = 14.9 Hz, 1 H), 3.57 (s, 3 H), 3.86 (s, 3 H), 6.08 (s, 1 H), 6.27 (s, 1 H), 7.29–7.48 (m, 5 H), 8.52 (s, 1 H). ES-LCMS <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine-8-carboxylic Acid 1,1-Dioxide (<b>5</b>)</h3><div class="NLM_p last">H<sub>2</sub>O (0.333 mL), MeOH (0.333 mL), and THF (1 mL) were added to <b>4</b> (0.046 g, 0.103 mmol) along with LiOH (0.013 g, 0.310 mmol), and the mixture stirred for 2 h at 25 °C. The reaction mixture was concentrated to half volume, then 6 N HCl was added. The mixture was extracted with EtOAc (2×), washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give <b>5</b> (0.039 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.67–0.99 (m, 6 H), 0.99–1.64 (m, 7 H), 1.87 (t, <i>J</i> = 11.8 Hz, 1 H), 2.08–2.29 (m, 1 H), 3.09 (d, <i>J</i> = 14.8 Hz, 1 H), 3.46 (d, <i>J</i> = 14.9 Hz, 1 H), 3.70 (br s, 3 H), 6.11 (br s, 1 H), 6.33 (br s, 1 H), 7.30–7.60 (m, 5 H), 8.73 (br s, 1 H). ES-LCMS <i>m</i>/<i>z</i> 432 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine-8-carbonitrile-1,1-dioxide (<b>6</b>)</h3><div class="NLM_p last">A mixture of <b>3</b> (0.535 g, 1.0 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.055 g, 0.06 mmol), dppf (0.066 g, 0.12 mmol), zinc powder (0.004 g, 0.06 mmol), and Zn(CN)<sub>2</sub> (0.117 g, 0.99 mmol) in DMF (10 mL) was stirred at 25 °C for 15 min under a stream of nitrogen. The reaction was heated to 80 °C and stirred for 8 h. After the mixture was cooled to 25 °C, DMF was removed in vacuo, Et<sub>2</sub>O was added, and the organics were washed with 2 N NH<sub>4</sub>OH followed by brine. The organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was triturated with hexanes/EtOAc, and a white solid was collected by filtration to give <b>6</b> (0.386 g, 92%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.73–0.97 (m, 6 H), 0.98–1.62 (m, 8 H), 1.77–1.92 (m, 1 H), 2.08–2.24 (m, 1 H), 3.01 (d, <i>J</i> = 14.9 Hz, 1 H), 3.45 (d, <i>J</i> = 14.9 Hz, 1H), 3.62 (s, 3 H), 6.08 (br s, 1 H), 6.26 (s, 1 H), 7.32–7.49 (m, 5 H), 8.28 (s, 1 H). ES-LCMS <i>m</i>/<i>z</i> 413 (M + H)<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine-8-carbaldehyde 1,1-Dioxide (<b>7</b>)</h3><div class="NLM_p last">Compound <b>6</b> (7.42 g, 17.99 mmol) dissolved in DCM (150 mL) was treated with 1 M DIBAL-H in toluene (36.0 mL, 36.0 mmol) at 0 °C with stirring for 1 h after which time LCMS indicated complete conversion. The reaction mixture was poured into an ice/1 N HCl mixture and stirred vigorously for 1 h. The organic phase was isolated, dried over MgSO<sub>4</sub>, filtered, and concentrated to give a yellow solid. The crude product was dissolved in 80 mL hot EtOAc to which was added hexanes (250 mL) until cloudy. The mixture was allowed to cool slowly to ambient temperature and then cooled in an ice bath. The resultant precipitate was filtered off, washed with cold 20% EtOAc/hexanes, and air-dried to give <b>7</b> (4.00 g, 53.5% yield) as a white solid. The mother liquor was concentrated to dryness, and the residue was purified on silica gel eluting with 20–40% EtOAc/hexanes to give additional product as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.74 (t, <i>J</i> = 7.0 Hz, 3 H), 0.81 (t, <i>J</i> = 7.4 Hz, 3 H), 0.96–1.29 (m, 4 H), 1.33–1.54 (m, 2 H), 1.68–1.81 (m, 1 H), 2.01–2.13 (m, 1 H), 2.80 (d, <i>J</i> = 9.8 Hz, 1 H), 3.13 (d, <i>J</i> = 15.0 Hz, 1 H), 3.58 (s, 3 H), 3.63 (d, <i>J</i> = 15.0 Hz, 1 H), 5.98 (d, <i>J</i> = 9.8 Hz, 1 H), 6.27 (s, 1 H), 7.32–7.40 (m, 1 H), 7.40–7.49 (m, 4 H), 8.23 (s, 1 H), 10.27 (s, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 416 [M + H].</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> {[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amine (<b>8</b>)</h3><div class="NLM_p last">A mixture of <b>6</b> (468 mg, 1.13 mmol) and 10% Pd/C (60.4 mg, 0.567 mmol) in EtOH (20 mL) was added 37% aqueous HCl (0.279 mL, 3.40 mmol) and subjected to H<sub>2</sub> atmosphere at 40 psi overnight then filtered. The residue was purified via HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) to give <b>8</b> (621 mg, 79%, TFA salt) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.90 (t, <i>J</i> = 7.2 Hz, 3H), 0.97–1.15 (m, 1H), 1.14–1.38 (m, 3H), 1.44–1.75 (m, 2H), 1.80–1.99 (m, 1H), 2.14–2.38 (m, 1H), 3.29 (d, <i>J</i> = 15.0 Hz, 1H), 3.38–3.48 (m, 1H), 3.55 (s, 3H), 3.98- 4.12 (m, 1H), 4.12–4.27 (m, 1H), 6.17 (s, 1H), 6.27 (s, 1H), 7.31–7.57 (m, 5H), 7.98 (s, 1H), 8.07–8.46 (br s, 2H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 417 (M + H)<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)acetic Acid (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (1.24 g, 3.07 mmol) in DMSO (10 mL) was added methyl bromoacetate (0.319 mL, 3.38 mmol) and potassium carbonate (0.85 g, 6.15 mmol). The reaction mixture was stirred for 2 h at 50 °C. The reaction mixture was diluted with EtOAc, washed twice with water and once with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give the intermediate ester as a clear oil. The material was dissolved in THF (30 mL) and treated with 1 M aqueous LiOH (30.7 mL, 30.7 mmol) at 25 °C for 16 h, at which time LCMS indicated complete conversion to the acid. The reaction mixture was concentrated to remove the THF, washed once with ether, and acidified with 1 N HCl with stirring and cooling in an ice bath until a heavy precipitate formed. The mixture was stirred for 30 min at ice bath temperature, filtered, and the cake washed once with dilute aqueous HCl to give <b>9</b> (1.19 g, 2.58 mmol, 84% yield) as a white solid. The mother liquor was extracted four times with ether and the organics were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated to give an additional batch of <b>9</b> (0.28 g, 0.61 mmol, 16% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.95–1.28 (m, 4H), 1.31–1.53 (m, 2H), 1.65–1.78 (m, 1H), 1.97–2.09 (m, 1H), 2.55 (d, <i>J</i> = 9.46 Hz, 1H), 3.03 (d, <i>J</i> = 15.04 Hz, 1H), 3.44 (s, 3H), 0.76 (m, 6H), 3.53 (d, <i>J</i> = 15.04 Hz, 1H), 4.70 (s, 2H), 5.88 (d, <i>J</i> = 7.95 Hz, 1H), 6.10 (s, 1H), 7.27–7.44 (m, 6H), 13.12 (br s, 1H), exchangeable protons (COOH @ 13.12 and NH @ 2.55) were no longer visible by <sup>1</sup>H NMR upon exposure to D<sub>2</sub>O. LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 460 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 462 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>24</sub>H<sub>31</sub>NO<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 462.1949, found 462.1950.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)butanoic Acid (<b>10</b>)</h3><div class="NLM_p last">Compound <b>2</b> (50 mg, 0.124 mmol) was dissolved in DMSO (0.5 mL) and treated with 1,1-dimethylethyl 4-bromobutanoate (27.6 mg, 0.124 mmol) and K<sub>2</sub>CO<sub>3</sub> (51.4 mg, 0.372 mmol) at 100 °C for 2 h, at which time LCMS indicated complete conversion to the intermediate ester. The reaction mixture was cooled to ambient temperature and then treated with excess water to precipitate the intermediate. The supernatant was decanted off, and the solid residue was washed twice with water and pumped dry to give the ester. The residue was diluted with DCM (1 mL) and treated with 4 N HCl in dioxane (2 mL, 8.00 mmol) at 25 °C for 2 h, after which time LCMS indicated complete conversion. The reaction mixture was concentrated to dryness and purified by RP-HPLC (Sunfire 30 mm × 150 mm, C18, 5 um, Waters column; 10–100% CH<sub>3</sub>CN + 0.05% TFA in H<sub>2</sub>O + 0.05% TFA over 10 min at 50 mL/min) to give <b>10</b> (41 mg, 0.083 mmol, 67% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.67–0.86 (m, 6H), 0.95–1.30 (m, 4H), 1.33–1.56 (m, 2H), 1.64–1.84 (m, 1H), 1.87–1.98 (m, 2H), 1.98–2.16 (m, 1H), 2.36 (t, <i>J</i> = 7.31 Hz, 2 H), 3.04–3.19 (m, 1H), 3.44 (br s, 3H), 3.49–3.63 (m, 1H), 3.96–4.07 (m, 2H), 5.81–6.05 (m, 1H), 6.05–6.21 (m, 1H), 7.22–7.56 (m, 6H), COOH proton not observed. LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 488 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 490 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>26</sub>H<sub>35</sub>NO<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 490.2263, found 490.2263.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)ethanesulfonic Acid (<b>11</b>)</h3><div class="NLM_p last">A solution of <b>2</b> (250 mg, 0.620 mmol) and 1,2-dibromoethane (1.16 g, 6.20 mmol) in THF was treated with 1 M KOH (9.29 mL, 9.29 mmol) and tetrabutylammonium bromide (60 mg, 0.186 mmol) at 100 °C for 16 h in a sealed tube apparatus, after which time LCMS indicated complete conversion to the intermediate bromide. The reaction mixture was partitioned between EtOAc and water, and the organic phase was isolated and dried over MgSO<sub>4</sub>. The mixture was filtered, and the filtrate was concentrated to dryness and pumped dry overnight to give the intermediate as an amber oil. The residue was dissolved in EtOH (6 mL) and added to a solution of sodium sulfite (78 mg, 0.620 mmol) in water (6 mL). The mixture was heated at 100 °C for 16 h with stirring, after which time LCMS indicated complete conversion to the desired sulfonic acid. The reaction mixture was concentrated to dryness and the residue was purified by RP-HPLC (30 mm × 150 mm Sunfire column at 50 mL/min; CH<sub>3</sub>CN and H<sub>2</sub>O + 0.05% TFA solvent system, solvent gradient consisted of 10–100 over 8 min, 100 to 100 to 10 min, sample collection at λ<sub>max</sub>) to give <b>11</b> (210 mg, 0.410 mmol, 66% yield) as a white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75–0.91 (m, 6H), 0.89–1.06 (m, 1H), 1.15–1.39 (m, 3H), 1.48–1.63 (m, 1H), 1.81–2.09 (m, 2H), 2.39–2.59 (m, 1H), 2.96 (td, <i>J</i> = 7.6, 2.0 Hz, 2H), 3.51 (s, 3H), 3.54 (d, <i>J</i> = 15.6 Hz, 1H), 4.01 (d, <i>J</i> = 15.6 Hz, 1H), 4.26 (dd, <i>J</i> = 8.2, 7.0 Hz, 2H), 6.37 (s, 1H), 6.22 (s, 1H), 7.45–7.66 (m, 6H), 2 exchangeable protons not observed. LCMS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 510 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 512 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>24</sub>H<sub>33</sub>NO<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>e</i> 512.1777, found 512.1777.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)propane-1-sulfonic Acid (<b>12</b>)</h3><div class="NLM_p last">Compound <b>2</b> (50 mg, 0.124 mmol) was dissolved in DMSO (0.5 mL) and treated with 3-bromo-1-propanesulfonic acid sodium salt (30.8 mg, 0.136 mmol) and K<sub>2</sub>CO<sub>3</sub> (34.2 mg, 0.248 mmol) at 100 °C for 2 h, after which time LCMS indicated complete conversion. The reaction mixture was diluted with water, acidified with 1 N HCl, and extracted with EtOAc (3×). The organic layers were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give <b>12</b> (22 mg, 0.042 mmol, 34% yield) as a clear glass. The majority of the product, however, remained in the aqueous phase. The aqueous layer was stored overnight in the refrigerator, and the resultant precipitate was filtered off, washed with water, and air-dried to give a second batch <b>12</b> (21 mg, 0.040 mmol, 32% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> with D<sub>2</sub>O) δ ppm 0.70–0.86 (m, 6H), 0.88–1.03 (m, 1H), 1.13–1.34 (m, 3H), 1.48 (dd, <i>J</i> = 13.75, 7.09 Hz, 1H), 1.69–1.83 (m, 1H), (1.84–1.95 (m, 1H), 2.01 (qd, <i>J</i> = 6.88, 6.66 Hz, 2H), 2.25–2.40 (m, 1H), 2.62 (t, <i>J</i> = 7.41 Hz, 2H), 3.37 (d, <i>J</i> = 15.26 Hz, 1H), 3.46 (s, 3H), 3.68–4.23 (m, 3H), 6.09 (br s, 1H), 6.28 (s, 1H), 7.36–7.60 (m, 6H), exchangeable protons were not observed. LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 524 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 526 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>35</sub>NO<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 526.1934, found 526.1933.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> ((((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)oxy)methyl)phosphonic Acid (<b>13</b>)</h3><div class="NLM_p">Step 1: A solution of <b>2</b> (100 mg, 0.248 mmol) in DMSO (3 mL) was treated with 1 M NaHMDS in THF (0.260 mL, 0.260 mmol) at ambient temperature for 20 min. [Bis(ethyloxy)phosphoryl]methyl 4-chlorobenzenesulfonate (140 mg, 0.408 mmol) was added to the reaction mixture, and the mixture was stirred at 25 °C for 16 h, after which time LCMS indicated ∼60% conversion to the desired product. The reaction mix was heated at 60 °C for 3 days, after which time LCMS indicated no discernible improvement. The reaction mixture was partitioned between EtOAc and water, and the organic phase was isolated, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified on silica gel eluted with 40–100% EtOAc/hexanes to give an intermediate phosphonate as a clear oil. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 554 [M + H]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.76 (t, <i>J</i> = 7.00 Hz, 3H), 0.80 (t, <i>J</i> = 7.42 Hz, 3H), 0.97–1.29 (m, 4H), 1.20–1.28 (m, 6H), 1.32–1.53 (m, 2H), 1.67–1.80 (m, 1H), 1.97–2.10 (m, 1H), 2.55 (d, <i>J</i> = 9.6 Hz, 1 H), 3.06 (d, <i>J</i> = 14.8 Hz, 1H), 3.45 (s, 3H), 3.56 (d, <i>J</i> = 15.1 Hz, 1H), 4.10 (m, 4H), 4.40–4.56 (m, 2H), 5.91 (d, <i>J</i> = 9.6 Hz, 1H), 6.12 (s, 1 H), 7.28–7.36 (m, 1H), 7.36–7.48 (m, 4H), 7.60 (s, 1H).</div><div class="NLM_p last">Step 2: A solution of the intermediate phosphonate (77.9 mg, 0.141 mmol) in DCM (3 mL) was treated with TMSBr (100 mg, 0.653 mmol) at 23 °C for 16 h, after which time LCMS indicated complete conversion. The reaction mixture was concentrated to dryness, chased with MeOH, and purified by RP-HPLC (30 mm × 150 mm Sunfire column at 50 mL/min. CH<sub>3</sub>CN and H<sub>2</sub>O + 0.05% TFA were used as solvent system. The samples were collected at λ<sub>max</sub>. Gradient consisted of: 10–100 over 8 min, 100 to 100 to 10 min) to give <b>13</b> [70 mg, 0.141 mmol, 57% yield (two steps)] as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.68–0.90 (m, 6 H), 0.97–1.32 (m, 4 H), 1.34–1.62 (m, 2 H), 1.67–1.88 (m, 1 H), 1.95–2.25 (m, 1 H), 2.43–2.63 (m, 1 H), 2.97–3.24 (m, 1 H), 3.47 (s, 3 H), 3.52–3.72 (m, 1 H), 4.03–4.29 (m, 2 H), 5.80–6.02 (m, 1 H), 6.04–6.24 (m, 1 H), 7.42 (br s, 5 H), 7.60 (br s, 1 H) (acidic protons not observed). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 496 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 498 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>23</sub>H<sub>32</sub>NO<sub>7</sub>PS (M + 1) <i>m</i>/<i>z</i> 498.1715, found 498.1716.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)ethyl)phosphonic Acid (<b>14</b>)</h3><div class="NLM_p">Step 1: To a solution of 1,2-dibromoethane (0.466 g, 2.478 mmol) and DIPEA (0.087 mL, 0.496 mmol) in THF (5 mL) was added <b>2</b> (100 mg, 0.248 mmol), and the mixture was stirred for 1 h, after which time LCMS indicated no reaction. K<sub>2</sub>CO<sub>3</sub> (0.068 g, 0.496 mmol) was added to the reaction mixture, and the mixture was stirred for an additional 16 h, after which time LCMS still showed no reaction. Then 1 M KOH (3.0 mL, 3.00 mmol), tetrabutylammonium bromide (24 mg, 0.074 mmol), and additional 1,2-dibromoethane (1.07 g, 5.70 mmol) were added to the reaction mixture and stirred for 3 days, after which time LCMS indicated good conversion to the intermediate bromide. The reaction mixture was partitioned between EtOAc and water, and the organic phase was isolated, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give the intermediate as a clear oil. The oil was dissolved in triethyl phosphite (5.26 mL, 30.1 mmol) and heated at 100 °C for 16 h with stirring, after which time LCMS indicated ∼20% conversion. The temperature was increased to 130 °C for 16 h, after which time LCMS indicated complete conversion to the desired product. The reaction mixture was concentrated to dryness, and the residue was purified on silica gel eluting with 60–100% EtOAc/hexanes to give an intermediate phosphonate (112 mg, 0.196 mmol, 79% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.76 (t, <i>J</i> = 7.05 Hz, 3 H), 0.80 (t, <i>J</i> = 7.42 Hz, 3 H), 0.96–1.30 (m, 4 H), 1.23 (t, <i>J</i> = 6.87 Hz, 6 H), 1.32–1.53 (m, 2 H), 1.66–1.79 (m, 1 H), 1.98–2.11 (m, 1 H), 2.21–2.37 (m, 2 H), 2.51–2.56 (m, 1 H), 3.11 (d, <i>J</i> = 14.83 Hz, 1 H), 3.43 (s, 3 H), 3.55 (d, <i>J</i> = 14.83 Hz, 1 H), 3.94–4.10 (m, 4 H), 4.10–4.26 (m, 2 H), 5.90 (d, <i>J</i> = 9.52 Hz, 1 H), 6.11 (s, 1 H), 7.25–7.36 (m, 1 H), 7.36–7.44 (m, 4 H), 7.46 (s, 1 H).</div><div class="NLM_p last">Step 2: A solution of intermediate phosphonate (111.5 mg, 0.196 mmol) in DCM (1 mL) was treated with TMSBr (120 mg, 0.786 mmol) at 23 °C for 16 h, after which time LCMS indicated complete conversion. The reaction mixture was concentrated to dryness and purified by RP-HPLC (basic conditions) to give <b>14</b> (37 mg, 0.073 mmol, 37% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.71–0.84 (m, 6 H), 0.97–1.28 (m, 4 H), 1.32–1.53 (m, 2 H), 1.66–1.91 (m, 3 H), 1.96–2.09 (m, 1 H), 2.51–2.55 (m, 1 H), 3.11 (d, <i>J</i> = 14.83 Hz, 1 H), 3.42 (s, 3 H), 3.53 (d, <i>J</i> = 15.04 Hz, 1 H), 4.02–4.17 (m, 2 H), 5.90 (d, <i>J</i> = 9.67 Hz, 1 H), 6.08 (s, 1 H), 7.31 (m, <i>J</i> = 8.65, 4.27, 4.27, 4.08 Hz, 1 H), 7.40 (d, <i>J</i> = 4.51 Hz, 4 H), 7.44 (s, 1 H) (acidic protons not observed). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 510 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 512 [M + H]. HRMS (ES+) calcd for C<sub>24</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>PS (M + 1) <i>m</i>/<i>z</i> 512.1872, found 512.1871.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3-(((3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]thiazepin-8-yl)oxy)propyl)phosphonic Acid (<b>15</b>)</h3><div class="NLM_p last">Prepared as in compound <b>14</b>. The crude material was purified by RP-HPLC to give <b>15</b> (61 mg, 0.117 mmol, 59% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.69–0.93 (m, 6 H), 0.97–1.33 (m, 4 H), 1.34–1.57 (m, 2 H), 1.58–1.71 (m, 2 H), 1.71–1.85 (m, 1 H), 1.84–1.98 (m, 2 H), 1.99–2.17 (m, 1 H), 3.00–3.26 (m, 1 H), 3.46 (s, 3 H), 3.52–3.71 (m, 1 H), 3.99–4.15 (m, 2 H), 5.70–6.05 (m, 1 H), 6.05–6.42 (m, 1 H), 7.01–7.85 (m, 6 H) (exchangeables were not observed). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 524 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 526 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>36</sub>NO<sub>7</sub>PS (M + 1) <i>m</i>/<i>z</i> 526.2028, found 526.2024.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propanoic Acid (<b>16</b>)</h3><div class="NLM_p">Step 1: In a sealed tube, a solution of <b>3</b> (3.5 g, 6.53 mmol) in DMF (30 mL) was treated with Et<sub>3</sub>N (4.55 mL, 32.7 mmol), followed by ethyl acrylate (3.56 mL, 32.7 mmol) and bis(triphenylphosphine)palladium(II) chloride (0.459 g, 0.653 mmol). The reaction mixture was stirred at 120 °C overnight, cooled to 25 °C, and partitioned between H<sub>2</sub>O and EtOAc. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification on silica gel (EtOAc/hexanes = 1:6 to 2:1) to give a crude cinnamate ester (3.06 g, 94%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ ppm 0.81 (t, <i>J</i> = 7.0 Hz, 3H), 0.88 (t, <i>J</i> = 7.4 Hz, 3H), 1.03–1.21 (m, 2H), 1.28–1.35 (m, 3H), 1.38–1.54 (m, 3H), 1.76–1.93 (m, 1H), 2.08–2.26 (m, 1H), 3.02 (d, <i>J</i> = 14.9 Hz, 1H), 3.44 (d, <i>J</i> = 14.9 Hz, 1H), 3.55 (s, 3H), 4.18–4.30 (m, 2H), 6.06 (d, <i>J</i> = 6.8 Hz, 1H), 6.19 (s, 1H), 6.56 (d, <i>J</i> = 16.0 Hz, 1H), 7.30–7.48 (m, 5H), 7.85 (d, <i>J</i> = 16.2 Hz, 1H), 8.21 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 486 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step 2: A mixture of cinnamate ester (0.27g, 0.556 mmol) and 10% Pd/C (0.012 g) in EtOH (10 mL) at 25 °C was hydrogenated under an atmosphere of H<sub>2</sub> at 1 atm overnight. The reaction mixture was filtered through diatomaceous earth and washed with EtOH. The filtrate was concentrated under reduced pressure to give an intermediate ester (182 mg, 57%) as a clear oil. ES-LCMS <i>m</i>/<i>z</i> 488 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 3: To a solution of ester (172 mg, 0.353 mmol) in a 1:1:2 mixture of THF/MeOH/H<sub>2</sub>O (12 mL) was added lithium hydroxide (84 mg, 3.53 mmol). The reaction mixture was stirred at room temperature overnight then partially concentrated under reduced pressure to remove organic solvents. The resulting aqueous layer was then acidified to pH 1–2 with 1 N HCl and extracted with DCM. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give <b>16</b> (149 mg, 87%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.81 (t, <i>J</i> = 7.0 Hz, 3H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H), 0.98–1.14 (m, 1H), 1.13–1.38 (m, 5H), 1.77–1.97 (m, 1H), 2.09–2.39 (m, 1H), 2.48–2.66 (m, 2H), 2.78–2.95 (m, 2H), 3.41 (d, <i>J</i> = 15.0 Hz, 1H), 3.50 (s, 3H), 5.97–6.32 (m, 2H), 7.41 (d, <i>J</i> = 7.0 Hz, 5H), 7.85 (s, 1H). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 458 (M – 1)<sup>−</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>33</sub>NO<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 460.2159, found 460.2158.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]-1-propanol (<b>16a</b>)</h3><div class="NLM_p last">To an ice-cold solution of <b>16</b> (100 mg, 0.22 mmol) in THF (5 mL) was added BH<sub>3</sub>-THF complex (0.653 mL, 0.653 mmol). The reaction mixture was stirred at 25 °C overnight then quenched by dropwise addition of MeOH. The reaction mixture was stirred for 30 min then concentrated under reduced pressure. The residue was taken up with MeOH and evaporated under reduced pressure again. The residue was purified using silica gel (MeOH/DCM = 0:100 to 10:90) to give <b>16a</b> (96 mg, 94%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.80 (t, <i>J</i> = 7.0 Hz, 3H), 0.86 (t, <i>J</i> = 7.3 Hz, 3H), 0.99–1.52 (m, 14H), 1.69–1.92 (m, 3H), 2.02–2.25 (m, 1H), 2.56–2.75 (m, 2H), 3.00 (d, <i>J</i> = 14.8 Hz, 1H), 3.40 (d, <i>J</i> = 14.8 Hz, 1H), 3.48 (s, 3H), 3.58 (t, <i>J</i> = 6.2 Hz, 2H), 6.01 (s, 1H), 6.11 (s, 1H), 7.26–7.48 (m, 5H), 7.84 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]butanoic Acid Trifluoroacetate Salt (<b>17</b>)</h3><div class="NLM_p">Step 1: To an ice-cold solution of <b>16a</b> (250 mg, 0.561 mmol) in DCM (10 mL) was added Et<sub>3</sub>N (0.235 mL, 1.683 mmol) and MsCl (0.048 mL, 0.62 mmol). The reaction mixture was stirred at 25 °C overnight and partitioned between H<sub>2</sub>O and DCM. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give an intermediate mesylate (280 mg, 91%) as a light-yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.80 (t, <i>J</i> = 6.8 Hz, 3H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H), 0.97–1.34 (m, 8H), 1.35–1.61 (m, 4H), 1.73–2.27 (m, 4H), 2.46–2.78 (m, 4H), 2.85–3.07 (m, 4H), 3.31–3.43 (m, 1H), 3.47 (s, 3H), 4.04–4.26 (m, 2H), 6.01 (d, <i>J</i> = 8.0 Hz, 1H), 6.11 (s, 1H), 7.27–7.52 (m, 5H), 7.82 (s, 1H).</div><div class="NLM_p">Step 2: To a solution of the above mesylate (90 mg, 0.172 mmol) in DMSO (5 mL) was added NaCN (17 mg, 0.344 mmol). The reaction mixture was stirred at 60 °C for 60 h and directly partitioned between H<sub>2</sub>O and EtOAc. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (EtOAc/hexanes = 10:90 to 1:1) afforded an intermediate nitrile (76 mg, 95%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.80 (t, <i>J</i> = 7.0 Hz, 3H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H), 0.99–1.35 (m, 4H), 1.37–1.51 (m, 2H), 1.75–1.98 (m, 3H), 2.08–2.21 (m, 1H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 2.64–2.80 (m, 2H), 3.01 (d, <i>J</i> = 14.6 Hz, 1H), 3.40 (d, <i>J</i> = 14.8 Hz, 1H), 6.02 (s, 1H), 6.12 (s, 1H), 7.26–7.48 (m, 5H), 7.81 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 455 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 3: A mixture of nitrile (40 mg, 0.088 mmol) and 37% HCl (4 mL) was stirred at 100 °C overnight, cooled to 25 °C, and concentrated under reduced pressure. MeOH was added to transfer the residue to a flask, and the solution was concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded trace amount of desired acid with the major product being the corresponding methyl ester of the acid, which was subsequently hydrolyzed in the presence of excess lithium hydroxide. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>17</b> (10 mg, 18%, TFA salt) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.86 (t, <i>J</i> = 7.0 Hz, 3H), 0.96 (t, <i>J</i> = 7.4 Hz, 4H), 1.26–1.47 (m, 3H), 1.62–2.25 (m, 5H), 2.26–2.38 (m, 1H), 2.40–2.66 (m, 2H), 2.83–2.97 (m, 1H), 3.45 (d, <i>J</i> = 15.4 Hz, 1H), 3.65 (d, <i>J</i> = 15.6 Hz, 1H), 6.32 (s, 1H), 6.59 (s, 1H), 7.41–7.65 (m, 5H), 7.87 (s, 1H). LC-MS (ES<sup>+</sup>)<i>m</i>/<i>z</i> 474 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>26</sub>H<sub>35</sub>NO<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 474.2316, found 474.2314.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> [(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methanesulfonic Acid Trifluoroacetate Salt (<b>18</b>)</h3><div class="NLM_p">Step 1: To a DCM (2 mL) solution of <b>4</b> (0.275 g, 0.617 mmol) at 0 °C under nitrogen was added a 1 M solution of DIBAL-H in toluene (1.3 mL, 1.30 mmol). The reaction was warmed to 25 °C and stirred for 1.5 h then MeOH was added followed by H<sub>2</sub>O. The reaction mixture was concentrated then redissolved in EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc, then the combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Chromatography on silica using hexanes/EtOAc provided an intermediate alcohol (0.238 g, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.76–0.93 (m, 6 H), 1.04–1.36 (m, 6 H), 1.36–1.59 (m, 6 H), 1.76–1.93 (m, 1 H), 2.05–2.24 (m, 2 H), 3.02 (d, <i>J</i> = 14.8 Hz, 1 H), 3.42 (d, <i>J</i> = 14.8 Hz, 1 H), 3.54 (s, 3 H), 4.65 (qd, <i>J</i> = 13.2, 6.3 Hz, 2 H), 6.07 (br s, 1 H), 6.17 (s, 1 H), 7.29–7.50 (m, 5 H), 8.03 (s, 2 H). ES-LCMS <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step 2: Imidazole (0.153 g, 0.563 mmol) was dissolved in DCM (2 mL), and the solution was cooled to 0 °C. Triphenylphosphine (0.295 g, 1.126 mmol) was added, followed by bromine (0.058 mL, 1.126 mmol). A solution of alcohol (0.235g, 0.563 mmol) in DCM (1 mL) was added slowly at 0 °C. The reaction was stirred at 0 °C for 2 h followed by addition of aqueous Na<sub>2</sub>SO<sub>3</sub>, and the resulting mixture separated. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered through a silica pad, and concentrated to give a thick oil which solidified upon standing to give an intermediate bromide (0.265 g, 84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.73–0.95 (m, 6 H), 1.02–1.36 (m, 5 H), 1.38–1.65 (m, 5 H), 1.76–1.92 (m, 1 H), 2.08–2.23 (m, 1 H), 3.02 (d, <i>J</i> = 14.8 Hz, 1 H), 3.43 (d, <i>J</i> = 14.8 Hz, 1 H), 3.57 (s, 3 H), 4.38–4.56 (m, 2 H), 6.06 (s, 1 H), 6.16 (s, 1 H), 7.28–7.45 (m, 5 H), 8.05 (s, 1 H). LC-MS <i>m</i>/<i>z</i> 480 (M + H)<sup>+</sup>. LC-MS 482 (M + H + 2)<sup>+</sup>.</div><div class="NLM_p last">Step 3: To a solution of bromide (0.100 g, 0.21 mmol) in 1,4-dioxane (1 mL) was added a solution of sodium sulfite (131 mg, 1.04 mmol) in H<sub>2</sub>O (1 mL). The mixture was stirred under reflux overnight then concentrated under vacuum, and the crude reaction mixture was washed with 1 N HCl. The supernatant was decanted, leaving a white gummy solid which was triturated with DCM and hexanes to give a solid that was collected via filtration. Purification was accomplished using the Agilent prep-HPLC (C18 packing with MeCN, H<sub>2</sub>O w/0.1% TFA as the mobile phase) to give <b>18</b> (83 mg, 66%) as a trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.62–1.13 (m, 7 H), 1.33 (br s, 3 H), 1.60 (br s, 1 H), 2.02 (br s, 2 H), 3.14–4.46 (m, 6 H + H<sub>2</sub>O), 6.33 (br s, 2 H), 7.59 (br s, 5 H), 8.17 (br s, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 482 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>23</sub>H<sub>31</sub>NO<sub>6</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 482.1669, found 482.1671.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]-1-propanesulfonic Acid (<b>19</b>)</h3><div class="NLM_p">Step 1: To a solution of compound <b>16a</b> (84.2 mg, 0.189 mmol) in THF (5 mL) was added triphenylphosphine (99 mg, 0.378 mmol) and CBr<sub>4</sub> (125 mg, 0.378 mmol). The reaction mixture was stirred at 25 °C overnight then partitioned between H<sub>2</sub>O and DCM. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (EtOAc/hexanes = 10:90 to 50:50) afforded an intermediate bromide (78 mg, 80%) as a clear oil. ES-LCMS <i>m</i>/<i>z</i> 508 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of bromide (70 mg, 0.138 mmol) in a 1:1 mixture of EtOH/H<sub>2</sub>O (10 mL) was added sodium sulfite (868 mg, 6.88 mmol). The reaction mixture was stirred at reflux overnight, cooled to 25 °C, and partially concentrated under reduced pressure to remove the organic solvents. The aqueous layer was then acidified to pH 1 with 1 N HCl. The aqueous layer was extracted with DCM. The combined organic layers were washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification on silica gel (MeOH/DCM = 0:100 to 20:80) afforded <b>19</b> (27.2 mg, 38%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.47–2.26 (m, 12H), 2.33–3.63 (m, 14H), 6.06 (br s, 2H), 7.16–7.60 (m, 5H), 7.78 (br s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 510 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>35</sub>NO<sub>6</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 510.1988, found 510.1984.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> {[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}phosphonic Acid Hydrochloride Salt (<b>20</b>)</h3><div class="NLM_p">Step 1: Prepared from bromomethyl intermediate (see compound <b>18</b>, step 2) (0.920 g, 1.92 mmol) upon reaction with triethyl phosphate (0.352 mL, 2.01 mmol) in toluene (10 mL) to give an intermediate phosphonate ester.</div><div class="NLM_p last">Step 2: The phosphonate ester from the previous step was dissolved in 2 mL of 6 N HCl and 1 mL EtOH then heated at reflux for 6 h. The reaction was cooled then concentrated. The residue was dissolved in EtOH then concentrated to give <b>20</b> (0.86 g, 85%) as a hydrochloride salt. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 0.89 (t, <i>J</i> = 6.88 Hz, 3 H), 0.98 (t, <i>J</i> = 7.41 Hz, 4 H), 1.23–1.46 (m, 3 H), 1.64 (dd, <i>J</i> = 14.15, 7.32 Hz, 1 H), 1.97 (dd, <i>J</i> = 14.15, 7.12 Hz, 2 H), 2.68 (br s, 1 H), 2.99–3.12 (m, 2 H), 3.16–3.25 (m, 1 H), 3.45 (d, <i>J</i> = 15.51 Hz, 1 H), 3.58 (s, 3 H), 3.79 (d, <i>J</i> = 15.51 Hz, 1 H), 6.36 (s, 1 H), 6.46 (s, 1 H), 7.57 (s, 5 H), 8.04 (d, <i>J</i> = 2.34 Hz, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 482 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>23</sub>H<sub>32</sub>NO<sub>6</sub>PS (M + 1) <i>m</i>/<i>z</i> 482.1766, found 482.1769.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> {2-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]ethyl}phosphonic Acid Bis-ammmonium Salt (<b>21</b>)</h3><div class="NLM_p">Step 1: Tetraethyl methanediylbis(phosphonate) (645 mg, 2.24 mmol) dissolved in THF (7 mL) was treated with NaH (83 mg, 2.075 mmol, 60% dispersion in oil) with stirring at 25 °C for 30 min. Compound <b>7</b> (300 mg, 0.722 mmol) was added, and the mixture was stirred for 1 h at 25 °C, after which time LCMS indicated complete conversion. The mixture was quenched with H<sub>2</sub>O and partitioned between EtOAc and brine. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to an oil. The residue was purified on silica gel eluting with 40–100% EtOAc/hexanes to give an intermediate phosphonate ester (342 mg, 86% yield) as a clear oil. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 550 [M + H].</div><div class="NLM_p last">Step 2: The ester (240 mg, 0.44 mmol) dissolved in EtOH (20 mL) was treated with 10% Pd/C (46.5 mg, 0.44 mmol) under a balloon of H<sub>2</sub> at 25 °C overnight. The catalyst was filtered off, and the filtrate was concentrated to dryness to give the intermediate phosphonate as a clear oil. The residue was dissolved in DCM (10 mL) and treated with TMSBr (0.227 mL, 1.75 mmol) for 16 h at 23 °C with stirring. The reaction mixture was concentrated to dryness then purified by RP-HPLC (30 mm × 100 mm XBridge column, MeCN/H<sub>2</sub>O containing 0.2% NH<sub>4</sub>OH buffer, 10 to 80 to 100% over 8 min) to give <b>21</b> (88 mg, 41% yield) bis-ammonium salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.70–0.85 (m, 6 H), 0.97–1.30 (m, 4 H), 1.29–1.64 (m, 4 H), 1.67–1.81 (m, 1 H), 2.00–2.12 (m, 1 H), 2.58 (d, <i>J</i> = 9.8 Hz, 1 H), 2.63–2.79 (m, 2 H), 3.05 (d, <i>J</i> = 14.9 Hz, 1 H), 3.39 (s, 3 H), 3.50 (d, <i>J</i> = 14.9 Hz, 1 H), 5.92 (d, <i>J</i> = 9.6 Hz, 1 H), 6.05 (s, 1 H), 7.26–7.36 (m, 1 H), 7.36–7.46 (m, 4 H), 7.65 (s, 1 H) (phosphonic acid protons not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 496 [M + H]. HRMS (ES+) calcd for C<sub>24</sub>H<sub>34</sub>NO<sub>6</sub>PS (M + 1) <i>m</i>/<i>z</i> 496.1922, found 496.1923.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> {3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propyl}phosphonic Acid Trifluoroacetate Salt (<b>22</b>)</h3><div class="NLM_p">Step 1: To a solution of diethylphosphite (119 mg, 0.859 mmol) in THF (5 mL) was added NaH (27.5 mg, 0.687 mmol). The reaction mixture was stirred for 30 min, followed by dropwise addition of mesylate (90 mg, 0.172 mmol) (see compound <b>17</b>, step 1) in THF (5 mL). The reaction mixture was stirred at 25 °C overnight then concentrated under reduced pressure. The residue was partitioned between 1 N HCl and EtOAc. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (EtOAc/hexanes = 10:90 to 100:0) afforded an intermediate phosphonate ester (55 mg, 53%) as a white solid. ES-LCMS <i>m</i>/<i>z</i> 566 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of phosphonate ester (50 mg, 0.088 mmol) in DCM (5 mL) was added TMSBr (0.115 mL, 0.884 mmol). The reaction mixture was stirred at 25 °C overnight then concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>22</b> (25 mg, 43%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.86 (t, <i>J</i> = 7.0 Hz, 3H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H), 0.99–1.13 (m, 1H), 1.20–1.45 (m, 3H), 1.48–1.72 (m, 3H), 1.75–2.10 (m, 4H), 2.51–2.66 (m, 1H), 2.73 (t, <i>J</i> = 7.4 Hz, 2H), 3.37 (d, <i>J</i> = 15.6 Hz, 1H), 3.55 (s, 3H), 3.79 (d, <i>J</i> = 15.6 Hz, 1H), 6.32 (s, 1H), 6.42 (s, 1H), 7.39–7.60 (m, 5H), 7.90 (s, 1H). LC-MS(ES<sup>+</sup>) <i>m</i>/<i>z</i> 510 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>36</sub>NO<sub>6</sub>PS (M + 1) <i>m</i>/<i>z</i> 510.2078, found 510.2079.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl}amino)-2,2-dimethylpropanoic Acid (<b>23</b>)</h3><div class="NLM_p">Step 1: To a DMF (0.5 mL) solution of <b>5</b> (0.025 g, 0.058 mmol) and ethyl 3-amino-2,2-dimethylpropanoate<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (0.009 g, 0.064 mmol) at 0 °C was added HATU (0.024 g, 0.064 mmol) followed by DIEA (0.012 mL, 0.070 mmol). The reaction was stirred for 10 min then warmed to 25 °C. After 1 h, the reaction was concentrated to half volume, and H<sub>2</sub>O (3 mL) was added. The precipitant was filtered and dried and then used without further purification in the next step.</div><div class="NLM_p last">Step 2: The material was dissolved in THF (0.5 mL), and H<sub>2</sub>O (0.25 mL) was added along with excess LiOH (7 mg, 0.174 mmol). The reaction was stirred at 25 °C for 3 h then concentrated. The residue was purified by silica chromatography using DCM/MeOH to give <b>23</b> (20 mg, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.71–0.96 (m, 6 H), 0.99–1.65 (m, 12 H), 1.83 (br s, 1 H), 2.18 (br s, 1 H), 3.11 (br s, 1 H), 3.31–3.70 (m, 7 H), 6.08 (br s, 1 H), 6.21 (br s, 1 H), 7.27–7.52 (m, 5 H), 8.13 (br s, 1 H), 8.71 (s, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 531 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 531.2530, found 531.2529.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> ({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl}amino)methanesulfonic Acid (<b>24</b>)</h3><div class="NLM_p last">Prepared in analogous fashion to compound <b>23</b> (step 1) via HATU amide-coupling using aminomethanesulfonic acid (0.013 g, 0.116 mmol) and <b>5</b> (50 mg, 0.12 mmol) to give compound <b>24</b> (45 mg, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.63–0.93 (m, 6 H), 0.93–1.32 (m, 5 H), 1.45 (br s, 2 H), 1.80 (br s, 1 H), 2.14 (br s, 1 H), 3.22 (br s, 1 H), 3.43–4.72 (m, 6 H + H<sub>2</sub>O), 6.02 (br s, 1 H), 6.29 (br s, 1 H), 7.47 (d, <i>J</i> = 3.62 Hz, 5 H), 8.28 (partially resolved t, <i>J</i> = 5.72 Hz, 1 H), 8.47 (s, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 525 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>24</sub>H<sub>32</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 525.1724, found 525.1729.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl}amino)ethanesulfonic Acid Trifluoroacetate (<b>25</b>)</h3><div class="NLM_p last">Prepared in an analogous fashion to compound <b>23</b> (step 1) via HATU amide-coupling using taurine (0.014 g, 0.116 mmol) and compound <b>5</b> (50 mg, 0.116 mmol). Purification via RP-HPLC (30 mm × 150 mm H<sub>2</sub>O Sunfire C18 column) using MeCN/H<sub>2</sub>O 10–100% with 0.1% TFA as mobile phase over 8 min provided <b>25</b> (15 mg, 19%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 0.91 (t, <i>J</i> = 7.13 Hz, 3 H), 1.02 (partially resolved t, <i>J</i> = 7.48 Hz, 4 H), 1.43 (d, <i>J</i> = 6.55 Hz, 3 H), 1.66 (s, 1 H), 2.13 (br s, 2 H), 2.77 (br s, 1 H), 2.91–3.02 (m, 2 H), 3.55 (d, <i>J</i> = 15.83 Hz, 1 H), 3.72 (s, 3 H), 3.75–3.83 (m, 2 H), 4.02 (d, <i>J</i> = 15.83 Hz, 1 H), 6.47 (s, 1 H), 6.68 (s, 1 H), 7.48–7.72 (m, 5 H), 8.74 (s, 1 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 539 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 539.1883, found 539.1886.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-{3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propanoyl}glycine (<b>26</b>)</h3><div class="NLM_p last">Step 1: Prepared in an analogous fashion to compound <b>23</b> using compound <b>16</b> (50 mg, 0.109 mmol), DIPEA (0.095 mL, 0.544 mmol), HATU (124 mg, 0.326 mmol), and glycine methyl ester hydrochloride (19.39 mg, 0.218 mmol) in DCM (4 mL). Purification on silica gel (MeOH/DCM = 0:100 to 10:90) afforded an intermediate methyl ester (45 mg, 76%) as a clear oil. ES-LCMS <i>m</i>/<i>z</i> 531 (M + H)<sup>+</sup>. The methyl ester was saponified in an analogous fashion to compound <b>23</b>. Step 2: Purification on silica gel (MeOH:DCM = 0:100 to 10:90) afforded <b>26</b> (21 mg, 47%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.49–0.93 (m, 13H), 1.76–1.96 (m, 1H), 2.27–2.66 (m, 3H), 2.70–2.90 (m, 1H), 3.02 (d, <i>J</i> = 6.8 Hz, 1H), 3.14–3.33 (m, 1H), 3.34–3.44 (m, 1H), 3.49 (s, 3H), 3.89 (br s, 2H), 6.02–6.37 (m, 3H), 7.31–7.62 (m, 5H), 7.83 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 515 (M – H)<sup>−</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 517.2374, found 517.2372.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> ({3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propanoyl}amino)methanesulfonic Acid (<b>27</b>)</h3><div class="NLM_p last">Prepared in an analogous fashion to compound <b>23</b> (step 1) using compound <b>16</b> (50 mg, 0.109 mmol), EDC (62.6 mg, 0.326 mmol), DMAP (39.9 mg, 0.326 mmol), and aminomethanesulfonic acid (12.1 mg, 0.109 mmol) in a 2:1 mixture of DCM/THF (6 mL). The reaction mixture was stirred at 25 °C overnight then partitioned between H<sub>2</sub>O and DCM. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification with HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>27</b> (11 mg, 18%, TFA salt) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.63–0.99 (m, 6H), 1.31 (m, 3H), 1.69–1.97 (m, 2H), 2.12–2.52 (m, 2H), 2.58–2.80 (m, 2H), 2.92 (br s, 1H), 3.21–3.50 (m, 2H), 3.67 (s, 3H), 3.85 (d, <i>J</i> = 15.2 Hz, 2H), 6.51 (d, <i>J</i> =  8.1 Hz, 2H), 7.35–7.77 (m, 5H), 7.85 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 553 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 553.2039, found 553.2042.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> ({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)(oxo)acetic Acid (<b>28</b>)</h3><div class="NLM_p">Step 1: A solution of compound <b>8</b> (77 mg, 0.19 mmol) in DCM (924 μL) at 0 °C was treated with Et<sub>3</sub>N (56.7 μL, 0.407 mmol) followed by methyl chloro(oxo)acetate (18.7 μL, 0.203 mmol). The reaction was stirred for 30 min then warmed to 25 °C and stirred for an additional 1 h. LCMS indicated 92:8/prod:SM. Added additional acid chloride (2 μL) then stirred at 25 °C for 2 h. The reaction was diluted with DCM and H<sub>2</sub>O, the layers separated, and the aqueous layer extracted with DCM (3×). The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo to give a methyl ester (93 mg, 100% yield) which was used as is in the next step. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.81 (t, <i>J</i> = 7.0 Hz, 3H), 0.88 (t, <i>J</i> = 7.4 Hz, 3H), 1.03–1.58 (m, 6H), 1.76–1.90 (m, 1H), 2.06–2.22 (m, 1H), 2.96–3.10 (m, 2H), 3.41 (d, <i>J</i> = 14.8 Hz, 1H), 3.54 (s, 3H), 3.87 (s, 3H), 4.48 (d, <i>J</i> = 6.0 Hz, 2H), 6.06 (s, 1H), 6.18 (s, 1H), 7.28–7.54 (m, 6H), 7.96 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 503 [M + H].</div><div class="NLM_p last">Step 2: A solution of methyl ester (93 mg, 0.185 mmol) in THF (694 μL) and H<sub>2</sub>O (231 μL) at 0 °C was treated with 1 M LiOH (204 μL, 0.204 mmol). The reaction was stirred at 0 °C for 60 min then warmed to 25 °C and stirred for 1 h. The reaction was diluted with EtOAc and acidified with dilute HCl. The layers were separated, and the aqueous layer was extracted with EtOAc (3×). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was triturated with hexanes/Et<sub>2</sub>O then a white solid was collected by filtration. <b>28</b> (79 mg, 87% yield) was obtained as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.46–0.95 (m, 6H), 0.94–1.61 (m, 6H), 1.62–1.88 (m, 1H), 1.95–2.26 (m, 1H), 3.03 (br s, 1H), 3.48 (m 4H), 4.16–4.38 (m, 2H), 5.92 (br s, 1H), 6.17 (br s, 1H), 7.27–7.65 (m, 5H), 7.75 (br s, 1H), 9.37 (br s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 489 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 489.2062, found 489.2059.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8- yl]methyl}amino)-2-oxoethanesulfonic Acid (<b>29</b>)</h3><div class="NLM_p">Step 1: To an ice-cold solution of compound <b>8</b> (50 mg, 0.120 mmol) in DCM (6 mL) was added pyridine (0.097 mL, 1.20 mmol) and chloroacetyl chloride (0.048 mL, 0.60 mmol). The reaction mixture was stirred at 25 °C overnight then concentrated under reduced pressure to give a light-yellow oil. The intermediate chloroacetamide (55 mg, 92%) was used in the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.80 (t, <i>J</i> = 7.0 Hz, 3H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H), 0.99–1.60 (m, 6H), 1.69–1.90 (m, 1H), 2.09–2.24 (m, 1H), 3.02 (s, 2H), 3.37 (s, 1H), 3.53 (s, 3H), 4.05 (d, <i>J</i> = 7.0 Hz, 3H), 4.44 (d, <i>J</i> = 6.1 Hz, 2H), 6.05 (s, 1H), 6.17 (s, 1H), 6.91–7.13 (m, 1H), 7.27–7.45 (m, 5H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 494 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of the intermediate chloroacetamide (55 mg, 0.112 mmol) in a 1:1 mixture of EtOH/H<sub>2</sub>O (6 mL) was added Na<sub>2</sub>SO<sub>3</sub> (141 mg, 1.115 mmol). The reaction mixture was stirred at 80 °C overnight, cooled to 25 °C, acidified with AcOH to pH 3–4, and concentrated under reduced pressure. Purification using silica gel (MeOH/DCM = 0:100 to 30:70) afforded <b>29</b> (32 mg, 52%) as an off-white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.81 (t, <i>J</i> = 6.6 Hz, 3H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H), 1.01–1.94 (m, 7H), 2.06–2.49 (m, 1H), 3.43–3.59 (m, 4H), 3.63–3.78 (m, 2H), 4.39 (br s, 2H), 6.06 (br s, 1H), 6.28 (br s, 1H), 7.16–7.68 (m, 5H), 7.94 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 539 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 539.1889, found 539.1886.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)-3-oxo-1-propanesulfonic Acid Ammonium Salt (<b>30</b>)</h3><div class="NLM_p">Step 1: To an ice-cold solution of <b>8</b> (150 mg, 0.233 mmol) in DCM (10 mL) was added pyridine (0.132 mL, 1.629 mmol) and 3-chloropropanoyl chloride (0.045 mL, 0.465 mmol). The reaction mixture was stirred at 25 °C for 4 h then partitioned between H<sub>2</sub>O and DCM. Purification via silica gel (MeOH/DCM = 0:100 to 3:97) afforded an intermediate chloropropanamide (105 mg, 89%) as a colorless oil. ES-LCMS <i>m</i>/<i>z</i> 508 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of chloropropanamide (150 mg, 0.296 mmol) in a 1:1 mixture of EtOH/H<sub>2</sub>O (10 mL) was added Na<sub>2</sub>SO<sub>3</sub> (186 mg, 1.479 mmol). The reaction mixture was stirred at 60 °C overnight, cooled to 25 °C, acidified with AcOH, and concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.5% ammonium hydroxide in H<sub>2</sub>O) afforded <b>30</b> (27 mg, 15%, ammonium salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.78 (t, <i>J</i> = 6.8 Hz, 3H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H), 1.03–1.32 (m, 4H), 1.32–1.46 (m, 1H), 1.48–1.66 (m, 1H), 1.67–1.85 (m, 1H), 2.08–2.31 (m, 1H), 2.57–2.73 (m, 2H), 2.95–3.11 (m, 3H), 3.44 (d, <i>J</i> =  14.8 Hz, 1H), 3.51 (s, 3H), 4.18–4.37 (m, 2H), 6.04 (s, 1H), 6.20 (s, 1H), 7.13–7.55 (m, 5H), 7.86 (s, 1H), 8.31–8.49 (m, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 553 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 553.2042, found 553.2042.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> [2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)-2-oxoethyl]phosphonic Acid Trifluoroacetate Salt (<b>31</b>)</h3><div class="NLM_p">Step 1: A mixture of intermediate chloroacetamide (see compound <b>29</b>, step 1) (82 mg, 0.166 mmol) and triethyl phosphite (2.9 mL, 16.63 mmol) was stirred at 135 °C overnight, cooled to 25 °C, and concentrated under reduced pressure. The crude diethyl phosphonate (99 mg, 98%) was used in the next step without further purification. ES-LCMS <i>m</i>/<i>z</i> 595 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of intermediate diethyl phosphonate (99 mg, 0.166 mmol) in DCM (5 mL) was added TMSBr (0.065 mL, 0.499 mmol), and the reaction mixture was stirred at 25 °C overnight. Additional TMSBr (0.216 mL, 1.66 mmol) was added, and the reaction mixture was stirred overnight at 25 °C. The reaction mixture was then concentrated under reduced pressure and treated with H<sub>2</sub>O. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>31</b> (69 mg, 63%, TFA salt) as a gray–white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.89 (t, <i>J</i> = 6.8 Hz, 3H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.22–1.49 (m, 3H), 1.56–1.75 (m, 1H), 1.96–2.13 (m, 2H), 2.57–2.87 (m), 3H), 3.61 (s, 3H), 3.66 (br s, 1H), 3.85 (d, <i>J</i> = 15.4 Hz, 1H), 4.24 (d, <i>J</i> = 14.1 Hz, 1H), 4.43 (d, <i>J</i> =  14.8 Hz, 1H), 6.42 (s, 1H), 6.51 (s, 1H), 7.35–7.75 (m, 5H), 8.01 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 539 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>35</sub>N<sub>2</sub>O<sub>7</sub>PS (M + 1) <i>m</i>/<i>z</i> 539.1980, found 539.1981.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2,2′-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl}imino)diacetic Acid Hydrochloride (<b>32</b>)</h3><div class="NLM_p last">Prepared in analogous fashion to compound <b>23</b> via HATU amide-coupling using diethyl iminodiacetate (0.022 g, 0.116 mmol) and compound <b>5</b> (0.050 g, 0.116 mmol) followed by LiOH (10 mg, 0.24 mmol) hydrolysis conditions to give <b>32</b> (45 mg, 63%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.64–0.92 (m, 6 H), 0.95–1.63 (m, 7 H), 1.66–1.91 (m, 1 H), 2.08 (br s, 1 H), 3.01–3.53 (m, 4 H + H<sub>2</sub>O), 3.86 (br s, 2 H), 4.15 (br s, 2 H), 5.97 (br s, 1 H), 6.15 (s, 1 H), 7.22–7.60 (m, 5 H), 7.73 (s, 1 H), 12.76 (br s, 2 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 547 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>34</sub>N<sub>2</sub>O<sub>8</sub>S (M + 1) <i>m</i>/<i>z</i> 547.2115, found 547.2114.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]carbonyl}amino)pentanedioic Acid (<b>33</b>)</h3><div class="NLM_p last">Prepared in analogous fashion to compound <b>23</b> via HATU amide-coupling using dimethyl 3-aminopentanedioate (81 mg, 0.463 mmol) and compound <b>5</b> (100 mg, 0.232 mmol) followed by LiOH (10 mg, 0.24 mmol) hydrolysis in 1:1:1 mixture of MeOH/H<sub>2</sub>O/THF (15 mL). Purification with HPLC (medium column, Gilson 845Z preparation system; Sunfire C18 5 μM, 30 mm × 150 mm. Method, 10–100% MeCN/H<sub>2</sub>O with 0.05% TFA over 10 min, 45 mL/min, λ = 220, 254 nm) afforded <b>33</b> as a light-yellow solid (61 mg, 38% yield) as a TFA salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.68–0.89 (m, 6H), 0.95–1.34 (m, 4H), 1.34–1.61 (m, 2H), 1.66–1.88 (m, 1H), 1.97–2.23 (m, 1H), 2.52–2.61 (m, 4H), 3.06–3.20 (m, 1H), 3.47–3.70 (m, 4H), 4.46–4.63 (m, 1H), 5.86–6.05 (m, 1H), 6.17–6.28 (m, 1H), 7.24–7.55 (m, 5H), 8.36 (s, 1H), 8.40–8.55 (m, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 561 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>36</sub>N<sub>2</sub>O<sub>8</sub>S (M + 1) <i>m</i>/<i>z</i> 561.2273, found 561.2271.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-({3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propanoyl}amino)pentanedioic Acid Trifluoroacetate Salt (<b>34</b>)</h3><div class="NLM_p last">Prepared in analogous fashion to compound <b>23</b> using <b>16</b> (100 mg, 0.218 mmol), dimethyl 3-aminopentanedioate (81 mg, 0.463 mmol), DIPEA (0.190 mL, 1.088 mmol), and HATU (165 mg, 0.435 mmol) in DCM (6 mL). Saponification with LiOH (10 mg, 0.24 mmol) in 1:1:1 mixture of MeOH/H<sub>2</sub>O/THF (15 mL). Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>34</b> (92 mg, 60%, TFA salt) as white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.87 (t, <i>J</i> =  7.0 Hz, 3H), 0.96 (t, <i>J</i> =  7.4 Hz, 3H), 1.33–1.39 (m, 3H), 1.49–1.67 (m, 1H), 1.86–2.13 (m, 2H), 2.37–2.46 (m, 2H), 2.48–2.58 (m, 4H), 2.60–2.75 (m, 1H), 2.78–3.03 (m, 2H), 3.46 (d, <i>J</i> =  15.6 Hz, 2H), 3.57 (s, 3H), 3.81 (d, <i>J</i> =  15.6 Hz, 1H), 4.33–4.48 (m, 1H), 6.37 (s, 1H), 6.44 (s, 1H), 7.48–7.62 (m, 5H), 7.90 (s, 1H). LC-MS (ES+) <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>30</sub>H<sub>40</sub>N<sub>2</sub>O<sub>8</sub>S (M + 1) <i>m</i>/<i>z</i> 589.2581, found 589.2584.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2,2′-({3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]propanoyl}imino)diacetic Acid (<b>35</b>)</h3><div class="NLM_p last">Step 1: Prepared in a similar fashion to compound <b>23</b> using compound <b>16</b> (50 mg, 0.109 mmol), diethyl 2,2′-iminodiacetate (41.2 mg, 0.218 mmol), EDC (62.6 mg, 0.326 mmol), and DMAP (39.9 mg, 0.326 mmol) in a 2:1 mixture of DCM/THF (6 mL). Purification using silica gel (EtOAc/hexanes = 10:90 to 50:50) afforded an intermediate diester (45 mg, 65%) as a clear oil. ES-LCMS <i>m</i>/<i>z</i> 631 (M + H)<sup>+</sup>. Saponification of intermediate diethyl diester (45 mg, 0.071 mmol) as in compound <b>23</b>, step 2 using LiOH (85 mg, 3.55 mmol) in a 1:1:1 mixture of THF/MeOH/H<sub>2</sub>O (9 mL). Purification with HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>35</b> (23 mg, 53%, TFA salt) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.55–1.45 (m, 8H), 1.69–2.09 (m, 3H), 2.31–2.48 (m, <i>J</i> =  14.1 Hz, 1H), 2.50–2.95 (m, 2H), 2.97–3.13 (m, 1H), 3.23–3.70 (m, 11H), 3.72–3.88 (m, <i>J</i> =  8.6 Hz, 2H), 3.96–4.25 (m, 2H), 6.42 (s, 1H), 6.54 (br s, 1H), 7.37–7.59 (m, 3H), 7.61–7.75 (m, 2H), 7.84 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 575 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>29</sub>H<sub>38</sub>N<sub>2</sub>O<sub>8</sub>S (M + 1) <i>m</i>/<i>z</i> 575.2428, found 575.2427.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-{[2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)-2-oxoethyl]amino}pentanedioic Acid Trifluoroacetate Salt (<b>36</b>)</h3><div class="NLM_p">Step 1: To a solution intermediate chloroacetamide (see compound <b>29</b>, step 1) (55 mg, 0.112 mmol) and diethyl 3-aminopentanedioate (45.3 mg, 0.223 mmol) in DMF (3 mL) was added K<sub>2</sub>CO<sub>3</sub> (61.7 mg, 0.446 mmol) and KI (74.1 mg, 0.446 mmol). The reaction mixture was stirred at 60 °C overnight, cooled to 25 °C, and partitioned between H<sub>2</sub>O and EtOAc. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (MeOH/DCM = 0:100 to10:90) afforded an intermediate diester (75 mg, 100%) as a yellow oil. ES-LCMS <i>m</i>/<i>z</i> 660 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of the diester (74 mg, 0.112 mmol) in a 1:1:1 mixture of THF/MeOH/H<sub>2</sub>O (6 mL) was added LiOH (134 mg, 5.60 mmol). The reaction mixture was stirred at 25 °C overnight, acidified with AcOH, and concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>36</b> (20 mg, 21%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.86 (t, <i>J</i> = 6.8 Hz, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H), 0.97–1.13 (m, 1H), 1.24–1.45 (m, 3H), 1.49–1.72 (m, 1H), 1.77–2.11 (m, 2H), 2.45–2.72 (m, 2H), 2.85 (d, <i>J</i> = 5.7 Hz, 3H), 3.46 (d, <i>J</i> = 15.4 Hz, 1H), 3.58 (s, 3H), 3.74 (d, <i>J</i> = 15.4 Hz, 1H), 3.82–4.00 (m, 3H), 4.41 (d, <i>J</i> = 3.3 Hz, 2H), 6.30 (s, 1H), 6.45 (s, 1H), 7.34–7.66 (m, 5H), 7.95 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 604 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>30</sub>H<sub>41</sub>N<sub>3</sub>O<sub>8</sub>S (M + 1) <i>m</i>/<i>z</i> 604.2697, found 604.2693.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)butanoic Acid Trifluoroacetate Salt (<b>37</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>7</b> (200 mg, 0.481 mmol) in 1,2-dichloroethane (5 mL) was added methyl 4-aminobutanoate (111 mg, 0.722 mmol) and AcOH (0.276 mL, 4.81 mmol). The reaction mixture was stirred at 25 °C overnight, treated with NaHB(OAc)<sub>3</sub> (255 mg, 1.20 mmol), and stirred for 1 h. The reaction mixture was treated with aqueous sodium carbonate solution and extracted with DCM. The organic layer was washed with H<sub>2</sub>O and saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (EtOAc/hexanes = 20:80 to 60:40) afforded an intermediate ester (210 mg, 83%) as a light-yellow oil. ES-LCMS <i>m</i>/<i>z</i> 517 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of ester (210 mg, 0.406 mmol) in a 1:1:1 mixture of THF/MeOH/H<sub>2</sub>O (3 mL) was added LiOH (10 mg, 0.406 mmol). The reaction mixture was stirred at 25 °C overnight then concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>37</b> (46 mg, 44%) trifluoroacetate salt as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.76 (t, <i>J</i> = 6.6 Hz, 3H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H), 0.96–1.32 (m, 4H), 1.35–1.61 (m, 2H), 1.67–1.90 (m, 3H), 1.99–2.15 (m, 1H), 2.33 (t, <i>J</i> = 7.2 Hz, 2H), 2.88–3.01 (m, 2H), 3.09 (d, <i>J</i> = 15.0 Hz, 1H), 3.49 (s, 3H), 3.63 (d, <i>J</i> = 14.8 Hz, 1H), 4.16 (br s, 2H), 5.97 (s, 1H), 6.18 (s, 1H), 7.30–7.56 (m, 5H), 8.09 (s, 1H), 8.67 (br s, 2H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 503 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 503.2584, found 503.2580.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-2-methylalanine Trifluoroacetate Salt (<b>39</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>37</b> using methyl 2-amino-2-methylpropanoate. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>39</b> (102 mg, 66%, TFA salt) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.77 (t, <i>J</i> = 6.8 Hz, 3H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H), 0.98–1.31 (m, 4H), 1.35–1.49 (m, 1H), 1.70–1.86 (m, 1H), 2.00–2.23 (m, 1H), 2.46–2.55 (m, 1H), 3.13 (d, <i>J</i> = 14.8 Hz, 1H), 3.49 (s, 3H), 3.64 (d, <i>J</i> = 15.0 Hz, 1H), 4.14 (d, <i>J</i> = 17.6 Hz, 2H), 6.00 (s, 1H), 6.18 (s, 1H), 7.28–7.55 (m, 5H), 8.10 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 503 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 503.2581, found 503.2580.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">d</span>-aspartic Acid Trifluoroacetate Salt (<b>50</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>37</b> using dimethyl <span class="smallcaps smallerCapital">d</span>-aspartate. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>50</b> (11 mg, 37%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.83 (t, <i>J</i> = 6.8 Hz, 3H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H), 1.04–1.41 (m, 4H), 1.43–1.57 (m, 1H), 1.58–1.78 (m, 1H), 1.80–1.96 (m, 1H), 2.92–3.14 (m, 2H), 3.58–3.67 (m, 4H), 4.13–4.24 (m, 1H), 4.31–4.45 (m, 2H), 6.18 (s, 1H), 6.42 (s, 1H), 7.33–7.54 (m, 5H), 8.10 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 533 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>7</sub>S (M + 1) <i>m</i>/<i>z</i> 533.2324, found 533.2321.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">l</span>-aspartic Acid Trifluoroacetate Salt (<b>51</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>37</b> using dimethyl <span class="smallcaps smallerCapital">l</span>-aspartate. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>51</b> (25 mg, 89%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.81 (t, <i>J</i> = 6.8 Hz, 3H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H), 1.03–1.40 (m, 4H), 1.42–1.58 (m, 1H), 1.62–1.77 (m, 1H), 1.79–1.95 (m, 1H), 2.38 (d, <i>J</i> = 4.1 Hz, 1H), 2.88–3.13 (m, 2H), 3.23 (d, <i>J</i> = 15.0 Hz, 1H), 3.55–3.66 (m, 4H), 4.19 (dd, <i>J</i> = 6.8, 4.3 Hz, 1H), 4.38 (d, <i>J</i> = 7.6 Hz, 2H), 6.17 (s, 1H), 6.40 (s, 1H), 7.32–7.56 (m, 5H), 8.10 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 533 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>7</sub>S (M + 1) <i>m</i>/<i>z</i> 533.2324, found 533.2321.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic Acid (<b>56</b>)</h3><div class="NLM_p">Prepared in a similar fashion to <b>37</b> using diethyl 3-aminopentanedioate (see below). Following saponfication, the reaction was concentrated under reduced pressure then dissolved in H<sub>2</sub>O and MeCN. The solution was acidified to pH 4–5 with AcOH, partially concentrated to remove MeCN under reduced pressure, and left to stand for 30 min. A white precipitate was collected by filtration then dried under reduced pressure at 50 °C overnight to give <b>56</b> as a white solid in >90% yield. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.78 (t, <i>J</i> = 7.0 Hz, 3H), 0.87 (t, <i>J</i> = 7.4 Hz, 3H), 1.05–1.48 (m, 5H), 1.48–1.63 (m, 1H), 1.69–1.84 (m, 1H), 2.12–2.27 (m, 1H), 2.52–2.73 (m, 4H), 3.09 (d, <i>J</i> = 14.8 Hz, 1H), 3.47 (d, <i>J</i> = 14.8 Hz, 1H), 3.58 (s, 3H), 3.60–3.68 (m, 1H), 4.25 (s, 2H), 6.06 (s, 1H), 6.29 (s, 1H), 7.27–7.49 (m, 5H), 8.05 (s, 1H). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.5, 13.9, 22.5, 24.5, 30.1, 32.4, 37.5, 43.2, 51.2, 54.3, 55.2, 56.8, 63.1, 110.3, 124.5, 126.9, 127.7, 128.1, 128.7, 131.8, 142.2, 147.1, 159.9, 172.7. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 547 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>39</sub>N<sub>2</sub>O<sub>7</sub>S (M + H<sup>+</sup>) <i>m</i>/<i>e</i> 547.2478, found 547.2474. C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>7</sub>S requires C, 61.52%; H, 7.01%; N, 5.12%; S, 5.87%. Found: C, 61.49%; H, 6.98%; N, 5.08%; S, 5.86%.</div><div class="NLM_p last">Preparation of diethyl 3-aminopentanedioate: To a solution of β-glutamic acid (500 mg, 3.40 mmol) in EtOH (10 mL) was added thionyl chloride (0.992 mL, 13.59 mmol) dropwise. The reaction mixture was stirred at 25 °C overnight and concentrated under reduced pressure. The residue was partitioned between DCM and saturated potassium carbonate solution. The organic layer was washed with saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the title compound (702 mg, 97%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.09–1.29 (m, 6H), 2.24–2.60 (m, 4H), 3.46–3.74 (m, 1H), 4.04–4.27 (m, 4H).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<i>N</i>-methyl-β-alanine Trifluoroacetate Salt (<b>38</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>7</b> (200 mg, 0.481 mmol) in 1,2-dichloroethane (10 mL) was added 1,1-dimethylethyl β-alaninate (175 mg, 0.963 mmol) and AcOH (0.276 mL, 4.81 mmol). After 1 h of stirring, NaHB(OAc)<sub>3</sub> (255 mg, 1.203 mmol) was added to the reaction mixture. The reaction mixture was stirred at 25 °C for 1 h then treated with an aqueous sodium carbonate solution. The layers were separated, and the aqueous layer was extracted with DCM. The combined organic layers were washed with H<sub>2</sub>O and saturated brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to afford an intermediate ester (210 mg, 80%) as an oil. ES-LCMS <i>m</i>/<i>z</i> 559 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To the ester (210 mg, 0.289 mmol) was added 4 N HCl in dioxane (3.61 mL, 14.46 mmol). The reaction mixture was stirred at 25 °C overnight then concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>38</b> (143 mg, 82%, TFA salt) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 0.86 (t, <i>J</i> = 6.8 Hz, 3H), 0.92 (t, <i>J</i> = 7.2 Hz, 3H), 1.00–1.17 (m, 1H), 1.18–1.46 (m, 3H), 1.51–1.68 (m, 1H), 1.68–1.82 (m, 1H), 1.89–2.10 (m, 1H), 2.35 (br s, 1H), 2.79 (br s, 2H), 3.25 (br s, 2H), 3.33–3.52 (m, 2H), 3.62 (s, 3H), 4.12–4.42 (m, 2H), 6.24 (s, 1H), 6.35 (s, 1H), 7.35–7.62 (m, 5H), 8.13 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 503 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 503.2581, found 503.2580.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">l</span>-proline Ammonium Salt (<b>40</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>38</b> using 1,1-dimethylethyl <span class="smallcaps smallerCapital">l</span>-prolinate HCl. Purification by RP-HPLC (30 mm × 100 mm XBridge column; MeCN + 0.2% NH<sub>4</sub>OH and H<sub>2</sub>O + 0.2% NH<sub>4</sub>OH were used as the solvent system; 10–70% over 8 min, 100–100% to 10 min) to give <b>40</b> (260 mg, 84% yield) ammonium salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 0.96–1.29 (m, 4 H), 1.32–1.53 (m, 2 H), 1.64–1.94 (m, 4 H), 1.99–2.16 (m, 2 H), 2.62 (d, <i>J</i> = 10.0 Hz, 1 H), 2.98–3.12 (m, 2 H), 3.26–3.37 (m, 2 H), 3.44 (s, 3 H), 3.55 (d, <i>J</i> = 15.0 Hz, 1 H), 3.82 (d, <i>J</i> = 14.1 Hz, 1 H), 3.89–4.00 (m, 1 H), 5.94 (d, <i>J</i> = 9.2 Hz, 1 H), 6.10 (s, 1 H), 7.27–7.37 (m, 1 H), 7.42 (d, <i>J</i> = 4.5 Hz, 4 H), 7.99 (s, 1 H) (COOH proton not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 513.5 [M + H]. HRMS (ES+) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 515.2583, found 515.2583.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">d</span>-proline Ammonium salt (<b>41</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>38</b> using 1,1-dimethylethyl <span class="smallcaps smallerCapital">d</span>-prolinate. Cleavage of the <i>t</i>-butyl ester was accomplished using TFA. Purification by RP-HPLC (30 mm × 100 mm XBridge column; MeCN + 0.1% NH<sub>4</sub>OH and H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH were used as the solvent system; 10–70% over 8 min) to give <b>41</b> ammonium salt (333 mg, >99% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.81 (t, <i>J</i> = 7.4 Hz, 3 H), 0.95–1.31 (m, 4 H), 1.34–1.56 (m, 2 H), 1.67–2.14 (m, 5 H), 2.36–2.47 (m, 1 H), 2.58–2.81 (m, 1 H), 3.06 (d, <i>J</i> = 15.0 Hz, 1 H), 3.14–3.27 (m, 1 H), 3.35–3.47 (m, 1 H), 3.49 (s, 3 H), 3.62 (d, <i>J</i> = 15.0 Hz, 1 H), 4.17–4.30 (m, 1 H), 4.36 (d, <i>J</i> = 13.1 Hz, 1 H), 4.50 (d, <i>J</i> = 13.1 Hz, 1 H), 5.96 (br s, 1 H), 6.17 (s, 1 H), 7.31–7.55 (m, 5 H), 8.09 (s, 1 H), 9.84 (br s, 1 H). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 513 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 515 [M + H]. HRMS (ES+) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 515.2584, found 515.2580.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i><sup>2</sup>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">l</span>-lysine Ammonium Salt (<b>42</b>)</h3><div class="NLM_p last">Prepared in a similar fashion to <b>38</b> using 1,1-dimethylethyl <i>N</i><sup>6</sup>-{[(1,1-dimethylethyl)oxy]carbonyl}-<span class="smallcaps smallerCapital">l</span>-lysinate·HCl. The crude material was purified by RP-HPLC (30 mm × 100 mm XBridge column, MeCN/H<sub>2</sub>O containing 0.2% NH<sub>4</sub>OH buffer, 10 to 80 to 100% over 10 min) to give <b>42</b> (297 mg, 38% yield) ammonium salt as a pink foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 0.97–1.60 (m, 12 H), 1.67–1.80 (m, 1 H), 1.99–2.14 (m, 1 H), 2.54 (d, <i>J</i> = 9.8 Hz, 1 H), 2.64–2.78 (m, 3 H), 3.06 (d, <i>J</i> = 14.9 Hz, 1 H), 3.41 (s, 3 H), 3.50 (dd, <i>J</i> = 15.0, 9.3 Hz, 2 H), 3.65 (d, <i>J</i> = 15.0 Hz, 1 H), 5.94 (d, <i>J</i> = 9.6 Hz, 1 H), 6.06 (s, 1 H), 7.32 (dq, <i>J</i> = 8.5, 4.2 Hz, 1 H), 7.41 (d, <i>J</i> = 4.5 Hz, 4 H), 7.99 (s, 1 H) (4 exchangeable protons not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 546 [M + H]. HRMS (ES+) calcd for C<sub>29</sub>H<sub>43</sub>N<sub>3</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 546.2998, found 546.3002.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">l</span>-threonine Ammonium Salt (<b>43</b>)</h3><div class="NLM_p last">Prepared as in <b>38</b> using 1,1-dimethylethyl <span class="smallcaps smallerCapital">l</span>-threoninate. The crude product mixture was purified by RP-HPLC (30 mm × 100 mm XBridge column, MeCN/H<sub>2</sub>O containing 0.2% NH<sub>4</sub>OH buffer, 10 to 70 to 100% over 10 min) to give <b>43</b> (188 mg, 60% yield) ammonium salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 0.97–1.28 (m, 4 H), 1.16 (d, <i>J</i> = 6.4 Hz, 3 H), 1.33–1.54 (m, 2 H), 1.68–1.79 (m, 1 H), 2.00–2.12 (m, 1 H), 2.59 (d, <i>J</i> = 9.8 Hz, 1 H), 2.96 (d, <i>J</i> = 4.7 Hz, 1 H), 3.06 (d, <i>J</i> = 14.9 Hz, 1 H), 3.44 (s, 3 H), 3.54 (d, <i>J</i> = 14.9 Hz, 1 H), 3.67–3.93 (m, 3 H), 5.94 (d, <i>J</i> = 9.4 Hz, 1 H), 6.09 (s, 1 H), 7.29–7.37 (m, 1 H), 7.37–7.46 (m, 4 H), 8.03 (s, 1 H) (3 exchangeable protons not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 519 [M + H]. HRMS (ES+) calcd for C<sub>27</sub>H<sub>38</sub>N<sub>2</sub>O<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 519.2532, found 519.2529.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<span class="smallcaps smallerCapital">l</span>-serine Bis-ammonium Salt (<b>44</b>)</h3><div class="NLM_p last">Prepared as in <b>38</b> using 1,1-dimethylethyl <span class="smallcaps smallerCapital">l</span>-serinate·HCl. The crude product was purified by RP-HPLC (30 mm × 100 mm XBridge column, MeCN/H<sub>2</sub>O containing 0.2% NH<sub>4</sub>OH buffer, 10 to 70 to 100% over 8 min) to give <b>44</b> (194 mg, 64% yield) bis-ammonium salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 0.96–1.29 (m, 4 H), 1.32–1.54 (m, 2 H), 1.66–1.82 (m, 1 H), 1.98–2.13 (m, 1 H), 2.62 (d, <i>J</i> = 9.6 Hz, 1 H), 3.06 (d, <i>J</i> = 15.0 Hz, 1 H), 3.16 (t, <i>J</i> = 5.2 Hz, 1 H), 3.45 (s, 3 H), 3.56 (d, <i>J</i> = 14.9 Hz, 1 H), 3.65 (qd, <i>J</i> = 11.1, 5.2 Hz, 2 H), 3.79–3.94 (m, 2 H), 5.02 (br s, 1 H), 5.94 (d, <i>J</i> = 9.6 Hz, 1 H), 6.10 (s, 1 H), 7.28–7.37 (m, 1 H), 7.37–7.47 (m, 4 H), 8.02 (s, 1 H) (2 exchangables not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 505 [M + H]. HRMS (ES+) calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>6</sub>S (M + 1) <i>m</i>/<i>z</i> 505.2372, found 505.2372.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}glycine (<b>45</b>)</h3><div class="NLM_p last">Prepared as in <b>38</b> using 1,1-dimethylethyl glycinate. Recrystallization from CH<sub>3</sub>CN provided <b>45</b> (5.0 g, 82%) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.78 (t, <i>J</i> = 6.8 Hz, 3H), 0.87 (t, <i>J</i> = 7.4 Hz, 3H), 1.01–1.34 (m, 4H), 1.34–1.48 (m, 1H), 1.49–1.64 (m, 1H), 1.67–1.86 (m, 1H), 2.12–2.31 (m, 1H), 3.08 (d, <i>J</i> = 15.0 Hz, 1H), 3.42 (s, 2H), 3.50 (d, <i>J</i> = 14.8 Hz, 1H), 3.58 (s, 3H), 4.22 (s, 2H), 6.06 (s, 1H), 6.30 (s, 1H), 7.25–7.50 (m, 5H), 8.06 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 475 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 475.2270, found 475.2267.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-{[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}-<i>N</i>-methylglycine Ammonium Salt (<b>46</b>)</h3><div class="NLM_p last">Prepared as in <b>38</b> using 1,1-dimethylethyl <i>N</i>-methylglycinate·HCl. The residue was purified by RP-HPLC (30 mm × 100 mm XBridge column; acetonitrile + 0.2% NH<sub>4</sub>OH and H<sub>2</sub>O + 0.2% NH<sub>4</sub>OH were used as the solvent system; 10% to 70% over 8 min, 100% to 100% to 10 min) to give <b>46</b> (130 mg, 44% yield) ammonium salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 0.96–1.28 (m, 4 H), 1.32–1.53 (m, 2 H), 1.68–1.80 (m, 1 H), 1.99–2.11 (m, 1 H), 2.30 (s, 3 H), 2.62 (d, <i>J</i> = 9.4 Hz, 1 H), 3.07 (d, <i>J</i> = 14.9 Hz, 1 H), 3.24 (s, 2 H), 3.42 (s, 3 H), 3.54 (d, <i>J</i> = 14.9 Hz, 1 H), 3.69 (s, 2 H), 5.93 (d, <i>J</i> = 8.2 Hz, 1 H), 6.10 (s, 1 H), 7.33 (dq, <i>J</i> = 8.5, 4.2 Hz, 1 H), 7.41 (d, <i>J</i> = 4.3 Hz, 4 H) 7.98 (s, 1 H) (COOH proton not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 489 [M + H]. HRMS (ES+) calcd for C<sub>26</sub>H<sub>36</sub>N<sub>2</sub>O<sub>5</sub>S (M + 1) <i>m</i>/<i>z</i> 489.2422, found 489.2423.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)ethanesulfonic Acid Ammonium Salt (<b>47</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (100 mg, 0.240 mmol) in DMF (4 mL) was added 2-bromoethane sulfonic acid sodium salt (25.3 mg, 0.120 mmol). The reaction mixture was stirred at 70 °C overnight, cooled to 25 °C, acidified with TFA, and concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN), followed by further purification with RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.5% ammonium hydroxide in H<sub>2</sub>O) afforded <b>47</b> (28 mg, 54%, ammonium salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.78 (t, <i>J</i> = 6.6 Hz, 3H), 0.87 (t, <i>J</i> = 7.4 Hz, 3H), 1.05–1.32 (m, 4H), 1.34–1.49 (m, 1H), 1.49–1.70 (m, 1H), 1.71–1.88 (m, <i>J</i> = 5.1 Hz, 1H), 2.09–2.31 (m, 1H), 2.96–3.15 (m, 3H), 3.30–3.38 (m, 2H), 3.49 (d, <i>J</i> = 15.0 Hz, 1H), 3.58 (s, 3H), 4.20 (s, 2H), 6.06 (s, 1H), 6.30 (s, 1H), 7.19–7.54 (m, 5H), 8.03 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 525 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>36</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> (M + 1) <i>m</i>/<i>z</i> 525.2093, found 525.2093.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> [({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)methyl]phosphonic Acid Trifluoroacetate Salt (<b>48</b>)</h3><div class="NLM_p">Step 1: Compound <b>8</b> (45.8 mg, 0.110 mmol) was combined with paraformaldehyde (3.5 mg, 0.11 mmol) and diethyl phosphite (0.014 mL, 0.11 mmol) in THF (4 mL) and stirred for 16 h at 75 °C, after which time all solvent was gone and LCMS indicated <20% conversion. The THF was replaced and additional diethyl phosphite (0.043 mL, 0.330 mmol) was added, and the mixture was heated an additional 24 h at 75 °C, after which time LCMS indicated ∼50% conversion. Additional diethyl phosphite (0.150 mL, 1.16 mmol) was added and heating was continued for 24 h, after which time LCMS indicated 70% completion. Additional paraformaldehyde (1.7 mg, 0.055 mmol) was added and heating was continued for 24 h, after which time LCMS indicated complete conversion of starting material to mono- and disubstituted products. The mixture was concentrated to dryness and purified on silica gel eluting with 0–20% MeOH/DCM to give an intermediate diethyl phosphonate (36 mg, 58% yield) as a clear oil. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 567 [M + H].</div><div class="NLM_p last">Step 2: The diethyl phosphonate (36 mg, 0.064 mmol) dissolved in DCM (1 mL) was treated with TMSBr (100 mg, 0.65 mmol) at 25 °C for 18 h. The mixture was concentrated to dryness, and the crude product was purified by RP-HPLC (30 mm × 75 mm , C18, 5 um H<sub>2</sub>O Sunfire column at 55 mL/min; MeCN + 0.05% TFA and H<sub>2</sub>O + 0.05% TFA were used as the solvent system; 10–100 over 8 min, 100 to 100 to 10 min) to give <b>48</b> (6 mg, 18% yield) trifluoroacetate salt as a white glass. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 7.0 Hz, 3 H), 0.81 (t, <i>J</i> = 7.4 Hz, 3 H), 0.95–1.32 (m, 4 H), 1.33–1.56 (m, 2 H), 1.68–1.80 (m, 1 H), 1.98–2.12 (m, 1 H), 2.63–2.73 (m, 1 H), 3.00–3.13 (m, 2 H), 3.48 (s, 3 H), 3.57–3.66 (m, 2 H), 4.14–4.30 (m, 2 H), 5.86–6.02 (m, 1 H), 6.15 (s, 1 H), 7.31–7.50 (m, 5 H), 8.10 (s, 1 H) (3 exchangable protons not observed). LC-MS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 509 [M – 1]. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 511 [M + H]. HRMS (ES+) calcd for C<sub>24</sub>H<sub>35</sub>N<sub>2</sub>O<sub>6</sub>PS (M + 1) <i>m</i>/<i>z</i> 511.2034, found 511.2032.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> [2-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)ethyl]phosphonic Acid Trifluoroacetate Salt (<b>49</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>7</b> (50 mg, 0.120 mmol) in 1,2-dichloroethane (3 mL) was added diethyl (2-aminoethyl)phosphonate (109 mg, 0.602 mmol). The reaction mixture was stirred for 3 h then treated with NaHB(OAc)<sub>3</sub> (128 mg, 0.602 mmol). The reaction mixture was stirred at 25 °C for 2 h then treated with H<sub>2</sub>O followed by 1 N HCl. The resulting mixture was concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded an intermediate diethyl aminophosphonate (70 mg, 71%) as a white solid. ES-LCMS <i>m</i>/<i>z</i> 581 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2: To a solution of the diethyl aminophosphonate (70 mg, 0.121 mmol) in DCM (3 mL) was added TMSBr (0.065 mL, 0.499 mmol). The reaction mixture was stirred at 25 °C overnight. Additional TMSBr (0.16 mL, 1.21 mmol) was added. The reaction mixture was stirred overnight, concentrated under reduced pressure, and treated with H<sub>2</sub>O. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>49</b> (51 mg, 55%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.81 (t, <i>J</i> = 7.0 Hz, 3H), 0.90 (t, <i>J</i> = 7.4 Hz, 3H), 1.00–1.38 (m, 4H), 1.38–1.55 (m, 1H), 1.59–1.75 (m, 1H), 1.76–2.06 (m, 3H), 2.23–2.40 (m, 1H), 3.14–3.24 (m, 3H), 3.57–3.65 (m, 4H), 4.12–4.35 (m, 2H), 6.15 (s, 1H), 6.39 (s, 1H), 7.30–7.53 (m, 5H), 8.09 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 525 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>37</sub>N<sub>2</sub>O<sub>6</sub>PS (M + 1) <i>m</i>/<i>z</i> 525.2185, found 525.2188.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]pentanedioic Acid (<b>52</b>)</h3><div class="NLM_p">Step 1: To a solution of <b>7</b> (109 mg, 0.262 mmol) in toluene (3 mL) was added diethyl malonate (0.048 mL, 0.315 mmol) and piperidine (0.013 mL, 0.131 mmol). The reaction mixture was stirred at 100 °C overnight, cooled to 25 °C, and concentrated under reduced pressure. Purification via SiO<sub>2</sub> chromatography (EtOAc/Hex = 10:90 to 80:20) afforded an intermediate diethyl propanedioate (146 mg, 90% pure, 90%) as a light-yellow oil. ES-LCMS <i>m</i>/<i>z</i> 558 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of diethyl malonate (0.096 mL, 0.628 mmol) in EtOH (3 mL) was added sodium ethoxide (0.254 mL, 0.681 mmol). The reaction mixture was stirred at 25 °C for 20 min and treated with a solution of the intermediate diethyl malonate (146 mg, 0.262 mmol) in EtOH (2 mL). The reaction mixture was stirred at 25 °C overnight, acidified with AcOH to pH 3–4, and partially concentrated under reduced pressure to remove the organic solvents. The residue was partitioned between water and DCM. The organic layer was washed with saturated brine, dried, (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Purification using silica gel (EtOAc/hexanes from 1:5 to 2:1) afforded an intermediate tetraethyl 1,1,3,3-propanetetracarboxylate (120 mg, 84% pure, 53%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.66–0.92 (m, 6H), 0.97–1.10 (m, 6H), 1.17–1.27 (m, 8H), 1.34–1.54 (m, 2H), 1.74–1.90 (m, 1H), 2.04 (d, <i>J</i> = 14.7 Hz, 1H), 2.07–2.23 (m, 2H), 2.90 (d, <i>J</i> = 14.9 Hz, 1H), 3.37 (d, <i>J</i> = 14.9 Hz, 1H), 3.86–4.03 (m, 4H), 4.04–4.20 (m, 6H), 4.43 (br s, 1H), 5.97 (s, 1H), 6.08 (s, 1H), 7.26–7.48 (m, 5H), 7.97 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 718 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 3: A mixture of the tetraethyl 1,1,3,3-propanetetracarboxylate (120 mg, 0.167 mmol) and 37% HCl (3 mL) was stirred at reflux for 20 h. LC-MS showed no starting material left but instead a mixture of triacid and diacid. Additional 37% HCl (3 mL) was added, and the reaction mixture was heated at reflux overnight. The reaction mixture was cooled to 25 °C then concentrated under reduced pressure. Purification with HPLC (eluting with MeCN/water with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>52</b> (76 mg, 95% pure, 68%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.68–0.92 (m, 6H), 0.95–2.26 (m, 7H), 2.59 (d, <i>J</i> = 7.2 Hz, 4H), 3.46 (s, 3H), 3.55–3.82 (m, 2H), 5.58–6.41 (m, 1H), 6.98–7.66 (m, 5H), 7.78 (br s, 1H), 12.14 (br s, 2H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 518 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>35</sub>NO<sub>2</sub>S (M + 1) <i>m</i>/<i>z</i> 518.2211, found 518.2212.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2,2′-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}imino)diacetic Acid Hydrochloride Salt (<b>53</b>)</h3><div class="NLM_p">Step 1: Prepared from bromomethyl intermediate (see compound <b>18</b>, step 2) (77 mg, 0.16 mmol) by heating a MeCN solution of diethyl iminodiacetic acid (33 mg, 0.18 mmol) at 65 °C for 4 h then concentrating to a thick oil. Chromatography on silica using hexanes/EtOAc provided a clear oil.</div><div class="NLM_p last">Step 2: H<sub>2</sub>O and THF were added to the product from step 1 along with LiOH (15 mg, 0.36 mmol), and the mixture stirred for 2 h at 25 °C to hydrolyze the diacid. The reaction mixture was concentrated to half volume, and 1 N HCl added to acidify the reaction contents then the organics were extracted with DCM. The combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was triturated (DCM/EtOAc), filtered, and dried. The material was redissolved in DCM/EtOAc/MeOH then concentrated to a solid and kept under N<sub>2</sub> overnight to dry. <b>53</b> was obtained as a white hydrochloride salt (45 mg, 47% over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.62–0.90 (m, 6 H), 0.98–1.56 (m, 8 H), 1.75 (br s, 1 H), 2.08 (br s, 1 H), 2.51 (br s, 14 H), 3.07 (d, <i>J</i> = 14.83 Hz, 1 H), 3.16–3.59 (m, 26 H), 3.81 (br s, 2 H), 5.95 (br s, 1 H), 6.09 (s, 1 H), 7.16–7.55 (m, 5 H), 8.03 (s, 1 H), 12.36 (br s, 2 H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 533 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>7</sub>S (M + 1) <i>m</i>/<i>z</i> 533.2321, found 533.2321.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2,2′-({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}imino)diethanesulfonic Acid Trifluoroacetate Salt (<b>54</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (25 mg, 0.060 mmol) in DMF (2 mL) was added 2-bromoethane sulfonic acid sodium salt (127 mg, 0.600 mmol). The reaction mixture was stirred at 70 °C overnight, cooled to room temperature, acidified to pH 3–4 with AcOH, and concentrated under reduced pressure. Purification by RP-HPLC (eluting with MeCN/H<sub>2</sub>O with 0.05% TFA-H<sub>2</sub>O and 0.05% TFA-MeCN) afforded <b>54</b> (13 mg, 24%, TFA salt) as a white solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ ppm 0.71–1.17 (m, 7H), 1.22–1.53 (m, 3H), 1.57–1.80 (m, 1H), 1.85–2.27 (m, 2H), 2.60–2.85 (m,1H), 3.41–3.83 (m, 8H), 3.95 (d, <i>J</i> = 15.8 Hz, 1H), 4.40 (d, <i>J</i> = 13.5 Hz, 1H), 4.72 (d, <i>J</i> = 13.3 Hz, 1H), 6.53 (s, 1H), 6.68 (s, 1H), 7.42–7.80 (m, 5H), 8.23 (s, 1H). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 633 (M + H)<sup>+</sup>. HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>40</sub>N<sub>2</sub>O<sub>9</sub>S<sub>3</sub> (M + 1) <i>m</i>/<i>z</i> 633.1974, found 633.1974.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> [({[(3<i>R</i>,5<i>R</i>)-3-Butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}imino)dimethanediyl]bis(phosphonic acid) Tetraammonium Salt (<b>55</b>)</h3><div class="NLM_p">Step 1: Compound <b>8</b> (155 mg, 0.37 mmol) was combined with TsOH (cat.) in toluene (20 mL) and concentrated to dryness to azeotrope off any residual H<sub>2</sub>O. Paraformaldehyde (11 mg, 0.37 mmol) and toluene (5 mL) were added, and the mixture was heated at 75 °C with vigorous stirring for 30 min, after which time diethyl phosphite (0.048 mL, 0.37 mmol) was added. After 30 min, THF (20 mL) was added to the mixture, and the resultant homogeneous reaction mixture was stirred overnight at 75 °C. The mixture was concentrated to dryness and purified by RP-HPLC (30 mm × 150 mm Sunfire column under acidic conditions; MeCN + 0.05% TFA and H<sub>2</sub>O + 0.05% TFA were used as the solvent system; 30–100% over 10 min, 100–100% to 12 min) to give an intermediate tetraethyl bis(phosphonate) (50 mg, 19% yield) as a yellow oil. LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 717 [M + H].</div><div class="NLM_p last">Step 2: The tetraethyl bis(phosphonate) (100 mg, 0.14 mmol) dissolved in DCM (5 mL) was treated with TMSBr (171 mg, 1.12 mmol) at 25 °C overnight. The mixture was concentrated to dryness, and the crude product was purified by RP-HPLC (30 mm × 100 mm XBridge column under basic conditions; MeCN + 0.1% NH<sub>4</sub>OH and H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH were used as the solvent system; 10% to 55% over 6 min, 100% to 100% to 8 min) to give <b>55</b> (45 mg, 54% yield) as an ammonium salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75 (t, <i>J</i> = 6.9 Hz, 3 H), 0.80 (t, <i>J</i> = 7.5 Hz, 3 H), 0.97–1.29 (m, 4 H), 1.32–1.55 (m, 2 H), 1.68–1.81 (m, 1 H), 1.98–2.14 (m, 1 H), 2.58–2.77 (m, 5 H), 3.09 (d, <i>J</i> = 14.8 Hz, 1 H), 3.41 (s, 3 H), 3.52 (d, <i>J</i> = 15.0 Hz, 1 H), 3.75–3.96 (m, 2 H), 5.94 (d, <i>J</i> = 8.6 Hz, 1 H), 6.08 (s, 1 H), 7.25–7.37 (m, 1 H), 7.36–7.49 (m, 4 H), 7.90 (s, 1 H) (phosphonic acid protons not observed). LC-MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 605 [M + H]. HRMS (ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>38</sub>N<sub>2</sub>O<sub>9</sub>P<sub>2</sub>S (M + 1) <i>m</i>/<i>z</i> 605.1852, found 605.1853.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Method for Determination of Human, Mouse, and Rat ASBT Inhibition</h3><div class="NLM_p">In preparation for measurement of bile acid uptake into cells expressing ASBT, HEK293 cells were cultured in DMEM/F12 supplemented with 10% FBS. Twenty-four h prior to running an experiment, cells were harvested when at a confluence of 80–90%. Cells were seeded in poly <span class="smallcaps smallerCapital">d</span>-lysine coated plates at 50000 cells per well, and ASBT Bacmam virus was added such that each well contains 3.67 × 10<sup>6</sup> pfu (73.4 pfu/cell). Each assay plate was covered with Breathe Easy Seal and placed in an incubator for 24 h to allow expression of the transporter.</div><div class="NLM_p">On the day of the uptake experiment, 10 mM HEPES was added to Hank’s Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The assay buffer was prepared by adding 100 pM [<sup>3</sup>H]-taurocholate and 10 μM cold taurocholate to room temperature HBSSH. A separate washing buffer was prepared by adding 10 μM cold taurocholate to HBSSH (∼30 mL per assay plate) and placed on ice. Using 100% DMSO, 8-point, 3-fold dilution curves for each test compound was prepared starting at 200 μM. Similarly, an 8-point dose response curve was prepared of the control compound <b>1</b> starting at 1.8 mM. Drug plates were created by adding 3 μL of each concentration to a v-bottom 96-well plate then diluted 60-fold with 177 μL of assay buffer. Plates were removed from the incubator and allowed to cool to 25 °C. Media was aspirated, and wells were washed once with 300 μL of HBSSH. Then 50 μL of each dose response curve concentration was added in triplicate by column to the assay plates, reserving column 10 for control (assay buffer + 1.67% DMSO) and columns 11 and 12 for the control compound. Plates were incubated at ambient temperature for 90 min then the plates were aspirated then washed 1× with 300 μL of wash buffer. Then 220 μL of Microscint 20 was added to each well, and the plates were sealed. The amount of [<sup>3</sup>H]-taurocholate in cell lysate was quantitated using a microplate scintillation counter on the following day.</div><div class="NLM_p last">Percent inhibition of uptake was determined using the following formula at each drug concentration: 100 × (1 – ((T1 – C2)/(C1 – C2))); where T1 is average cpm for the test compound, C1 is average cpm observed in the absence of any added inhibitor, and C2 is average cpm observed in the presence of a substance known to elicit 100% inhibition of uptake (30 μM control compound). IC<sub>50</sub>s can be generated using the formula, <i>y</i> = (<i>V</i><sub>max</sub> × <i>x</i><sub>n</sub>)/(<i>K</i><sub>n</sub> + <i>x</i><sub>n</sub>).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Method for Determination of MDCK Permeability</h3><div class="NLM_p">Passive permeability was measured in vitro using stably transfected human Multi-Drug Resistance 1–Madin–Darby Canine Kidney (hMDR1-MDCK, Netherlands Cancer Institute) cells incubated under conditions relevant to intestinal absorption. Briefly, hMDR1-MDCK cells were seeded at 6.6 × 10<sup>5</sup> cells/well onto 12-well polycarbonate Transwells filter membranes with 0.4 μm pore size (Corning (Corning, NY)) and maintained in Dulbecco’s Modified Eagle’s Media containing 10% fetal bovine serum (DMEM-FBS) at 37 °C in an atmosphere of 5% CO<sub>2</sub> and 95% relative humidity. After three days, media was removed from both the apical and basolateral chambers and replaced with transport buffer (HBSS containing 25 mM glucose and 25 mM HEPES) containing the P-gp inhibitor GF120918A at a final concentration of 2 μM. After a 30 min equilibration, the transport buffer was removed from the apical chambers and replaced with fasted-state simulated intestinal fluid (FaSSIF) containing 3 μM test compound, 2 μM GF120918A, 25 mM glucose, and 250 μM Lucifer Yellow CH. Next, the transport buffer was removed from the basolateral chambers and replaced with transport buffer containing 1% (w/v) human serum albumin and 2 μM GF120918A.</div><div class="NLM_p">After 60 min incubation at 37 °C, samples were collected from the apical (donor) and basolateral (receiver) compartments and added to acetonitrile (1:1 and 1:2 (v/v), respectively). Receiver samples were then centrifuged and the supernatants were removed and analyzed by LC-MS/MS.</div><div class="NLM_p last">The final DMSO concentration in all dose solutions was 0.3% (v/v). Each treatment was performed in duplicate. Propranolol, a high permeability marker compound, and amprenavir, a marker compound for P-gp activity, were included in separate wells as controls for the assay. Cell monolayer integrity was assessed by measuring Lucifer yellow transport via a fluorescence-based assay.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Rat Luminal Contents Stability Assay</h3><div class="NLM_p">A 10% (w/v) homogenate of the luminal contents from rat cecum and colon in phosphate buffered saline (PBS, pH 7.4) was prepared as follows.</div><div class="NLM_p">Two male SD rats (Charles River Laboratories, Raleigh, NC) were fasted overnight and euthanized by CO<sub>2</sub> asphyxiation, followed by exsanguination. The large intestine and cecum were removed from both animals and cut lengthwise. The luminal contents were removed, pooled into a preweighed 50 mL conical tube, diluted with PBS (10 mL/g sample weight), and gently mixed by inversion. The homogenate was placed on wet ice until use.</div><div class="NLM_p last">Test compounds (10 μM final concentration) were added to a 4 mL glass screwcap vial containing 3 mL of the homogenate of the luminal contents from rat cecum and colon. Immediately after the addition of test compound, the vial was gently mixed and 3 × 100 μL aliquots were removed (<i>t</i> = 0) and placed into a 96-deepwell plate containing 400 μL of stopping solution (80% acetonitrile/20% methanol). Next, the glass vial was purged under a gentle stream of nitrogen gas for approximately 30 s, capped, and placed in a 37 °C shaking water bath. At <i>t</i> = 2, 4, and 24 h, 3 × 100 μL aliquots were removed from the vial and placed into a 96-deepwell plate containing 400 μL of stopping solution. The vial was purged under a gentle stream of nitrogen gas for approximately 30 s, capped, and placed in a 37 °C shaking water bath after each time point. Samples were covered and stored at −10 °C until LC-MS/MS analysis.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Rat Oral Absorption Assay</h3><div class="NLM_p">Male Sprague–Dawley (SD) rats (271–303 g; Charles River Laboratories, Raleigh, NC) were housed with free access to standard chow (PMI 5002 block chow) and water, unless otherwise noted. Animals for intravenous treatment groups were surgically implanted with a jugular and femoral vein cannula. Animals for oral treatment groups were surgically implanted with a jugular and portal vein cannula. Food was withheld from rats overnight prior to dosing and was returned at approximately 4 h postdose.</div><div class="NLM_p last">Oral treatment groups received test compounds formulated as a homogeneous suspension in 0.5% HPMC/0.1% Tween via oral gavage at a dose of 10 mg/kg. Blood samples were collected from both jugular and portal vein cannulae at 0.25, 0.5, 1, 2, 4, and 8 h postdose. Plasma samples were prepared and stored at −70 °C until analysis.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Rat Fecal Drug Recovery</h3><div id="sec5_63_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Fecal Recovery</h4><div class="NLM_p last">Male SD rats (Charles River Laboratories, Raleigh, NC) were administered test compounds formulated as a homogeneous suspension in 0.1% HPMC:0.5% Tween via oral gavage at a dose of 10 mg/kg. Fecal samples were collected across the following intervals: 0–6, 6–12, 12–24, 24–36, 36–48, 48–60, and 60–72 h postdose. After each collection interval, the samples were capped and stored at −70 °C until analysis. Prior to analysis, the samples were diluted with 5 volumes of 20% EtOH:80% H<sub>2</sub>O, soaked overnight at 10 °C, and then homogenized using a Polytron hand-held homogenizer. The homogenates were extracted with 3 volumes of acetonitrile and then centrifuged for 15 min at 2304<i>g</i> and 4 °C. Aliquots of each acetonitrile supernatant was transferred to clean 96-well plates and diluted with an equal volume of water. Drug concentrations were quantified via LC-MS/MS.</div></div><div id="sec5_63_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Animals for Efficacy Studies</h4><div class="NLM_p last">Male C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, Maine) at seven weeks old and fed with normal rodent diet (Purina 5001, Harlan Teklad, Indianapolis, IN). Male Zucker Diabetic Fatty (ZDF/GmiCrl-fa/fa) mice were purchased from Charles River (Raleigh, NC) and had free access to rodent food (Purina 5008, Harlan Teklad, Indianapolis, IN). All animals were housed under controlled conditions (12/12 light–dark cycle, 24 °C and 50% relative humidity). All procedures performed were in compliance with the Animal Welfare Act and U.S. Department of Agriculture regulations and were approved by the GlaxoSmithKline Animal Care and Use Committee.</div></div><div id="sec5_63_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Fecal Collection in Mice</h4><div class="NLM_p last">Male C57BL/6J mice were dosed with vehicle (0.5% hydroxypropyl methylcellulose (HPMC), 0.1% Tween80) or six doses (0.0001, 0.001, 0.01, 0.1, 1, and 10 mg/kg) of compounds at 0700 and 1500 for one day, and fecal samples were collected for 24 h (0700–0700). Animals were used for up to five studies with one week washout between studies.</div></div><div id="sec5_63_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Fecal Collection in Rat</h4><div class="NLM_p last">Male ZDF rats arrived at seven weeks of age (±3 days). After a one-week acclimation period, rats were assigned to different treatment groups (<i>n</i> = 6–8/group) based upon baseline glucose/vehicle (0.5% hydroxypropyl methylcellulose (HPMC), 0.1%Tween80); one vehicle group for each compound) and six doses (0.05, 0.1, 0.5, 1, 5, and 10 mg/kg) of compounds <b>20</b>, <b>45</b>, and <b>56</b>. All treatments were given via oral gavage twice a day. Fecal samples were collected for 24 h on day 7 of treatment.</div></div><div id="sec5_63_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Metabolic Effects in ZDF Rats</h4><div class="NLM_p last">Male ZDF rats arrived at seven weeks of age (±3 days). After a one-week acclimation period, rats were anesthetized with isoflurane (Abbott Laboratories, IL) and tail-vein blood samples were collected at 0900 without fasting. To ensure balanced treatment groups, ZDF rats were assigned to six treatment groups based upon baseline glucose/vehicle (0.5% hydroxypropyl methylcellulose (HPMC), 0.1%Tween80) and selected doses of compounds (0.05, 0.1, 0.5, 1, 5, and 10 mg/kg or 0.001, 0.01, 0.1, 1, and 10 mg/kg for compounds <b>20</b> and <b>45</b> or <b>56</b>, respectively). All treatments were given via oral gavage twice a day, and animals were followed for two weeks with blood samples collected from tail vein on day 14 at 0900 without fasting. Plasma samples were stored at −80 °C for further analyses.</div></div><div id="sec5_63_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Measurement of Clinical Chemistry Parameters</h4><div class="NLM_p last">Plasma glucose and bile acids in fecal extraction were measured using the Olympus AU640 clinical chemistry analyzer (Beckman Coulter, Irving, TX). Glucose test reagents were manufactured by Beckman Coulter. Bile acids reagents were manufactured by Trinity Biotech. HbA1c was measured by the Primus Affinity Ultra2 HPLC system using Primus Affinity Assay reagents (Primus Diagnostics, Kansas City, MO). Insulin, total GLP-1 (tGLP-1), PYY, and GIP were assayed using the Meso Scale Discovery (MSD) assay kits. Total Glp-1 was assayed by the MSD Total Glp-1 assay kit and analyzed on an MSD Sector Imager 6000 (Meso Scale Discovery, Gaithersburg, MD).</div></div><div id="sec5_63_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Fecal Bile Acid Extraction</h4><div class="NLM_p last">Fecal samples were air-dried for five days and extracted in methanol–KOH (300 mM) at 60 °C for 24 h. Fecal extract was then mixed with 150 mM Mg<sub>2</sub>SO<sub>4</sub> (1:1). After centrifugation, the supernatant was saved and submitted for bile acids measurement as described above.</div></div><div id="sec5_63_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Data Analysis</h4><div class="NLM_p">All of the in vivo studies described above were analyzed as described in this paragraph.</div><div class="NLM_p last">Values are given as mean ± SEM. The data were analyzed in JMP 7.0.0 (SAS Institute, 174 Cary, NC) using one-way ANOVA with prespecified contrasts to compare each group to the appropriate control group (fecal BA data) or two-way ANOVA with Bonferroni post-tests. <i>P</i> values <0.05 were considered to indicate a significant difference between treatment groups. Dose–responses were fit to four-parameter logistic functions (GraphPad Prism v5.04, San Diego, CA).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm400459m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon L. Collins</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#175d7879395b3954787b7b7e79645770647c3974787a"><span class="__cf_email__" data-cfemail="f0ba9f9edebcdeb39f9c9c999e83b097839bde939f9d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yulin Wu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Aquino</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Cowan</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Don L. Anderson</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff L. Ambroso</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Bishop</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric E. Boros</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lihong Chen</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Cunningham</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert L. Dobbins</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul L. Feldman</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lindsey T. Harston</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Istvan W. Kaldor</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan Klein</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xi Liang</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maggie S. McIntyre</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine L. Merrill</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin M. Patterson</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith S. Prescott</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John S. Ray</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shane G. Roller</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaozhou Yao</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Young</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josephine Yuen</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d46e8755-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Erin D. Swiger for purification support as well as Mike Lewandowski and Iris Paulus for generation of HRMS data, and the many other GlaxoSmithKline scientists who made ancillary contributions to the work that is described in this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i86" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i86"> Abbreviations Used</h2><tr><td class="NLM_term">ASBT</td><td class="NLM_def"><p class="first last">apical sodium-dependent bile acid transporter</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">bile acids</p></td></tr><tr><td class="NLM_term">DPP-4</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase-4</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like-1</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">glucose dependent insulinotropic peptide</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human embryonic kidney 293</p></td></tr><tr><td class="NLM_term">iBAT</td><td class="NLM_def"><p class="first last">ileal bile acid transporter</p></td></tr><tr><td class="NLM_term">HbA1c</td><td class="NLM_def"><p class="first last">hemoglobin A1c</p></td></tr><tr><td class="NLM_term">hMDR1-MDCK</td><td class="NLM_def"><p class="first last">human multidrug resistance 1–Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">PYY</td><td class="NLM_def"><p class="first last">peptide YY</p></td></tr><tr><td class="NLM_term">tGLP-1</td><td class="NLM_def"><p class="first last">total GLP-1</p></td></tr><tr><td class="NLM_term">ZDF</td><td class="NLM_def"><p class="first last">Zucker Diabetic Fatty</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><div class="note"><p class="first last">Recent facts about diabetes can be found via the Internet at the World Health Organization website:</p></div>Diabetes, <span class="NLM_series">Fact Sheet no. 312</span>: <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_month">March</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs312/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs312/en/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Recent+facts+about+diabetes+can+be+found+via+the+Internet+at+the+World+Health+Organization+website%3ADiabetes%2C+Fact+Sheet+no.+312%3A+World+Health+Organization%3A+Geneva%2C+March%2C+2013%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312%2Fen%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%26pub%3DWorld%2520Health%2520Organization%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Inzucchi, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergenstal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buse, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrannini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsapas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span> </span><span class="NLM_article-title">Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1364</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1364-1379&author=S.+E.+Inzucchiauthor=R.+M.+Bergenstalauthor=J.+B.+Buseauthor=M.+Diamantauthor=E.+Ferranniniauthor=M.+Nauckauthor=A.+L.+Petersauthor=A.+Tsapasauthor=R.+Wenderauthor=D.+Matthews&title=Management+of+hyperglycemia+in+type+2+diabetes%3A+a+patient-centered+approach.+Position+statement+of+the+American+Diabetes+Association+%28ADA%29+and+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInzucchi%26aufirst%3DS.%2BE.%26aulast%3DBergenstal%26aufirst%3DR.%2BM.%26aulast%3DBuse%26aufirst%3DJ.%2BB.%26aulast%3DDiamant%26aufirst%3DM.%26aulast%3DFerrannini%26aufirst%3DE.%26aulast%3DNauck%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DA.%2BL.%26aulast%3DTsapas%26aufirst%3DA.%26aulast%3DWender%26aufirst%3DR.%26aulast%3DMatthews%26aufirst%3DD.%26atitle%3DManagement%2520of%2520hyperglycemia%2520in%2520type%25202%2520diabetes%253A%2520a%2520patient-centered%2520approach.%2520Position%2520statement%2520of%2520the%2520American%2520Diabetes%2520Association%2520%2528ADA%2529%2520and%2520the%2520European%2520Association%2520for%2520the%2520Study%2520of%2520Diabetes%2520%2528EASD%2529%26jtitle%3DDiabetes%2520Care%26date%3D2012%26volume%3D35%26spage%3D1364%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Todd, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, S. R.</span><span> </span><span class="NLM_article-title">Incretins and other peptides in the treatment of diabetes</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1111%2Fj.1464-5491.2006.02071.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=17263764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=223-232&issue=3&author=J.+R.+Toddauthor=S.+R.+Bloom&title=Incretins+and+other+peptides+in+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Incretins and other peptides in the treatment of diabetes</span></div><div class="casAuthors">Todd, J. F.; Bloom, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucagon-like peptide-1 (7-36) amide (GLP-1) is a gut hormone, released postprandially, which stimulates insulin secretion and insulin gene expression as well as pancreatic B-cell growth.  Together with glucose-dependent insulinotropic polypeptide (GIP), it is responsible for the incretin effect which is the augmentation of insulin secretion following oral administration of glucose.  Patients with Type 2 diabetes have greatly impaired or absent incretin-mediated insulin secretion which is mainly as a result of decreased secretion of GLP-1.  However, the insulinotropic action of GLP-1 is preserved in patients with Type 2 diabetes, and this has encouraged attempts to treat Type 2 diabetic patients with GLP-1.  GLP-1 also possesses a no. of potential advantages over existing agents for the treatment of Type 2 diabetes.  In addn. to stimulating insulin secretion and promoting pancreatic B-cell mass, GLP-1 suppresses glucagon secretion, delays gastric emptying and inhibits food intake.  Continuous i.v. and s.c. administration significantly improves glycemic control and causes redns. in both HbA1c and body wt.  However, GLP-1 is metabolized extremely rapidly in the circulation by the enzyme dipeptidyl peptidase IV (DPP-IV).  This is the probable explanation for the short-lived effect of single doses of native GLP-1, making it an unlikely glucose-lowering agent.  The DPP-IV resistant analog, exenatide, has Food and Drug Administration (FDA) approval for the treatment of Type 2 diabetes and selective DPP-IV inhibitors are under development.  Both approaches have demonstrated remarkable efficacy in animal models and human clin. studies.  Both are well tolerated and appear to have advantages over current therapies for Type 2 diabetes, particularly in terms of the effects on pancreatic B-cell restoration and potential wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8H7YGj0lUrVg90H21EOLACvtfcHk0ljUIOyavfJhqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWls7Y%253D&md5=c4db56f8d2bf6dec2f2cdd82de4b5a7a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2006.02071.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2006.02071.x%26sid%3Dliteratum%253Aachs%26aulast%3DTodd%26aufirst%3DJ.%2BR.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DIncretins%2520and%2520other%2520peptides%2520in%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DDiabetic%2520Med.%26date%3D2007%26volume%3D24%26issue%3D3%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">The incretin system and its role in type 2 diabetes mellitus</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1016%2Fj.mce.2008.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=18786605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=127-136&issue=1%E2%80%932&author=J.+J.+Holstauthor=T.+Vilsb%C3%B8llauthor=C.+F.+Deacon&title=The+incretin+system+and+its+role+in+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The incretin system and its role in type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Vilsboell, Tina; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The incretin hormones are released during meals from gut endocrine cells.  They potentiate glucose-induced insulin secretion and may be responsible for up to 70% of postprandial insulin secretion.  The incretin hormones include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which may also promote proliferation/neogenesis of beta cells and prevent their decay (apoptosis).  Both hormones contribute to insulin secretion from the beginning of a meal and their effects are progressively amplified as plasma glucose concns. rise.  The current interest in the incretin hormones is due to the fact that the incretin effect is severely reduced or absent in patients with type 2 diabetes mellitus (T2DM).  In addn., there is hyperglucagonemia, which is not suppressible by glucose.  In such patients, the secretion of GIP is near normal, but its effect on insulin secretion, particularly the late phase, is severely impaired.  The loss of GIP action is probably a consequence of diabetes, since it is also obsd. in patients with diabetes secondary to chronic pancreatitis, in whom the incretin effect is also lost.  GLP-1 secretion, on the other hand, is also impaired, but its insulinotropic and glucagon-suppressive actions are preserved, although the potency of GLP-1 in this respect is decreased compared to healthy subjects.  However, in supraphysiol. doses, GLP-1 administration may completely normalize beta as well as alpha cell sensitivity to glucose.  The impaired action of GLP-1 and GIP in T2DM may be at least partly restored by improved glycemic control, as shown in studies involving 4 wk of intensive insulin therapy.  The reduced incretin effect is believed to contribute to impaired regulation of insulin and glucagon secretion in T2DM, and, in support of this, exogenous GLP-1 administration may restore blood glucose regulation to near normal levels.  Thus, the pathogenesis of T2DM seems to involve a dysfunction of both incretins.  Enhancement of incretin action may therefore represent a therapeutic soln.  Clin. strategies therefore include the development of metabolically stable activators of the GLP-1 receptor; and inhibition of DPP-4, the enzyme that destroys native GLP-1 almost immediately.  Orally active DPP-4 inhibitors and the metabolically stable activators, exenatide (Byetta), are now on the market, and numerous clin. studies have shown that both principles are assocd. with durable antidiabetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt5VBmX7VnLVg90H21EOLACvtfcHk0ljUIOyavfJhqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P&md5=5995635fd35fb982d0b8740353f86dc3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DThe%2520incretin%2520system%2520and%2520its%2520role%2520in%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Creutzfeldt, W.</span><span> </span><span class="NLM_article-title">The entero-insular axis in type 2 diabetes—incretins as therapeutic agents</span> <span class="citation_source-journal">Exp. Clin. Endocrinol. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S288</span><span class="NLM_x">–</span> <span class="NLM_lpage">S303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=S288-S303&issue=Suppl.+2&author=W.+Creutzfeldt&title=The+entero-insular+axis+in+type+2+diabetes%E2%80%94incretins+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreutzfeldt%26aufirst%3DW.%26atitle%3DThe%2520entero-insular%2520axis%2520in%2520type%25202%2520diabetes%25E2%2580%2594incretins%2520as%2520therapeutic%2520agents%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2001%26volume%3D109%26issue%3DSuppl.%25202%26spage%3DS288%26epage%3DS303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Plaisanciė, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumoulin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chayvialle, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuber, J.-C.</span><span> </span><span class="NLM_article-title">Luminal glucagon-like peptide-1(7–36) amide-releasing factors in the isolated vascularly perfused rat colon</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1677%2Fjoe.0.1450521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=7636436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADyaK2MXmtV2gtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1995&pages=521-526&issue=3&author=P.+Plaisanci%C4%97author=V.+Dumoulinauthor=J.-A.+Chayvialleauthor=J.-C.+Cuber&title=Luminal+glucagon-like+peptide-1%287%E2%80%9336%29+amide-releasing+factors+in+the+isolated+vascularly+perfused+rat+colon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon</span></div><div class="casAuthors">Plaisancie, P.; Dumoulin, V.; Chayvialle, J.-A.; Cuber, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-6</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Journal of Endocrinology</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is released from endocrine cells of the distal part of the gut after ingestion of a meal.  GLP-1 secretion is, in part, under the control of hormonal and/or neural mechanisms.  However, stimulation of the colonic L cells may also occur directly by the luminal contents.  This was examd. in the present study, using an isolated vascularly perfused rat colon.  GLP-1 immunoreactivity was measured in the portal effluent after luminal infusion of a variety of compds. which are found in colonic contents (nutrients, fibers, bile acids, short-chain fatty acids (SCFAs)).  Oleic acid (100 mM) or a mixt. of amino acids (total concn. 250 mM), or starch (0.5%, w/v) did not increase GLP-1 secretion over basal value.  A pharmacol. concn. of glucose (250 mM) elicited a marked release of GLP-1 which was maximal at the end of infusion (400% of basal), while 5 mM glucose was without effect on secretion.  Pectin evoked a dose-dependent release of GLP-1 over the range 0.1-0.5% (w/v) with a maximal response at 360% of basal when 0.5% pectin was infused.  Cellulose or gum arabic (0.5%) did not modify GLP-1 secretion.  The SCFAs acetate, propionate or butyrate (5, 20 and 100 mM) did not induce a significant release of GLP-1.  Among the four bile acids tested, namely taurocholate, cholate, deoxycholate and hyodeoxycholate, the last one was the most potent at eliciting a GLP-1 response with a maximal release at 300% and 400% of the basal value when 2 and 20 mM bile acid were administered resp.  In conclusion, some fibers and bile acids are capable of releasing colonic GLP-1 in rats and may contribute to the secretory activity of colonic L cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqon6gR_1sVobVg90H21EOLACvtfcHk0lggUo-mpOtQ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtV2gtr4%253D&md5=f9a4233cd24017cbdb7bf72ffffba309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1450521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1450521%26sid%3Dliteratum%253Aachs%26aulast%3DPlaisanci%25C4%2597%26aufirst%3DP.%26aulast%3DDumoulin%26aufirst%3DV.%26aulast%3DChayvialle%26aufirst%3DJ.-A.%26aulast%3DCuber%26aufirst%3DJ.-C.%26atitle%3DLuminal%2520glucagon-like%2520peptide-1%25287%25E2%2580%259336%2529%2520amide-releasing%2520factors%2520in%2520the%2520isolated%2520vascularly%2520perfused%2520rat%2520colon%26jtitle%3DJ.%2520Endocrinol.%26date%3D1995%26volume%3D145%26issue%3D3%26spage%3D521%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dumoulin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barcelo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuber, J.-C.</span><span> </span><span class="NLM_article-title">Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3780</span><span class="NLM_x">–</span> <span class="NLM_lpage">3786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=3780-3786&issue=9&author=V.+Dumoulinauthor=F.+Moroauthor=A.+Barceloauthor=T.+Dakkaauthor=J.-C.+Cuber&title=Peptide+YY%2C+glucagon-like+peptide-1%2C+and+neurotensin+responses+to+luminal+factors+in+the+isolated+vascularly+perfused+rat+ileum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumoulin%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DF.%26aulast%3DBarcelo%26aufirst%3DA.%26aulast%3DDakka%26aufirst%3DT.%26aulast%3DCuber%26aufirst%3DJ.-C.%26atitle%3DPeptide%2520YY%252C%2520glucagon-like%2520peptide-1%252C%2520and%2520neurotensin%2520responses%2520to%2520luminal%2520factors%2520in%2520the%2520isolated%2520vascularly%2520perfused%2520rat%2520ileum%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26issue%3D9%26spage%3D3780%26epage%3D3786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Adrian, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilchik, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tierney, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, I. M.</span><span> </span><span class="NLM_article-title">Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=1219-1224&issue=9&author=T.+E.+Adrianauthor=G.+H.+Ballantyneauthor=W.+E.+Longoauthor=A.+J.+Bilchikauthor=S.+Grahamauthor=M.+D.+Bassonauthor=R.+P.+Tierneyauthor=I.+M.+Modlin&title=Deoxycholate+is+an+important+releaser+of+peptide+YY+and+enteroglucagon+from+the+human+colon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdrian%26aufirst%3DT.%2BE.%26aulast%3DBallantyne%26aufirst%3DG.%2BH.%26aulast%3DLongo%26aufirst%3DW.%2BE.%26aulast%3DBilchik%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DBasson%26aufirst%3DM.%2BD.%26aulast%3DTierney%26aufirst%3DR.%2BP.%26aulast%3DModlin%26aufirst%3DI.%2BM.%26atitle%3DDeoxycholate%2520is%2520an%2520important%2520releaser%2520of%2520peptide%2520YY%2520and%2520enteroglucagon%2520from%2520the%2520human%2520colon%26jtitle%3DGut%26date%3D1993%26volume%3D34%26issue%3D9%26spage%3D1219%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hofmann, A. F.</span><span> </span><span class="NLM_article-title">The enterohepatic circulation of bile acids in mammals: form and functionas</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2741%2F3399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=19273221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2nsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=2584-2598&author=A.+F.+Hofmann&title=The+enterohepatic+circulation+of+bile+acids+in+mammals%3A+form+and+functionas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The enterohepatic circulation of bile acids in mammals: form and functions</span></div><div class="casAuthors">Hofmann, Alan F.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2584-2598</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The features of the enterohepatic circulation of bile acids in mammals are reviewed.  Inputs into the circulating bile acids are primary bile acids synthesized from cholesterol in the hepatocyte and secondary bile acids formed by bacterial modification of primary bile acids in the distal intestine.  Intestinal conservation of bile acids generates pools of individual bile acids whose relative sizes det. biliary bile acid compn.  Efficient hepatic clearance results in low plasma bile acid levels, and virtually no renal excretion.  Methods for characterizing the enterohepatic circulation are summarized.  Bile acids have numerous physiol. functions in the liver, biliary tract, and intestine resulting from their signaling and physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcytQeFu5q7rVg90H21EOLACvtfcHk0lggUo-mpOtQ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2nsbc%253D&md5=79908d57e756691f0c5c2daa7c7c9db3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2741%2F3399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3399%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DA.%2BF.%26atitle%3DThe%2520enterohepatic%2520circulation%2520of%2520bile%2520acids%2520in%2520mammals%253A%2520form%2520and%2520functionas%26jtitle%3DFront.%2520Biosci.%26date%3D2009%26volume%3D14%26spage%3D2584%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Roberts, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burczynski, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span> </span><span class="NLM_article-title">Enterohepatic circulation: physiological, pharmacokinetic and clinical implications</span> <span class="citation_source-journal">Clin. Pharmacokinetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2165%2F00003088-200241100-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=12162761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFyru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=751-790&issue=10&author=M.+S.+Robertsauthor=B.+M.+Magnussonauthor=F.+J.+Burczynskiauthor=M.+Weiss&title=Enterohepatic+circulation%3A+physiological%2C+pharmacokinetic+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enterohepatic circulation: physiological, pharmacokinetic and clinical implications</span></div><div class="casAuthors">Roberts, Michael S.; Magnusson, Beatrice M.; Burczynski, Frank J.; Weiss, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">751-790</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Enterohepatic recycling occurs by biliary excretion and intestinal reabsorption of a solute, sometimes with hepatic conjugation and intestinal deconjugation.  Cycling is often assocd. with multiple peaks and a longer apparent half-life in a plasma concn.-time profile.  Factors affecting biliary excretion include drug characteristics (chem. structure, polarity and mol. size), transport across sinusoidal plasma membrane and canniculae membranes, biotransformation and possible reabsorption from intrahepatic bile ductules.  Intestinal reabsorption to complete the enterohepatic cycle may depend on hydrolysis of a drug conjugate by gut bacteria.  Bioavailability is also affected by the extent of intestinal absorption, gut-wall P-glycoprotein efflux and gut-wall metab.  Recently, there has been a considerable increase in our understanding of the role of transporters, of gene expression of intestinal and hepatic enzymes, and of hepatic zonation.  Drugs, disease and genetics may result in induced or inhibited activity of transporters and metabolizing enzymes.  Reduced expression of one transporter, for example hepatic canalicular multidrug resistance-assocd. protein (MRP) 2, is often assocd. with enhanced expression of others, for example the usually quiescent basolateral efflux MRP3, to limit hepatic toxicity.  In addn., physiol. relevant pharmacokinetic models, which describe enterohepatic recirculation in terms of its determinants (such as sporadic gall bladder emptying), have been developed.  In general, enterohepatic recirculation may prolong the pharmacol. effect of certain drugs and drug metabolites.  Of particular importance is the potential amplifying effect of enterohepatic variability in defining differences in the bioavailability, apparent vol. of distribution and clearance of a given compd.  Genetic abnormalities, disease states, orally administered adsorbents and certain co-administered drugs all affect enterohepatic recycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmTzuEhf7QLVg90H21EOLACvtfcHk0lia3ZnvTIWPog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFyru78%253D&md5=514a6ffb4ee275ccd2a7082fe2fe3d87</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F00003088-200241100-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200241100-00005%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DM.%2BS.%26aulast%3DMagnusson%26aufirst%3DB.%2BM.%26aulast%3DBurczynski%26aufirst%3DF.%2BJ.%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DEnterohepatic%2520circulation%253A%2520physiological%252C%2520pharmacokinetic%2520and%2520clinical%2520implications%26jtitle%3DClin.%2520Pharmacokinetics%26date%3D2002%26volume%3D41%26issue%3D10%26spage%3D751%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Schneider, B. L.</span><span> </span><span class="NLM_article-title">Intestinal bile acid transport: biology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Pediatr. Gastroenterol. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1097%2F00005176-200104000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=11396803" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=407-417&author=B.+L.+Schneider&title=Intestinal+bile+acid+transport%3A+biology%2C+physiology%2C+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00005176-200104000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005176-200104000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%2BL.%26atitle%3DIntestinal%2520bile%2520acid%2520transport%253A%2520biology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Pediatr.%2520Gastroenterol.%2520Nutr.%26date%3D2001%26volume%3D32%26spage%3D407%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Root, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundseth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. C.</span><span> </span><span class="NLM_article-title">Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94</span> <span class="citation_source-journal">J. Lipid. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1320-1330&author=C.+Rootauthor=C.+S.+Smithauthor=S.+S.+Sundsethauthor=H.+M.+Pinkauthor=J.+G.+Wilsonauthor=M.+C.+Lewis&title=Ileal+bile+acid+transporter+inhibition%2C+CYP7A1+induction%2C+and+antilipemic+action+of+264W94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoot%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BS.%26aulast%3DSundseth%26aufirst%3DS.%2BS.%26aulast%3DPink%26aufirst%3DH.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26atitle%3DIleal%2520bile%2520acid%2520transporter%2520inhibition%252C%2520CYP7A1%2520induction%252C%2520and%2520antilipemic%2520action%2520of%2520264W94%26jtitle%3DJ.%2520Lipid.%2520Res.%26date%3D2002%26volume%3D43%26spage%3D1320%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kramer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glombik, H.</span><span> </span><span class="NLM_article-title">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2174%2F092986706776361003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=16611081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=997-1016&author=W.+Kramerauthor=H.+Glombik&title=Bile+acid+reabsorption+inhibitors+%28BARI%29%3A+novel+hypolipidemic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span></div><div class="casAuthors">Kramer, Werner; Glombik, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1016</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The enterohepatic circulation of bile acids is a major regulator of serum cholesterol homeostasis.  After biosynthesis from cholesterol in the liver, bile acids are secreted with bile into the lumen of the small intestine to aid in the digestion and absorption of fat and fat-sol. vitamins.  The bile acids are nearly quant. reabsorbed in the terminal ileum by a Na+-dependent transport system (IBAT) and are transported with portal blood to the liver and taken up by a second Na+-/bile acid cotransporter (LBAT) to be resecreted into bile.  In the liver bile acids inhibit the rate-limiting enzyme for the conversion of cholesterol into bile acid: cholesterol-7α-hydroxylase; interruption of the enterohepatic circulation of bile acids withdraws this feedback inhibition and leads to an upregulation of hepatic LDL-receptors with a concomitant decrease of serum LDL-levels.  Specific inhibitors of the ileal bile acid transporter belonging to different chemotypes have been developed in recent years for this purpose, some now entering clin. stage.  To exert a profound systemic effect these compds. do not need to be available systemically but can act from the luminal side of the small intestine, which offers the advantage to avoid the well-known adverse side effects of other hypolipidemic drugs like statins due to metab. and drug-drug interactions in the liver.  This implies several aspects in compd. optimization and drug development quite different from std. procedures, for example the concept of low absorption drugs was established to avoid systemic side effects.  This review article covers the mechanistic and therapeutic principles of the approach and presents an overview on the mol. target, the discovery of specific inhibitors and resp. optimization strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXNSDtAqiZbVg90H21EOLACvtfcHk0lia3ZnvTIWPog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D&md5=8411f5d6f3e3218ad5ba6cb8fe2075c4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986706776361003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DGlombik%26aufirst%3DH.%26atitle%3DBile%2520acid%2520reabsorption%2520inhibitors%2520%2528BARI%2529%253A%2520novel%2520hypolipidemic%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D997%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajpal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamlet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedulin, B.</span><span> </span><span class="NLM_article-title">Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">E68</span><span class="NLM_x">–</span> <span class="NLM_lpage">E76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=E68-E76&author=L.+Chenauthor=X.+Yaoauthor=A.+Youngauthor=J.+McNultyauthor=D.+Andersonauthor=Y.+Liuauthor=C.+Nystromauthor=D.+Croomauthor=S.+Rossauthor=J.+Collinsauthor=D.+Rajpalauthor=K.+Hamletauthor=S.+Smithauthor=B.+Gedulin&title=Inhibition+of+apical+sodium-dependent+bile+acid+transporter+as+a+novel+treatment+for+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNystrom%26aufirst%3DC.%26aulast%3DCroom%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DD.%26aulast%3DHamlet%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DGedulin%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520apical%2520sodium-dependent%2520bile%2520acid%2520transporter%2520as%2520a%2520novel%2520treatment%2520for%2520diabetes%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D302%26spage%3DE68%26epage%3DE76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lundåsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Őstlund-Lindqvist, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudling, M.</span><span> </span><span class="NLM_article-title">Inhibition of intestinal bile acid transporter slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1-14&issue=5&author=T.+Lund%C3%A5senauthor=E.-M.+Anderssonauthor=M.+Snaithauthor=H.+Lindmarkauthor=J.+Lundbergauthor=A.-M.+%C5%90stlund-Lindqvistauthor=B.+Angelinauthor=M.+Rudling&title=Inhibition+of+intestinal+bile+acid+transporter+slc10a2+improves+triglyceride+metabolism+and+normalizes+elevated+plasma+glucose+levels+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLund%25C3%25A5sen%26aufirst%3DT.%26aulast%3DAndersson%26aufirst%3DE.-M.%26aulast%3DSnaith%26aufirst%3DM.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DLundberg%26aufirst%3DJ.%26aulast%3D%25C5%2590stlund-Lindqvist%26aufirst%3DA.-M.%26aulast%3DAngelin%26aufirst%3DB.%26aulast%3DRudling%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520intestinal%2520bile%2520acid%2520transporter%2520slc10a2%2520improves%2520triglyceride%2520metabolism%2520and%2520normalizes%2520elevated%2520plasma%2520glucose%2520levels%2520in%2520mice%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26issue%3D5%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span> </span><span class="NLM_article-title">Hypolipidemic 1,4-benzothiazepen-1,1-dioxides</span>. (<span class="NLM_publisher-name">Wellcome Foundation</span>, <span class="NLM_publisher-loc">London</span>). Patent WO9605188, <span class="NLM_month">February</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=L.+E.+Brieaddy&title=Hypolipidemic+1%2C4-benzothiazepen-1%2C1-dioxides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26atitle%3DHypolipidemic%25201%252C4-benzothiazepen-1%252C1-dioxides%26pub%3DWellcome%2520Foundation%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ghosh, M.; Christopher, K.; Zhang, X.; Tarrant, J. G.; Lee, C.-W.; Kaiser, B.; Zablocki, M.-M.; Chenard, B. L.; Doller, D.; Yamaguchi, Y.; Wustrow, D. J.; Li, G.</span><span> </span><span class="NLM_article-title">Aminopiperidines and related compounds a MCH modulators and their preparation, pharmaceutical compositions and use in the treatment of metabolic, feeding and sexual disorders</span>. (<span class="NLM_publisher-name">Neurogen Corporation</span>) Patent WO2008016811, <span class="NLM_month">July</span><span class="NLM_day">25</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Ghosh&author=K.+Christopher&author=X.+Zhang&author=J.+G.+Tarrant&author=C.-W.+Lee&author=B.+Kaiser&author=M.-M.+Zablocki&author=B.+L.+Chenard&author=D.+Doller&author=Y.+Yamaguchi&author=D.+J.+Wustrow&author=G.+Li&title=Aminopiperidines+and+related+compounds+a+MCH+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+metabolic%2C+feeding+and+sexual+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DM.%26atitle%3DAminopiperidines%2520and%2520related%2520compounds%2520a%2520MCH%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520metabolic%252C%2520feeding%2520and%2520sexual%2520disorders%26pub%3DNeurogen%2520Corporation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cornforth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R. H.</span><span> </span><span class="NLM_article-title">A general reagent for <i>O</i>-phosphonomethylation of phenols</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1897-1900&author=J.+Cornforthauthor=J.+R.+H.+Wilson&title=A+general+reagent+for+O-phosphonomethylation+of+phenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornforth%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%2BH.%26atitle%3DA%2520general%2520reagent%2520for%2520O-phosphonomethylation%2520of%2520phenols%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1994%26volume%3D14%26spage%3D1897%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Fields, E. K.</span><span> </span><span class="NLM_article-title">The synthesis of esters of substituted amino phosphonic acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1531</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01126a054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADyaG2cXntl0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1952&pages=1528-1531&author=E.+K.+Fields&title=The+synthesis+of+esters+of+substituted+amino+phosphonic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of esters of substituted amino phosphonic acids</span></div><div class="casAuthors">Fields, Ellis K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1528-31</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">R2R3NCRR4P(O)(OR1)2 can be synthesized by treating a phosphorus acid diester with (1) an aldehyde or ketone and an imine, (2) an α-alkylol amine, (3) an alkylidene diamine, (4) an N-substituted amino Me ether, or (5) an aldimine or ketimine derived from a primary amine.  Table I; R, R4, R1, R2, R3, Yield (%), B.p.(°C.)/mm.; H, H, Me, Me, Me, 88, 88/2; H, H, Et, Et, Et, 94, 96/3; H, H, Et, iso-Pr, iso-Pr, 91, 112/2; H, H, Et, Bu, Bu, 94, 127/2; H, H, Et, Cyclohexyl, Cyclohexyl, 81, 149/2; H, H, Et, Octyl, Octyl, 86, 175/2; H, H, Et, , Oxydiethylene, 92, 137/3; H, H, Et, , Pentamethylene, 87, 124/3; H, H, Et, Et, Ph, 47, 126/1; H, H, Et, H, Bu, 38, 89, 114/2.5; H, H, Et, H, PhCH2CH2, 32, 91, 109/0.4; H, Me, Et, Et, Et, 81, 94/1; H, Et, Et, Et, Et, 78, 95/0.8; H, Pr, Et, Et, Et, 79, 104-7/1; Me, Me, Et, Et, Et, 64, 103-5/2-5; H, α-Furyl, Et, Et, Et, 84, 140/2; H, Vinyl, Et, Et, Et, 87, 116/4; H, Pr, Et, Bu, Bu, 91, 147/2; H, H, Bu, Et, Et, 93, 131/1; H, H, 2-Ethylhexyl, Et, Et, 90, 162-6/0.7; H, Me, Et, H, Me, 94, 87/2.2; H, Me, Et, H, Et, 91, 84/1; Me, Me, Et, H, Et, 97, 91/2.3; H, Pr, Et, H, Me, 93, 110/1.5; H, Pr, Et, H, Bu, 94, 119/2; H, Et, Et, H, Et, 89, 93/1.5; H, Pr, Bu, H, Me, 84, 118-22/2; H, Ph, Et, H, Ph, 97, m. 92; H, α-Furyl, Et, H, Et, 85, 127/0.75; H, Ph, Et, H, p-MeOC6H4, 89, sirup; H, Ph, Et, H, diethylene, 97, m. 95; H, Pr, Et, H, 1-Diethylamino-4-pentyl, 84, 133-5/2; H, p-MeOC6H4, Et, H, 1-Diethylamino-4-pentyl, 92, decompd.; H, ο-ClC6H4, Et, H, Me, 88, 130-2/1.5; H, H, Et, H, 2,4,4-Trimethyl-2-pentyl, 96, 123/0.74</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfw5zhGvy-LVg90H21EOLACvtfcHk0ljZQBoZDLjXZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXntl0%253D&md5=7c65e6ac220540eab3d0ae74aa034183</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja01126a054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01126a054%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DE.%2BK.%26atitle%3DThe%2520synthesis%2520of%2520esters%2520of%2520substituted%2520amino%2520phosphonic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1952%26volume%3D74%26spage%3D1528%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stefely, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palchaudhuri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraski, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title"><i>N</i>-((1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3395</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3389-3395&author=J.+A.+Stefelyauthor=R.+Palchaudhuriauthor=P.+A.+Millerauthor=R.+J.+Petersonauthor=G.+C.+Moraskiauthor=P.+J.+Hergenrotherauthor=M.+J.+Miller&title=N-%28%281-Benzyl-1H-1%2C2%2C3-triazol-4-yl%29methyl%29arylamide+as+a+new+scaffold+that+provides+rapid+access+to+antimicrotubule+agents%3A+synthesis+and+evaluation+of+antiproliferative+activity+against+select+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm1000979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000979%26sid%3Dliteratum%253Aachs%26aulast%3DStefely%26aufirst%3DJ.%2BA.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DPeterson%26aufirst%3DR.%2BJ.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DN-%2528%25281-Benzyl-1H-1%252C2%252C3-triazol-4-yl%2529methyl%2529arylamide%2520as%2520a%2520new%2520scaffold%2520that%2520provides%2520rapid%2520access%2520to%2520antimicrotubule%2520agents%253A%2520synthesis%2520and%2520evaluation%2520of%2520antiproliferative%2520activity%2520against%2520select%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3389%26epage%3D3395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Brown, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, R. D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, N. W.</span><span> </span><span class="NLM_article-title">Adaptation of hydrogen analysis to measure stomach to caecum transit time in the rat</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1987&pages=849-854&author=N.+J.+Brownauthor=R.+D.+E.+Rumseyauthor=N.+W.+Read&title=Adaptation+of+hydrogen+analysis+to+measure+stomach+to+caecum+transit+time+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BJ.%26aulast%3DRumsey%26aufirst%3DR.%2BD.%2BE.%26aulast%3DRead%26aufirst%3DN.%2BW.%26atitle%3DAdaptation%2520of%2520hydrogen%2520analysis%2520to%2520measure%2520stomach%2520to%2520caecum%2520transit%2520time%2520in%2520the%2520rat%26jtitle%3DGut%26date%3D1987%26volume%3D28%26spage%3D849%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Thomas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioiello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noriega, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mataki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruzanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonjans, K.</span><span> </span><span class="NLM_article-title">TGR5-mediated bile acid sensing controls glucose homeostasis</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1016%2Fj.cmet.2009.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=19723493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=167-177&author=C.+Thomasauthor=A.+Gioielloauthor=L.+Noriegaauthor=A.+Strehleauthor=J.+Ouryauthor=G.+Rizzoauthor=A.+Macchiaruloauthor=H.+Yamamotoauthor=C.+Matakiauthor=M.+Pruzanskiauthor=R.+Pellicciariauthor=J.+Auwerxauthor=K.+Schoonjans&title=TGR5-mediated+bile+acid+sensing+controls+glucose+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TGR5-mediated bile acid sensing controls glucose homeostasis</span></div><div class="casAuthors">Thomas, Charles; Gioiello, Antimo; Noriega, Lilia; Strehle, Axelle; Oury, Julien; Rizzo, Giovanni; Macchiarulo, Antonio; Yamamoto, Hiroyasu; Mataki, Chikage; Pruzanski, Mark; Pellicciari, Roberto; Auwerx, Johan; Schoonjans, Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">TGR5 is a G protein-coupled recpetor expressed in brown adipose tissue and muscle, where its activation by bile acids triggers an increase in energy expenditure and attenuates diet-induced obesity.  Using a combination of pharmacol. and genetic gain- and loss-of-function studies in vivo, we show here that TGR5 signaling induces intestinal glucagon-like peptide-1 (GLP-1) release, leading to improved liver and pancreatic function and enhanced glucose tolerance in obese mice.  In addn., we show that the induction of GLP-1 release in enteroendocrine cells by 6α-ethyl-23(S)-methyl-cholic acid (EMCA, INT-777), a specific TGR5 agonist, is linked to an increase of the intracellular ATP/ADP ratio and a subsequent rise in intracellular calcium mobilization.  Altogether, these data show that the TGR5 signaling pathway is crit. in regulating intestinal GLP-1 secretion in vivo, and suggest that pharmacol. targeting of TGR5 may constitute a promising incretin-based strategy for the treatment of diabesity and assocd. metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou5U1cAgVnYbVg90H21EOLACvtfcHk0liDrC5vMsblsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChtLnM&md5=05938b6d2028551cc1e7691d42421bf3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2009.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2009.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGioiello%26aufirst%3DA.%26aulast%3DNoriega%26aufirst%3DL.%26aulast%3DStrehle%26aufirst%3DA.%26aulast%3DOury%26aufirst%3DJ.%26aulast%3DRizzo%26aufirst%3DG.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DMataki%26aufirst%3DC.%26aulast%3DPruzanski%26aufirst%3DM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26atitle%3DTGR5-mediated%2520bile%2520acid%2520sensing%2520controls%2520glucose%2520homeostasis%26jtitle%3DCell%2520Metab.%26date%3D2009%26volume%3D10%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dalmer, O.; Diehl, C.; Pieper, H.</span><span> </span><span class="NLM_article-title">Derivatives of tertiary amino aliphatic acids</span>. (<span class="NLM_publisher-name">Merck & Co., Inc.</span>, <span class="NLM_publisher-loc">Rahway, NJ</span>). U. S. Patent US2,370,015, <span class="NLM_month">February</span><span class="NLM_day">20</span>,<span class="NLM_x"> </span><span class="NLM_year">1945</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1945&author=O.+Dalmer&author=C.+Diehl&author=H.+Pieper&title=Derivatives+of+tertiary+amino+aliphatic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDalmer%26aufirst%3DO.%26atitle%3DDerivatives%2520of%2520tertiary%2520amino%2520aliphatic%2520acids%26pub%3DMerck%2520%2526%2520Co.%252C%2520Inc%26date%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Fubao Huang, Mengmeng Ning, Kai Wang, Jia Liu, Wenbo Guan, Ying Leng, <span class="NLM_string-name hlFld-ContribAuthor">Jianhua Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (23)
                                     , 10919-10925. <a href="https://doi.org/10.1021/acs.jmedchem.9b01649" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01649%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPolar%252B%2525CE%2525B2-Homophenylalanine%252BDerivatives%252Bas%252BNonsystemic%252BIntestine-Targeted%252BDipeptidyl%252BPeptidase%252BIV%252BInhibitors%26aulast%3DHuang%26aufirst%3DFubao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04102019%26date%3D03122019%26date%3D20112019%26volume%3D62%26issue%3D23%26spage%3D10919%26epage%3D10925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paresh
P. Chothe, Lindsay C. Czuba, Ebehiremen N. Ayewoh, <span class="NLM_string-name hlFld-ContribAuthor">Peter W. Swaan</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Phosphorylation Regulates Plasma Membrane Expression and Stability of the Human Bile Acid Transporter ASBT (SLC10A2). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (8)
                                     , 3569-3576. <a href="https://doi.org/10.1021/acs.molpharmaceut.9b00426" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.9b00426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.9b00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.9b00426%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DTyrosine%252BPhosphorylation%252BRegulates%252BPlasma%252BMembrane%252BExpression%252Band%252BStability%252Bof%252Bthe%252BHuman%252BBile%252BAcid%252BTransporter%252BASBT%252B%252528SLC10A2%252529%26aulast%3DChothe%26aufirst%3DParesh%2BP.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20042019%26date%3D13062019%26date%3D11062019%26date%3D08072019%26date%3D13062019%26volume%3D16%26issue%3D8%26spage%3D3569%26epage%3D3576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shixian  Deng</span>, <span class="hlFld-ContribAuthor ">Zhenzhuang  Cheng</span>, <span class="hlFld-ContribAuthor ">Charles  Ingalls</span>, <span class="hlFld-ContribAuthor ">Ferenc  Kontes</span>, <span class="hlFld-ContribAuthor ">Jiaming  Yan</span>, and <span class="hlFld-ContribAuthor ">Sandro  Belvedere</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,3,4,5-Tetrahydrobenzo[1,4]thiazepines via N-Acyliminium Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (11)
                                     , 1801-1805. <a href="https://doi.org/10.1021/acs.oprd.7b00260" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00260%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252B2%25252C3%25252C4%25252C5-Tetrahydrobenzo%25255B1%25252C4%25255Dthiazepines%252Bvia%252BN-Acyliminium%252BCyclization%26aulast%3DDeng%26aufirst%3DShixian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01082017%26date%3D09102017%26date%3D17112017%26date%3D28092017%26volume%3D21%26issue%3D11%26spage%3D1801%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jooho  Park</span>, <span class="hlFld-ContribAuthor ">Taslim A.  Al-Hilal</span>, <span class="hlFld-ContribAuthor ">Jee-Heon  Jeong</span>, <span class="hlFld-ContribAuthor ">Jeong uk  Choi</span>, and <span class="hlFld-ContribAuthor ">Youngro  Byun</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Therapeutic Evaluation of Poly(acrylic acid)–tetraDOCA Conjugate as a Bile Acid Transporter Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2015,</strong> <em>26 </em>
                                    (8)
                                     , 1597-1605. <a href="https://doi.org/10.1021/acs.bioconjchem.5b00230" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.5b00230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.5b00230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.5b00230%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BTherapeutic%252BEvaluation%252Bof%252BPoly%252528acrylic%252Bacid%252529%2525E2%252580%252593tetraDOCA%252BConjugate%252Bas%252Ba%252BBile%252BAcid%252BTransporter%252BInhibitor%26aulast%3DPark%26aufirst%3DJooho%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D22042015%26date%3D16062015%26date%3D26062015%26date%3D19082015%26date%3D18062015%26volume%3D26%26issue%3D8%26spage%3D1597%26epage%3D1605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongliang  Duan</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Ning</span>, <span class="hlFld-ContribAuthor ">Qingan  Zou</span>, <span class="hlFld-ContribAuthor ">Yangliang  Ye</span>, <span class="hlFld-ContribAuthor ">Ying  Feng</span>, <span class="hlFld-ContribAuthor ">Lina  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Leng</span>, and <span class="hlFld-ContribAuthor ">Jianhua  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3315-3328. <a href="https://doi.org/10.1021/jm500829b" title="DOI URL">https://doi.org/10.1021/jm500829b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500829b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500829b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIntestinal%252BTargeted%252BTGR5%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BType%252B2%252BDiabetes%26aulast%3DDuan%26aufirst%3DHongliang%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D30052014%26date%3D02042015%26date%3D23042015%26date%3D24022015%26volume%3D58%26issue%3D8%26spage%3D3315%26epage%3D3328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Cowan</span>, <span class="hlFld-ContribAuthor ">Jon L.  Collins</span>, <span class="hlFld-ContribAuthor ">Mark B.  Mitchell</span>, <span class="hlFld-ContribAuthor ">John A.  Ray</span>, <span class="hlFld-ContribAuthor ">Peter W.  Sutton</span>, <span class="hlFld-ContribAuthor ">Amy A.  Sarjeant</span>, and <span class="hlFld-ContribAuthor ">Eric E.  Boros</span>  . </span><span class="cited-content_cbyCitation_article-title">Enzymatic- and Iridium-Catalyzed Asymmetric Synthesis of a Benzothiazepinylphosphonate Bile Acid Transporter Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (24)
                                     , 12726-12734. <a href="https://doi.org/10.1021/jo402311e" title="DOI URL">https://doi.org/10.1021/jo402311e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo402311e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo402311e%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnzymatic-%252Band%252BIridium-Catalyzed%252BAsymmetric%252BSynthesis%252Bof%252Ba%252BBenzothiazepinylphosphonate%252BBile%252BAcid%252BTransporter%252BInhibitor%26aulast%3DCowan%26aufirst%3DDavid%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D16102013%26date%3D04122013%26date%3D20122013%26date%3D20112013%26volume%3D78%26issue%3D24%26spage%3D12726%26epage%3D12734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Matye</span>, <span class="hlFld-ContribAuthor ">Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Chao</span>, <span class="hlFld-ContribAuthor ">Huaiwen  Wang</span>, <span class="hlFld-ContribAuthor ">Hongmin  Ni</span>, <span class="hlFld-ContribAuthor ">Wen‐Xing  Ding</span>, <span class="hlFld-ContribAuthor ">Tiangang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Gut‐restricted apical sodium‐dependent bile acid transporter inhibitor attenuates alcohol‐induced liver steatosis and injury in mice. </span><span class="cited-content_cbyCitation_journal-name">Alcoholism: Clinical and Experimental Research</span><span> <strong>2021,</strong> <em>45 </em>
                                    (6)
                                     , 1188-1199. <a href="https://doi.org/10.1111/acer.14619" title="DOI URL">https://doi.org/10.1111/acer.14619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/acer.14619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Facer.14619%26sid%3Dliteratum%253Aachs%26jtitle%3DAlcoholism%253A%2520Clinical%2520and%2520Experimental%2520Research%26atitle%3DGut%2525E2%252580%252590restricted%252Bapical%252Bsodium%2525E2%252580%252590dependent%252Bbile%252Bacid%252Btransporter%252Binhibitor%252Battenuates%252Balcohol%2525E2%252580%252590induced%252Bliver%252Bsteatosis%252Band%252Binjury%252Bin%252Bmice%26aulast%3DMatye%26aufirst%3DDavid%2BJ.%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D6%26spage%3D1188%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong  Xie</span>, <span class="hlFld-ContribAuthor ">Weikun  Huang</span>, <span class="hlFld-ContribAuthor ">Richard L.  Young</span>, <span class="hlFld-ContribAuthor ">Karen L.  Jones</span>, <span class="hlFld-ContribAuthor ">Michael  Horowitz</span>, <span class="hlFld-ContribAuthor ">Christopher K.  Rayner</span>, <span class="hlFld-ContribAuthor ">Tongzhi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 1104. <a href="https://doi.org/10.3390/nu13041104" title="DOI URL">https://doi.org/10.3390/nu13041104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu13041104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu13041104%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DRole%252Bof%252BBile%252BAcids%252Bin%252Bthe%252BRegulation%252Bof%252BFood%252BIntake%25252C%252Band%252BTheir%252BDysregulation%252Bin%252BMetabolic%252BDisease%26aulast%3DXie%26aufirst%3DCong%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jize  Sun</span>, <span class="hlFld-ContribAuthor ">Xi  Liang</span>, <span class="hlFld-ContribAuthor ">Youyou  Lv</span>, <span class="hlFld-ContribAuthor ">Lu  Bai</span>, <span class="hlFld-ContribAuthor ">Junxue  Zhang</span>, <span class="hlFld-ContribAuthor ">Pimin  Gong</span>, <span class="hlFld-ContribAuthor ">Tongjie  Liu</span>, <span class="hlFld-ContribAuthor ">Huaxi  Yi</span>, <span class="hlFld-ContribAuthor ">Jingfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Lanwei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Lactobacillus casei
              YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Nutrition</span><span> <strong>2021,</strong> <em>125 </em>
                                    (5)
                                     , 521-529. <a href="https://doi.org/10.1017/S0007114520003001" title="DOI URL">https://doi.org/10.1017/S0007114520003001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S0007114520003001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS0007114520003001%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Nutrition%26atitle%3DLactobacillus%252Bcasei%252BYRL577%252Bameliorates%252Bmarkers%252Bof%252Bnon-alcoholic%252Bfatty%252Bliver%252Band%252Balters%252Bexpression%252Bof%252Bgenes%252Bwithin%252Bthe%252Bintestinal%252Bbile%252Bacid%252Bpathway%26aulast%3DZhang%26aufirst%3DZhe%26date%3D2021%26date%3D2020%26volume%3D125%26issue%3D5%26spage%3D521%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiunan  Zhu</span>, <span class="hlFld-ContribAuthor ">Hisakazu  Komori</span>, <span class="hlFld-ContribAuthor ">Rikako  Imamura</span>, <span class="hlFld-ContribAuthor ">Ikumi  Tamai</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Fluorescence-Based Method to Evaluate Ileal Apical Sodium-Dependent Bile Acid Transporter ASBT. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>110 </em>
                                    (3)
                                     , 1392-1400. <a href="https://doi.org/10.1016/j.xphs.2020.11.030" title="DOI URL">https://doi.org/10.1016/j.xphs.2020.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xphs.2020.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xphs.2020.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DA%252BNovel%252BFluorescence-Based%252BMethod%252Bto%252BEvaluate%252BIleal%252BApical%252BSodium-Dependent%252BBile%252BAcid%252BTransporter%252BASBT%26aulast%3DZhu%26aufirst%3DQiunan%26date%3D2021%26volume%3D110%26issue%3D3%26spage%3D1392%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavlo V.  Khodakivskyi</span>, <span class="hlFld-ContribAuthor ">Christian L.  Lauber</span>, <span class="hlFld-ContribAuthor ">Aleksey  Yevtodiyenko</span>, <span class="hlFld-ContribAuthor ">Arkadiy A.  Bazhin</span>, <span class="hlFld-ContribAuthor ">Stephen  Bruce</span>, <span class="hlFld-ContribAuthor ">Tamar  Ringel-Kulka</span>, <span class="hlFld-ContribAuthor ">Yehuda  Ringel</span>, <span class="hlFld-ContribAuthor ">Bertrand  Bétrisey</span>, <span class="hlFld-ContribAuthor ">Joana  Torres</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Hu</span>, <span class="hlFld-ContribAuthor ">Chieh Jason  Chou</span>, <span class="hlFld-ContribAuthor ">Elena A.  Goun</span>. </span><span class="cited-content_cbyCitation_article-title">Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , eaaz9857. <a href="https://doi.org/10.1126/sciadv.aaz9857" title="DOI URL">https://doi.org/10.1126/sciadv.aaz9857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.aaz9857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.aaz9857%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DNoninvasive%252Bimaging%252Band%252Bquantification%252Bof%252Bbile%252Bsalt%252Bhydrolase%252Bactivity%25253A%252BFrom%252Bbacteria%252Bto%252Bhumans%26aulast%3DKhodakivskyi%26aufirst%3DPavlo%2BV.%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D6%26spage%3Deaaz9857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. E.  Saveleva</span>, <span class="hlFld-ContribAuthor ">E. S.  Tyutrina</span>, <span class="hlFld-ContribAuthor ">T.  Nakanishi</span>, <span class="hlFld-ContribAuthor ">I.  Tamai</span>, <span class="hlFld-ContribAuthor ">A. B.  Salmina</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Apical Sodium-Dependent Bile Acid Transporter (ASBT) as Promising Drugs. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry</span><span> <strong>2021,</strong> <em>15 </em>
                                    (1)
                                     , 16-26. <a href="https://doi.org/10.1134/S1990750821010078" title="DOI URL">https://doi.org/10.1134/S1990750821010078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1990750821010078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1990750821010078%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520%2528Moscow%2529%252C%2520Supplement%2520Series%2520B%253A%2520Biomedical%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bthe%252BApical%252BSodium-Dependent%252BBile%252BAcid%252BTransporter%252B%252528ASBT%252529%252Bas%252BPromising%252BDrugs%26aulast%3DSaveleva%26aufirst%3DE.%2BE.%26date%3D2021%26date%3D2021%26volume%3D15%26issue%3D1%26spage%3D16%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Sumedha  Gunewardena</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">David J.  Matye</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Chao</span>, <span class="hlFld-ContribAuthor ">Taeyoon  Jung</span>, <span class="hlFld-ContribAuthor ">Yuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Maciej  Czerwiński</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Ni</span>, <span class="hlFld-ContribAuthor ">Wen-Xing  Ding</span>, <span class="hlFld-ContribAuthor ">Tiangang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17363-6" title="DOI URL">https://doi.org/10.1038/s41467-020-17363-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17363-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17363-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DAn%252BFGF15%25252F19-TFEB%252Bregulatory%252Bloop%252Bcontrols%252Bhepatic%252Bcholesterol%252Band%252Bbile%252Bacid%252Bhomeostasis%26aulast%3DWang%26aufirst%3DYifeng%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Shengtian  Cao</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongqing  Wang</span>, <span class="hlFld-ContribAuthor ">Guozhu  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Baohua  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>212 </em>, 107539. <a href="https://doi.org/10.1016/j.pharmthera.2020.107539" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107539%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DApical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%25252C%252Bdrug%252Btarget%252Bfor%252Bbile%252Bacid%252Brelated%252Bdiseases%252Band%252Bdelivery%252Btarget%252Bfor%252Bprodrugs%25253A%252BCurrent%252Band%252Bfuture%252Bchallenges%26aulast%3DLi%26aufirst%3DMing%26date%3D2020%26volume%3D212%26spage%3D107539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binita M.  Kamath</span>, <span class="hlFld-ContribAuthor ">Philip  Stein</span>, <span class="hlFld-ContribAuthor ">Roderick H. J.  Houwen</span>, <span class="hlFld-ContribAuthor ">Henkjan J.  Verkade</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis. </span><span class="cited-content_cbyCitation_journal-name">Liver International</span><span> <strong>2020,</strong> <em>40 </em>
                                    (8)
                                     , 1812-1822. <a href="https://doi.org/10.1111/liv.14553" title="DOI URL">https://doi.org/10.1111/liv.14553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/liv.14553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fliv.14553%26sid%3Dliteratum%253Aachs%26jtitle%3DLiver%2520International%26atitle%3DPotential%252Bof%252Bileal%252Bbile%252Bacid%252Btransporter%252Binhibition%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252BAlagille%252Bsyndrome%252Band%252Bprogressive%252Bfamilial%252Bintrahepatic%252Bcholestasis%26aulast%3DKamath%26aufirst%3DBinita%2BM.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D8%26spage%3D1812%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo R.  Fitzpatrick</span>, <span class="hlFld-ContribAuthor ">Paniz  Jenabzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">IBD and Bile Acid Absorption: Focus on Pre-clinical and Clinical Observations. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphys.2020.00564" title="DOI URL">https://doi.org/10.3389/fphys.2020.00564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2020.00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2020.00564%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DIBD%252Band%252BBile%252BAcid%252BAbsorption%25253A%252BFocus%252Bon%252BPre-clinical%252Band%252BClinical%252BObservations%26aulast%3DFitzpatrick%26aufirst%3DLeo%2BR.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.E.  Saveleva</span>, <span class="hlFld-ContribAuthor ">E.S.  Tyutrina</span>, <span class="hlFld-ContribAuthor ">T.  Nakanishi</span>, <span class="hlFld-ContribAuthor ">I.  Tamai</span>, <span class="hlFld-ContribAuthor ">A.B.  Salmina</span>. </span><span class="cited-content_cbyCitation_article-title">The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs. </span><span class="cited-content_cbyCitation_journal-name">Biomeditsinskaya Khimiya</span><span> <strong>2020,</strong> <em>66 </em>
                                    (3)
                                     , 185-195. <a href="https://doi.org/10.18097/pbmc20206603185" title="DOI URL">https://doi.org/10.18097/pbmc20206603185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18097/pbmc20206603185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18097%2Fpbmc20206603185%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomeditsinskaya%2520Khimiya%26atitle%3DThe%252Binhibitors%252Bof%252Bthe%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%252B%252528ASBT%252529%252Bas%252Bpromising%252Bdrugs%26aulast%3DSaveleva%26aufirst%3DE.E.%26date%3D2020%26date%3D2020%26volume%3D66%26issue%3D3%26spage%3D185%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander L.  Ticho</span>, <span class="hlFld-ContribAuthor ">Pooja  Malhotra</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Manzella</span>, <span class="hlFld-ContribAuthor ">Pradeep K.  Dudeja</span>, <span class="hlFld-ContribAuthor ">Seema  Saksena</span>, <span class="hlFld-ContribAuthor ">Ravinder K.  Gill</span>, <span class="hlFld-ContribAuthor ">Waddah A.  Alrefai</span>. </span><span class="cited-content_cbyCitation_article-title">S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (14)
                                     , 4488-4497. <a href="https://doi.org/10.1074/jbc.RA119.011032" title="DOI URL">https://doi.org/10.1074/jbc.RA119.011032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.011032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.011032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DS-acylation%252Bmodulates%252Bthe%252Bfunction%252Bof%252Bthe%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%252Bin%252Bhuman%252Bcells%26aulast%3DTicho%26aufirst%3DAlexander%2BL.%26date%3D2020%26volume%3D295%26issue%3D14%26spage%3D4488%26epage%3D4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Brønden</span>, <span class="hlFld-ContribAuthor ">Filip K  Knop</span>. </span><span class="cited-content_cbyCitation_article-title">Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Endocrinology & Metabolism</span><span> <strong>2020,</strong> <em>105 </em>
                                    (1)
                                     , 362-373. <a href="https://doi.org/10.1210/clinem/dgz025" title="DOI URL">https://doi.org/10.1210/clinem/dgz025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/clinem/dgz025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fclinem%2Fdgz025%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Endocrinology%2520%2526%2520Metabolism%26atitle%3DGluco-Metabolic%252BEffects%252Bof%252BPharmacotherapy-Induced%252BModulation%252Bof%252BBile%252BAcid%252BPhysiology%26aulast%3DBr%25C3%25B8nden%26aufirst%3DAndreas%26date%3D2020%26date%3D2019%26volume%3D105%26issue%3D1%26spage%3D362%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander L.  Ticho</span>, <span class="hlFld-ContribAuthor ">Pooja  Malhotra</span>, <span class="hlFld-ContribAuthor ">Pradeep K.  Dudeja</span>, <span class="hlFld-ContribAuthor ">Ravinder K.  Gill</span>, <span class="hlFld-ContribAuthor ">Waddah A.  Alrefai</span>. </span><span class="cited-content_cbyCitation_article-title">Intestinal Absorption of Bile Acids in Health and Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 21-56. <a href="https://doi.org/10.1002/cphy.c190007" title="DOI URL">https://doi.org/10.1002/cphy.c190007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphy.c190007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphy.c190007%26sid%3Dliteratum%253Aachs%26atitle%3DIntestinal%252BAbsorption%252Bof%252BBile%252BAcids%252Bin%252BHealth%252Band%252BDisease%26aulast%3DTicho%26aufirst%3DAlexander%2BL.%26date%3D2019%26date%3D2019%26spage%3D21%26epage%3D56%26pub%3DWiley%26atitle%3DComprehensive%252BPhysiology%26aulast%3DTerjung%26aufirst%3DRonald%26date%3D2011%26date%3D2011%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshimitsu  Kiriyama</span>, <span class="hlFld-ContribAuthor ">Hiromi  Nochi</span>. </span><span class="cited-content_cbyCitation_article-title">The Biosynthesis, Signaling, and Neurological Functions of Bile Acids. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (6)
                                     , 232. <a href="https://doi.org/10.3390/biom9060232" title="DOI URL">https://doi.org/10.3390/biom9060232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9060232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9060232%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DThe%252BBiosynthesis%25252C%252BSignaling%25252C%252Band%252BNeurological%252BFunctions%252Bof%252BBile%252BAcids%26aulast%3DKiriyama%26aufirst%3DYoshimitsu%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D6%26spage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ghandi</span>, <span class="hlFld-ContribAuthor ">Irene  Efteghar</span>, <span class="hlFld-ContribAuthor ">Alireza  Abbasi</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of quinoline-fused [1,4]thiazepines via the tandem Ugi/post-Ugi reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 325-332. <a href="https://doi.org/10.1007/s13738-018-1511-z" title="DOI URL">https://doi.org/10.1007/s13738-018-1511-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-018-1511-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-018-1511-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DOne-pot%252Bsynthesis%252Bof%252Bquinoline-fused%252B%25255B1%25252C4%25255Dthiazepines%252Bvia%252Bthe%252Btandem%252BUgi%25252Fpost-Ugi%252Breactions%26aulast%3DGhandi%26aufirst%3DMehdi%26date%3D2019%26date%3D2018%26volume%3D16%26issue%3D2%26spage%3D325%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Becerra-Rivas</span>, <span class="hlFld-ContribAuthor ">Paola  Cuervo-Prado</span>, <span class="hlFld-ContribAuthor ">Fabian  Orozco-Lopez</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient catalyst-free tricomponent synthesis of new spiro[cyclohexane-1,4′-pyrazolo[3,4-
              e
              ][1, 4]thiazepin]-7′(6′
              H
              )-ones. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2019,</strong> <em>49 </em>
                                    (3)
                                     , 367-376. <a href="https://doi.org/10.1080/00397911.2018.1554143" title="DOI URL">https://doi.org/10.1080/00397911.2018.1554143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2018.1554143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2018.1554143%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEfficient%252Bcatalyst-free%252Btricomponent%252Bsynthesis%252Bof%252Bnew%252Bspiro%25255Bcyclohexane-1%25252C4%2525E2%252580%2525B2-pyrazolo%25255B3%25252C4-%252Be%252B%25255D%25255B1%25252C%252B4%25255Dthiazepin%25255D-7%2525E2%252580%2525B2%2525286%2525E2%252580%2525B2%252BH%252B%252529-ones%26aulast%3DBecerra-Rivas%26aufirst%3DChristian%26date%3D2019%26date%3D2019%26volume%3D49%26issue%3D3%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroko  Ino</span>, <span class="hlFld-ContribAuthor ">Akira  Endo</span>, <span class="hlFld-ContribAuthor ">Akira  Wakamatsu</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Ogura</span>, <span class="hlFld-ContribAuthor ">Yotaro  Numachi</span>, <span class="hlFld-ContribAuthor ">Stuart  Kendrick</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2019,</strong> <em>8 </em>
                                    (1)
                                     , 70-77. <a href="https://doi.org/10.1002/cpdd.576" title="DOI URL">https://doi.org/10.1002/cpdd.576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.576%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DSafety%25252C%252BTolerability%25252C%252BPharmacokinetic%252Band%252BPharmacodynamic%252BEvaluations%252BFollowing%252BSingle%252BOral%252BDoses%252Bof%252BGSK2330672%252Bin%252BHealthy%252BJapanese%252BVolunteers%26aulast%3DIno%26aufirst%3DHiroko%26date%3D2019%26date%3D2018%26volume%3D8%26issue%3D1%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim  van Zutphen</span>, <span class="hlFld-ContribAuthor ">Anna  Bertolini</span>, <span class="hlFld-ContribAuthor ">Hilde D.  de Vries</span>, <span class="hlFld-ContribAuthor ">Vincent W.  Bloks</span>, <span class="hlFld-ContribAuthor ">Jan Freark  de Boer</span>, <span class="hlFld-ContribAuthor ">Johan W.  Jonker</span>, <span class="hlFld-ContribAuthor ">Folkert  Kuipers</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 207-234. <a href="https://doi.org/10.1007/164_2019_233" title="DOI URL">https://doi.org/10.1007/164_2019_233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_233%26sid%3Dliteratum%253Aachs%26atitle%3DPotential%252Bof%252BIntestine-Selective%252BFXR%252BModulation%252Bfor%252BTreatment%252Bof%252BMetabolic%252BDisease%26aulast%3Dvan%2BZutphen%26aufirst%3DTim%26date%3D2019%26date%3D2019%26spage%3D207%26epage%3D234%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBile%252BAcids%252Band%252BTheir%252BReceptors%26aulast%3DFiorucci%26aufirst%3DStefano%26date%3D2019%26volume%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaru  Xue</span>, <span class="hlFld-ContribAuthor ">Chenhui  Ma</span>, <span class="hlFld-ContribAuthor ">Imad  Hanna</span>, <span class="hlFld-ContribAuthor ">Guoyu  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Intestinal Transporter-Associated Drug Absorption and Toxicity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 361-405. <a href="https://doi.org/10.1007/978-981-13-7647-4_8" title="DOI URL">https://doi.org/10.1007/978-981-13-7647-4_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-7647-4_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-7647-4_8%26sid%3Dliteratum%253Aachs%26atitle%3DIntestinal%252BTransporter-Associated%252BDrug%252BAbsorption%252Band%252BToxicity%26aulast%3DXue%26aufirst%3DYaru%26date%3D2019%26date%3D2019%26spage%3D361%26epage%3D405%26pub%3DSpringer%2520Singapore%26atitle%3DDrug%252BTransporters%252Bin%252BDrug%252BDisposition%25252C%252BEffects%252Band%252BToxicity%26aulast%3DLiu%26aufirst%3DXiaodong%26date%3D2019%26volume%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander L.  Ticho</span>, <span class="hlFld-ContribAuthor ">Hyunjin  Lee</span>, <span class="hlFld-ContribAuthor ">Ravinder K.  Gill</span>, <span class="hlFld-ContribAuthor ">Pradeep K.  Dudeja</span>, <span class="hlFld-ContribAuthor ">Seema  Saksena</span>, <span class="hlFld-ContribAuthor ">Daesung  Lee</span>, <span class="hlFld-ContribAuthor ">Waddah A.  Alrefai</span>. </span><span class="cited-content_cbyCitation_article-title">A novel bioluminescence-based method to investigate uptake of bile acids in living cells. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Gastrointestinal and Liver Physiology</span><span> <strong>2018,</strong> <em>315 </em>
                                    (4)
                                     , G529-G537. <a href="https://doi.org/10.1152/ajpgi.00133.2018" title="DOI URL">https://doi.org/10.1152/ajpgi.00133.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpgi.00133.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpgi.00133.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Gastrointestinal%2520and%2520Liver%2520Physiology%26atitle%3DA%252Bnovel%252Bbioluminescence-based%252Bmethod%252Bto%252Binvestigate%252Buptake%252Bof%252Bbile%252Bacids%252Bin%252Bliving%252Bcells%26aulast%3DTicho%26aufirst%3DAlexander%2BL.%26date%3D2018%26volume%3D315%26issue%3D4%26spage%3DG529%26epage%3DG537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Ivan  Vokral</span>, <span class="hlFld-ContribAuthor ">Bernard  Evers</span>, <span class="hlFld-ContribAuthor ">Inge A.M.  de Graaf</span>, <span class="hlFld-ContribAuthor ">Marina H.  de Jager</span>, <span class="hlFld-ContribAuthor ">Geny M.M.  Groothuis</span>. </span><span class="cited-content_cbyCitation_article-title">Human and rat precision-cut intestinal slices as ex vivo models to study bile acid uptake by the apical sodium-dependent bile acid transporter. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>121 </em>, 65-73. <a href="https://doi.org/10.1016/j.ejps.2018.05.005" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DHuman%252Band%252Brat%252Bprecision-cut%252Bintestinal%252Bslices%252Bas%252Bex%252Bvivo%252Bmodels%252Bto%252Bstudy%252Bbile%252Bacid%252Buptake%252Bby%252Bthe%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%26aulast%3DLi%26aufirst%3DMing%26date%3D2018%26volume%3D121%26spage%3D65%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Li</span>, <span class="hlFld-ContribAuthor ">Amal  Dutta</span>, <span class="hlFld-ContribAuthor ">Charles  Kresge</span>, <span class="hlFld-ContribAuthor ">Abhijit  Bugde</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Feranchak</span>. </span><span class="cited-content_cbyCitation_article-title">Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl
              −
              channels. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2018,</strong> <em>68 </em>
                                    (1)
                                     , 187-199. <a href="https://doi.org/10.1002/hep.29804" title="DOI URL">https://doi.org/10.1002/hep.29804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.29804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.29804%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DBile%252Bacids%252Bstimulate%252Bcholangiocyte%252Bfluid%252Bsecretion%252Bby%252Bactivation%252Bof%252Btransmembrane%252Bmember%252B16A%252BCl%252B%2525E2%252588%252592%252Bchannels%26aulast%3DLi%26aufirst%3DQin%26date%3D2018%26date%3D2018%26volume%3D68%26issue%3D1%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Xing  Ding</span>, <span class="hlFld-ContribAuthor ">Tiangang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2018,</strong> <em>1863 </em>
                                    (7)
                                     , 726-733. <a href="https://doi.org/10.1016/j.bbalip.2018.04.005" title="DOI URL">https://doi.org/10.1016/j.bbalip.2018.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2018.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DCholesterol%252Band%252Bbile%252Bacid-mediated%252Bregulation%252Bof%252Bautophagy%252Bin%252Bfatty%252Bliver%252Bdiseases%252Band%252Batherosclerosis%26aulast%3DWang%26aufirst%3DYifeng%26date%3D2018%26volume%3D1863%26issue%3D7%26spage%3D726%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter L. M.  Jansen</span>. </span><span class="cited-content_cbyCitation_article-title">New therapies target the toxic consequences of cholestatic liver disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2018,</strong> <em>12 </em>
                                    (3)
                                     , 277-285. <a href="https://doi.org/10.1080/17474124.2018.1424538" title="DOI URL">https://doi.org/10.1080/17474124.2018.1424538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17474124.2018.1424538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17474124.2018.1424538%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DNew%252Btherapies%252Btarget%252Bthe%252Btoxic%252Bconsequences%252Bof%252Bcholestatic%252Bliver%252Bdisease%26aulast%3DJansen%26aufirst%3DPeter%2BL.%2BM.%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3D3%26spage%3D277%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Angelina V.  Biitseva</span>, <span class="hlFld-ContribAuthor ">Serhii  Zhersh</span>. </span><span class="cited-content_cbyCitation_article-title">Amino sulfonic acids, peptidosulfonamides and other related compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (13)
                                     , 1355-1421. <a href="https://doi.org/10.1016/j.tet.2018.01.033" title="DOI URL">https://doi.org/10.1016/j.tet.2018.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAmino%252Bsulfonic%252Bacids%25252C%252Bpeptidosulfonamides%252Band%252Bother%252Brelated%252Bcompounds%26aulast%3DGrygorenko%26aufirst%3DOleksandr%2BO.%26date%3D2018%26volume%3D74%26issue%3D13%26spage%3D1355%26epage%3D1421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hagit  Shapiro</span>, <span class="hlFld-ContribAuthor ">Aleksandra A.  Kolodziejczyk</span>, <span class="hlFld-ContribAuthor ">Daniel  Halstuch</span>, <span class="hlFld-ContribAuthor ">Eran  Elinav</span>. </span><span class="cited-content_cbyCitation_article-title">Bile acids in glucose metabolism in health and disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Medicine</span><span> <strong>2018,</strong> <em>215 </em>
                                    (2)
                                     , 383-396. <a href="https://doi.org/10.1084/jem.20171965" title="DOI URL">https://doi.org/10.1084/jem.20171965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1084/jem.20171965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1084%2Fjem.20171965%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Medicine%26atitle%3DBile%252Bacids%252Bin%252Bglucose%252Bmetabolism%252Bin%252Bhealth%252Band%252Bdisease%26aulast%3DShapiro%26aufirst%3DHagit%26date%3D2018%26date%3D2018%26volume%3D215%26issue%3D2%26spage%3D383%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Bakulina</span>, <span class="hlFld-ContribAuthor ">Maria  Chizhova</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar'in</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">A General Way to Construct Arene-Fused Seven-Membered Nitrogen Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (3)
                                     , 362-371. <a href="https://doi.org/10.1002/ejoc.201701642" title="DOI URL">https://doi.org/10.1002/ejoc.201701642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701642%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BGeneral%252BWay%252Bto%252BConstruct%252BArene-Fused%252BSeven-Membered%252BNitrogen%252BHeterocycles%26aulast%3DBakulina%26aufirst%3DOlga%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D3%26spage%3D362%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Libor  Vítek</span>. </span><span class="cited-content_cbyCitation_article-title">Bile Acids in the Treatment of Cardiometabolic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Annals of Hepatology</span><span> <strong>2017,</strong> <em>16 </em>, S43-S52. <a href="https://doi.org/10.5604/01.3001.0010.5496" title="DOI URL">https://doi.org/10.5604/01.3001.0010.5496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5604/01.3001.0010.5496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5604%2F01.3001.0010.5496%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Hepatology%26atitle%3DBile%252BAcids%252Bin%252Bthe%252BTreatment%252Bof%252BCardiometabolic%252BDiseases%26aulast%3DV%25C3%25ADtek%26aufirst%3DLibor%26date%3D2017%26volume%3D16%26spage%3DS43%26epage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven M.  Sparks</span>, <span class="hlFld-ContribAuthor ">Paul K.  Spearing</span>, <span class="hlFld-ContribAuthor ">Caroline J.  Diaz</span>, <span class="hlFld-ContribAuthor ">David J.  Cowan</span>, <span class="hlFld-ContribAuthor ">Channa  Jayawickreme</span>, <span class="hlFld-ContribAuthor ">Grace  Chen</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Rimele</span>, <span class="hlFld-ContribAuthor ">Claudia  Generaux</span>, <span class="hlFld-ContribAuthor ">Lindsey T.  Harston</span>, <span class="hlFld-ContribAuthor ">Shane G.  Roller</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4673-4677. <a href="https://doi.org/10.1016/j.bmcl.2017.09.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpotent%25252C%252Bnonabsorbable%252Bagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252Bfor%252BGI-specific%252Badministration%26aulast%3DSparks%26aufirst%3DSteven%2BM.%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4673%26epage%3D4677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Xiao</span>, <span class="hlFld-ContribAuthor ">Guoyu  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT). </span><span class="cited-content_cbyCitation_journal-name">Clinics and Research in Hepatology and Gastroenterology</span><span> <strong>2017,</strong> <em>41 </em>
                                    (5)
                                     , 509-515. <a href="https://doi.org/10.1016/j.clinre.2017.02.001" title="DOI URL">https://doi.org/10.1016/j.clinre.2017.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinre.2017.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinre.2017.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DClinics%2520and%2520Research%2520in%2520Hepatology%2520and%2520Gastroenterology%26atitle%3DAn%252Bimportant%252Bintestinal%252Btransporter%252Bthat%252Bregulates%252Bthe%252Benterohepatic%252Bcirculation%252Bof%252Bbile%252Bacids%252Band%252Bcholesterol%252Bhomeostasis%25253A%252BThe%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%252B%252528SLC10A2%25252FASBT%252529%26aulast%3DXiao%26aufirst%3DLing%26date%3D2017%26volume%3D41%26issue%3D5%26spage%3D509%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin L.  Kårhus</span>, <span class="hlFld-ContribAuthor ">Andreas  Brønden</span>, <span class="hlFld-ContribAuthor ">David P.  Sonne</span>, <span class="hlFld-ContribAuthor ">Tina  Vilsbøll</span>, <span class="hlFld-ContribAuthor ">Fillip K.  Knop</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence connecting old, new and neglected glucose‐lowering drugs to bile acid‐induced
              GLP
              ‐1 secretion:
              A
              review. </span><span class="cited-content_cbyCitation_journal-name">Diabetes, Obesity and Metabolism</span><span> <strong>2017,</strong> <em>19 </em>
                                    (9)
                                     , 1214-1222. <a href="https://doi.org/10.1111/dom.12946" title="DOI URL">https://doi.org/10.1111/dom.12946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/dom.12946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fdom.12946%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%252C%2520Obesity%2520and%2520Metabolism%26atitle%3DEvidence%252Bconnecting%252Bold%25252C%252Bnew%252Band%252Bneglected%252Bglucose%2525E2%252580%252590lowering%252Bdrugs%252Bto%252Bbile%252Bacid%2525E2%252580%252590induced%252BGLP%252B%2525E2%252580%2525901%252Bsecretion%25253A%252BA%252Breview%26aulast%3DK%25C3%25A5rhus%26aufirst%3DMartin%2BL.%26date%3D2017%26date%3D2017%26volume%3D19%26issue%3D9%26spage%3D1214%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinod S  Hegade</span>, <span class="hlFld-ContribAuthor ">Stuart F W  Kendrick</span>, <span class="hlFld-ContribAuthor ">Robert L  Dobbins</span>, <span class="hlFld-ContribAuthor ">Sam R  Miller</span>, <span class="hlFld-ContribAuthor ">Douglas  Thompson</span>, <span class="hlFld-ContribAuthor ">Duncan  Richards</span>, <span class="hlFld-ContribAuthor ">James  Storey</span>, <span class="hlFld-ContribAuthor ">George E  Dukes</span>, <span class="hlFld-ContribAuthor ">Margaret  Corrigan</span>, <span class="hlFld-ContribAuthor ">Ronald P J  Oude Elferink</span>, <span class="hlFld-ContribAuthor ">Ulrich  Beuers</span>, <span class="hlFld-ContribAuthor ">Gideon M  Hirschfield</span>, <span class="hlFld-ContribAuthor ">David E  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study. </span><span class="cited-content_cbyCitation_journal-name">The Lancet</span><span> <strong>2017,</strong> <em>389 </em>
                                    (10074)
                                     , 1114-1123. <a href="https://doi.org/10.1016/S0140-6736(17)30319-7" title="DOI URL">https://doi.org/10.1016/S0140-6736(17)30319-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0140-6736(17)30319-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0140-6736%2817%2930319-7%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%26atitle%3DEffect%252Bof%252Bileal%252Bbile%252Bacid%252Btransporter%252Binhibitor%252BGSK2330672%252Bon%252Bpruritus%252Bin%252Bprimary%252Bbiliary%252Bcholangitis%25253A%252Ba%252Bdouble-blind%25252C%252Brandomised%25252C%252Bplacebo-controlled%25252C%252Bcrossover%25252C%252Bphase%252B2a%252Bstudy%26aulast%3DHegade%26aufirst%3DVinod%2BS%26date%3D2017%26volume%3D389%26issue%3D10074%26spage%3D1114%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Eyckens</span>, <span class="hlFld-ContribAuthor ">Luke C.  Henderson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-aminophosphonates using solvate ionic liquids. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (45)
                                     , 27900-27904. <a href="https://doi.org/10.1039/C7RA04407K" title="DOI URL">https://doi.org/10.1039/C7RA04407K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA04407K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA04407K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-aminophosphonates%252Busing%252Bsolvate%252Bionic%252Bliquids%26aulast%3DEyckens%26aufirst%3DDaniel%2BJ.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D45%26spage%3D27900%26epage%3D27904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. J.  Nunez</span>, <span class="hlFld-ContribAuthor ">X.  Yao</span>, <span class="hlFld-ContribAuthor ">J.  Lin</span>, <span class="hlFld-ContribAuthor ">A.  Walker</span>, <span class="hlFld-ContribAuthor ">P.  Zuo</span>, <span class="hlFld-ContribAuthor ">L.  Webster</span>, <span class="hlFld-ContribAuthor ">S.  Krug-Gourley</span>, <span class="hlFld-ContribAuthor ">M. J.  Zamek-Gliszczynski</span>, <span class="hlFld-ContribAuthor ">D. S.  Gillmor</span>, <span class="hlFld-ContribAuthor ">S. L.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. </span><span class="cited-content_cbyCitation_journal-name">Diabetes, Obesity and Metabolism</span><span> <strong>2016,</strong> <em>18 </em>
                                    (7)
                                     , 654-662. <a href="https://doi.org/10.1111/dom.12656" title="DOI URL">https://doi.org/10.1111/dom.12656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/dom.12656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fdom.12656%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%252C%2520Obesity%2520and%2520Metabolism%26atitle%3DGlucose%252Band%252Blipid%252Beffects%252Bof%252Bthe%252Bileal%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%252Binhibitor%252BGSK2330672%25253A%252Bdouble-blind%252Brandomized%252Btrials%252Bwith%252Btype%252B2%252Bdiabetes%252Bsubjects%252Btaking%252Bmetformin%26aulast%3DNunez%26aufirst%3DD.%2BJ.%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D7%26spage%3D654%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven M.  Sparks</span>, <span class="hlFld-ContribAuthor ">Huiqiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Claudia  Generaux</span>, <span class="hlFld-ContribAuthor ">Lindsey  Harston</span>, <span class="hlFld-ContribAuthor ">David  Moncol</span>, <span class="hlFld-ContribAuthor ">Channa  Jayawickreme</span>, <span class="hlFld-ContribAuthor ">Janet  Parham</span>, <span class="hlFld-ContribAuthor ">Patrick  Condreay</span>, <span class="hlFld-ContribAuthor ">Thomas  Rimele</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of nonabsorbable inhibitors of the scavenger receptor-BI (SR-BI) for tissue-specific administration. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 1901-1904. <a href="https://doi.org/10.1016/j.bmcl.2016.03.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnonabsorbable%252Binhibitors%252Bof%252Bthe%252Bscavenger%252Breceptor-BI%252B%252528SR-BI%252529%252Bfor%252Btissue-specific%252Badministration%26aulast%3DSparks%26aufirst%3DSteven%2BM.%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D1901%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annarosa  Floreani</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Zheng Sheng  Zou</span>, <span class="hlFld-ContribAuthor ">Baosen  Li</span>, <span class="hlFld-ContribAuthor ">Nora  Cazzagon</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Bowlus</span>, <span class="hlFld-ContribAuthor ">M. Eric  Gershwin</span>. </span><span class="cited-content_cbyCitation_article-title">Proposed therapies in primary biliary cholangitis. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2016,</strong> <em>10 </em>
                                    (3)
                                     , 371-382. <a href="https://doi.org/10.1586/17474124.2016.1121810" title="DOI URL">https://doi.org/10.1586/17474124.2016.1121810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17474124.2016.1121810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17474124.2016.1121810%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DProposed%252Btherapies%252Bin%252Bprimary%252Bbiliary%252Bcholangitis%26aulast%3DFloreani%26aufirst%3DAnnarosa%26date%3D2016%26date%3D2016%26volume%3D10%26issue%3D3%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.T.  Fyfe</span>. </span><span class="cited-content_cbyCitation_article-title">Non-systemic Intestine-Targeted Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-44. <a href="https://doi.org/10.1016/bs.pmch.2015.10.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2015.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DNon-systemic%252BIntestine-Targeted%252BDrugs%26aulast%3DFyfe%26aufirst%3DMatthew%2BC.T.%26date%3D2016%26spage%3D1%26epage%3D44%26pub%3DElsevier%26date%3D2016%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lawrence  Lin</span>, <span class="hlFld-ContribAuthor ">Sook Wah  Yee</span>, <span class="hlFld-ContribAuthor ">Richard B.  Kim</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Giacomini</span>. </span><span class="cited-content_cbyCitation_article-title">SLC transporters as therapeutic targets: emerging opportunities. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2015,</strong> <em>14 </em>
                                    (8)
                                     , 543-560. <a href="https://doi.org/10.1038/nrd4626" title="DOI URL">https://doi.org/10.1038/nrd4626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4626%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DSLC%252Btransporters%252Bas%252Btherapeutic%252Btargets%25253A%252Bemerging%252Bopportunities%26aulast%3DLin%26aufirst%3DLawrence%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D8%26spage%3D543%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael  Alhadeff</span>, <span class="hlFld-ContribAuthor ">Assaf  Ganoth</span>, <span class="hlFld-ContribAuthor ">Isaiah T.  Arkin</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic studies of the apical sodium-dependent bile acid transporter. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2015,</strong> <em>83 </em>
                                    (6)
                                     , 1107-1117. <a href="https://doi.org/10.1002/prot.24796" title="DOI URL">https://doi.org/10.1002/prot.24796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.24796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.24796%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DMechanistic%252Bstudies%252Bof%252Bthe%252Bapical%252Bsodium-dependent%252Bbile%252Bacid%252Btransporter%26aulast%3DAlhadeff%26aufirst%3DRaphael%26date%3D2015%26date%3D2015%26volume%3D83%26issue%3D6%26spage%3D1107%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Dawson</span>, <span class="hlFld-ContribAuthor ">Saul J.  Karpen</span>. </span><span class="cited-content_cbyCitation_article-title">Intestinal transport and metabolism of bile acids. </span><span class="cited-content_cbyCitation_journal-name">Journal of Lipid Research</span><span> <strong>2015,</strong> <em>56 </em>
                                    (6)
                                     , 1085-1099. <a href="https://doi.org/10.1194/jlr.R054114" title="DOI URL">https://doi.org/10.1194/jlr.R054114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1194/jlr.R054114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1194%2Fjlr.R054114%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Lipid%2520Research%26atitle%3DIntestinal%252Btransport%252Band%252Bmetabolism%252Bof%252Bbile%252Bacids%26aulast%3DDawson%26aufirst%3DPaul%2BA.%26date%3D2015%26volume%3D56%26issue%3D6%26spage%3D1085%26epage%3D1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Ryan</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Jeremy  Just</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 521-571. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00016-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00016-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00016-9%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DRyan%26aufirst%3DJohn%2BH.%26date%3D2014%26spage%3D521%26epage%3D571%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Ding</span>, <span class="hlFld-ContribAuthor ">Shuguang  Pang</span>, <span class="hlFld-ContribAuthor ">Yongmei  Sun</span>, <span class="hlFld-ContribAuthor ">Yuling  Tian</span>, <span class="hlFld-ContribAuthor ">Li  Yu</span>, <span class="hlFld-ContribAuthor ">Ningning  Dang</span>. </span><span class="cited-content_cbyCitation_article-title">Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Endocrinology</span><span> <strong>2014,</strong> <em>2014 </em>, 1-13. <a href="https://doi.org/10.1155/2014/751859" title="DOI URL">https://doi.org/10.1155/2014/751859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/751859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F751859%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Endocrinology%26atitle%3DCoordinated%252BActions%252Bof%252BFXR%252Band%252BLXR%252Bin%252BMetabolism%25253A%252BFrom%252BPathogenesis%252Bto%252BPharmacological%252BTargets%252Bfor%252BType%252B2%252BDiabetes%26aulast%3DDing%26aufirst%3DLin%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen P.H.  Alexander</span>, <span class="hlFld-ContribAuthor ">Helen E.  Benson</span>, <span class="hlFld-ContribAuthor ">Elena  Faccenda</span>, <span class="hlFld-ContribAuthor ">Adam J.  Pawson</span>, <span class="hlFld-ContribAuthor ">Joanna L.  Sharman</span>, <span class="hlFld-ContribAuthor ">Michael  Spedding</span>, <span class="hlFld-ContribAuthor ">John A.  Peters</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Harmar</span>, . </span><span class="cited-content_cbyCitation_article-title">The Concise Guide to PHARMACOLOGY 2013/14: Transporters. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (8)
                                     , 1706-1796. <a href="https://doi.org/10.1111/bph.12450" title="DOI URL">https://doi.org/10.1111/bph.12450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12450%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252BConcise%252BGuide%252Bto%252BPHARMACOLOGY%252B2013%25252F14%25253A%252BTransporters%26aulast%3DAlexander%26aufirst%3DStephen%2BP.H.%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D8%26spage%3D1706%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0014.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Select ASBT Inhibitors That Have Advanced to Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Key Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HCl(<i>g</i>), AlCl<sub>3</sub>, DCE; (b) Tf<sub>2</sub>O, pyridine, DCM; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, CO, MeOH, 70 °C; (d) LiOH, THF, MeOH, H<sub>2</sub>O; (e) ZnCN<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, Zn<sup>o</sup>, DMF, 80 °C; (f) DiBAL-H, toluene, DCM; (g) H<sub>2</sub>, 10% Pd/C, EtOH, 40 psi.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route to Oxygen-Linked Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RX, K<sub>2</sub>CO<sub>3</sub>, DMSO, 70–100 °C; (b) 1,2-dibromoethane, 1 M KOH, Bu<sub>4</sub>NBr, DMSO, 100 °C; (c) Na<sub>2</sub>SO<sub>3</sub>, EtOH, 100 °C; (d) 4 N HCl, 1,4-dioxane, DCM or LiOH, THF, MeOH, H<sub>2</sub>O; (e) TMSBr, DCM; (f) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>OSO<sub>2</sub>-(4-Cl-Ph), NaHMDS, THF, DMSO.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl acrylate, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> Et<sub>3</sub>N, DMF, 120 °C; (b) H<sub>2</sub>, 10% Pd/C, EtOH; (c) LiOH, THF, MeOH, H<sub>2</sub>O; (d) RNH<sub>2</sub>, HATU, DIPEA, DCM or EDC, DMAP, DCM; (e) BH<sub>3</sub>-THF, THF; (f) PPh<sub>3</sub>, CBr<sub>4</sub>, THF; (g) Na<sub>2</sub>SO<sub>3</sub>, EtOH, H<sub>2</sub>O, Δ; (h) MsCl, Et<sub>3</sub>N, DCM; (i) NaCN, DMSO, 60 °C; (j) 37% aq HCl, 100 °C; (k) HP(O)(OEt)<sub>2</sub>, NaH, THF; (l) TMSBr, DCM.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ROCOCOCl, Et<sub>3</sub>N, DCM; (b) LiOH, THF, H<sub>2</sub>O; (c) Cl(CH<sub>2</sub>)<sub><i>x</i></sub>COCl, pyridine, DCM; (d) Na<sub>2</sub>SO<sub>3</sub>, EtOH, H<sub>2</sub>O; (e) P(OEt)<sub>3</sub>, 135 °C; (f) TMSBr, DCM; (g) R<sup>1</sup>NH<sub>2</sub>, KI, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (h) Na<sup>+–</sup>O<sub>3</sub>SCH<sub>2</sub>CH<sub>2</sub>Br, DMF, 70 °C; (i) paraformaldehyde, HP(O)(OEt)<sub>2</sub>, THF or toluene, 70 °C.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RNH<sub>2</sub>, NaHB(OAc)<sub>3</sub>, AcOH, DCE; (b) LiOH, THF, MeOH, H<sub>2</sub>O; (c) 4 N HCl, 1,4-dioxane; (d) TMSBr, DCM; (e) piperidine, diethylmalonate, toluene, 100 °C; (f) diethyl malonate, NaOEt, EtOH; (g) 37% HCl, Δ; (h) (EtO)<sub>2</sub>P(O)CH<sub>2</sub>P(O)(OEt)<sub>2</sub>, NaH, THF; (i) H<sub>2</sub>, 10% Pd/C, EtOH.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DiBAL-H, toluene; (b) PPh<sub>3</sub>, Br<sub>2</sub>, imidazole, DCM, 0 °C; (c) diethyl iminodiacetate, CH<sub>3</sub>CN, 65 °C; (d) LiOH, THF, H<sub>2</sub>O; (e) Na<sub>2</sub>SO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O; (f) P(OEt)<sub>3</sub>, toluene; (g) 6 N HCl, EtOH, Δ.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of compound <b>20</b> on portal vein plasma bile acids (BA), total GLP-1 (tGLP-1), PYY, and GIP. Compound <b>20</b> (○, 1 mg/kg) or vehicle (●) was administered orally in portal vein cannulated male SD rats at 0800 (time 0) without fasting. Portal vein blood samples were collected at indicated time points up to 8 h. Plasma BA, tGLP-1, PYY, and GIP were measured as described in methods. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of ASBT inhibitors at the indicated doses on fecal bile acid concentrations in ZDF rats. Male ZDF rats were treated orally twice a day with vehicle, compound <b>20</b> (open bar), compound <b>56</b> (gray bar), or compound <b>45</b> (black bar) for two weeks. Twenty-four h fecal samples were collected on day 14 and extracted for fecal bile acid (BA) measurement. Data are presented as relative fold change from vehicle groups (dashed line). All treatment groups were statistically different from vehicle groups (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/medium/jm-2013-00459m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of ASBT inhibitors on blood HbA1c, plasma glucose, insulin, and total GLP-1 in 8-week-old male ZDF rats. Rats were treated orally twice a day with compound <b>20</b> (○), <b>45</b> (▲), or <b>56</b> (△) at the indicated doses for two weeks in two separate studies. Blood samples were collected on day 14 from tail vein. Blood HbA1c, plasma glucose, insulin, and total GLP-1 were measured as described in methods. *<i>p</i> < 0.05 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400459m/production/images/large/jm-2013-00459m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400459m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><div class="note"><p class="first last">Recent facts about diabetes can be found via the Internet at the World Health Organization website:</p></div>Diabetes, <span class="NLM_series">Fact Sheet no. 312</span>: <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_month">March</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs312/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs312/en/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Recent+facts+about+diabetes+can+be+found+via+the+Internet+at+the+World+Health+Organization+website%3ADiabetes%2C+Fact+Sheet+no.+312%3A+World+Health+Organization%3A+Geneva%2C+March%2C+2013%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312%2Fen%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%26pub%3DWorld%2520Health%2520Organization%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Inzucchi, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergenstal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buse, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrannini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsapas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span> </span><span class="NLM_article-title">Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1364</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1364-1379&author=S.+E.+Inzucchiauthor=R.+M.+Bergenstalauthor=J.+B.+Buseauthor=M.+Diamantauthor=E.+Ferranniniauthor=M.+Nauckauthor=A.+L.+Petersauthor=A.+Tsapasauthor=R.+Wenderauthor=D.+Matthews&title=Management+of+hyperglycemia+in+type+2+diabetes%3A+a+patient-centered+approach.+Position+statement+of+the+American+Diabetes+Association+%28ADA%29+and+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInzucchi%26aufirst%3DS.%2BE.%26aulast%3DBergenstal%26aufirst%3DR.%2BM.%26aulast%3DBuse%26aufirst%3DJ.%2BB.%26aulast%3DDiamant%26aufirst%3DM.%26aulast%3DFerrannini%26aufirst%3DE.%26aulast%3DNauck%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DA.%2BL.%26aulast%3DTsapas%26aufirst%3DA.%26aulast%3DWender%26aufirst%3DR.%26aulast%3DMatthews%26aufirst%3DD.%26atitle%3DManagement%2520of%2520hyperglycemia%2520in%2520type%25202%2520diabetes%253A%2520a%2520patient-centered%2520approach.%2520Position%2520statement%2520of%2520the%2520American%2520Diabetes%2520Association%2520%2528ADA%2529%2520and%2520the%2520European%2520Association%2520for%2520the%2520Study%2520of%2520Diabetes%2520%2528EASD%2529%26jtitle%3DDiabetes%2520Care%26date%3D2012%26volume%3D35%26spage%3D1364%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Todd, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, S. R.</span><span> </span><span class="NLM_article-title">Incretins and other peptides in the treatment of diabetes</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1111%2Fj.1464-5491.2006.02071.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=17263764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=223-232&issue=3&author=J.+R.+Toddauthor=S.+R.+Bloom&title=Incretins+and+other+peptides+in+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Incretins and other peptides in the treatment of diabetes</span></div><div class="casAuthors">Todd, J. F.; Bloom, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucagon-like peptide-1 (7-36) amide (GLP-1) is a gut hormone, released postprandially, which stimulates insulin secretion and insulin gene expression as well as pancreatic B-cell growth.  Together with glucose-dependent insulinotropic polypeptide (GIP), it is responsible for the incretin effect which is the augmentation of insulin secretion following oral administration of glucose.  Patients with Type 2 diabetes have greatly impaired or absent incretin-mediated insulin secretion which is mainly as a result of decreased secretion of GLP-1.  However, the insulinotropic action of GLP-1 is preserved in patients with Type 2 diabetes, and this has encouraged attempts to treat Type 2 diabetic patients with GLP-1.  GLP-1 also possesses a no. of potential advantages over existing agents for the treatment of Type 2 diabetes.  In addn. to stimulating insulin secretion and promoting pancreatic B-cell mass, GLP-1 suppresses glucagon secretion, delays gastric emptying and inhibits food intake.  Continuous i.v. and s.c. administration significantly improves glycemic control and causes redns. in both HbA1c and body wt.  However, GLP-1 is metabolized extremely rapidly in the circulation by the enzyme dipeptidyl peptidase IV (DPP-IV).  This is the probable explanation for the short-lived effect of single doses of native GLP-1, making it an unlikely glucose-lowering agent.  The DPP-IV resistant analog, exenatide, has Food and Drug Administration (FDA) approval for the treatment of Type 2 diabetes and selective DPP-IV inhibitors are under development.  Both approaches have demonstrated remarkable efficacy in animal models and human clin. studies.  Both are well tolerated and appear to have advantages over current therapies for Type 2 diabetes, particularly in terms of the effects on pancreatic B-cell restoration and potential wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8H7YGj0lUrVg90H21EOLACvtfcHk0ljSRhBMcpvCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWls7Y%253D&md5=c4db56f8d2bf6dec2f2cdd82de4b5a7a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2006.02071.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2006.02071.x%26sid%3Dliteratum%253Aachs%26aulast%3DTodd%26aufirst%3DJ.%2BR.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DIncretins%2520and%2520other%2520peptides%2520in%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DDiabetic%2520Med.%26date%3D2007%26volume%3D24%26issue%3D3%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">The incretin system and its role in type 2 diabetes mellitus</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1016%2Fj.mce.2008.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=18786605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=127-136&issue=1%E2%80%932&author=J.+J.+Holstauthor=T.+Vilsb%C3%B8llauthor=C.+F.+Deacon&title=The+incretin+system+and+its+role+in+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The incretin system and its role in type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Vilsboell, Tina; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The incretin hormones are released during meals from gut endocrine cells.  They potentiate glucose-induced insulin secretion and may be responsible for up to 70% of postprandial insulin secretion.  The incretin hormones include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which may also promote proliferation/neogenesis of beta cells and prevent their decay (apoptosis).  Both hormones contribute to insulin secretion from the beginning of a meal and their effects are progressively amplified as plasma glucose concns. rise.  The current interest in the incretin hormones is due to the fact that the incretin effect is severely reduced or absent in patients with type 2 diabetes mellitus (T2DM).  In addn., there is hyperglucagonemia, which is not suppressible by glucose.  In such patients, the secretion of GIP is near normal, but its effect on insulin secretion, particularly the late phase, is severely impaired.  The loss of GIP action is probably a consequence of diabetes, since it is also obsd. in patients with diabetes secondary to chronic pancreatitis, in whom the incretin effect is also lost.  GLP-1 secretion, on the other hand, is also impaired, but its insulinotropic and glucagon-suppressive actions are preserved, although the potency of GLP-1 in this respect is decreased compared to healthy subjects.  However, in supraphysiol. doses, GLP-1 administration may completely normalize beta as well as alpha cell sensitivity to glucose.  The impaired action of GLP-1 and GIP in T2DM may be at least partly restored by improved glycemic control, as shown in studies involving 4 wk of intensive insulin therapy.  The reduced incretin effect is believed to contribute to impaired regulation of insulin and glucagon secretion in T2DM, and, in support of this, exogenous GLP-1 administration may restore blood glucose regulation to near normal levels.  Thus, the pathogenesis of T2DM seems to involve a dysfunction of both incretins.  Enhancement of incretin action may therefore represent a therapeutic soln.  Clin. strategies therefore include the development of metabolically stable activators of the GLP-1 receptor; and inhibition of DPP-4, the enzyme that destroys native GLP-1 almost immediately.  Orally active DPP-4 inhibitors and the metabolically stable activators, exenatide (Byetta), are now on the market, and numerous clin. studies have shown that both principles are assocd. with durable antidiabetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt5VBmX7VnLVg90H21EOLACvtfcHk0ljSRhBMcpvCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P&md5=5995635fd35fb982d0b8740353f86dc3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DThe%2520incretin%2520system%2520and%2520its%2520role%2520in%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Creutzfeldt, W.</span><span> </span><span class="NLM_article-title">The entero-insular axis in type 2 diabetes—incretins as therapeutic agents</span> <span class="citation_source-journal">Exp. Clin. Endocrinol. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S288</span><span class="NLM_x">–</span> <span class="NLM_lpage">S303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=S288-S303&issue=Suppl.+2&author=W.+Creutzfeldt&title=The+entero-insular+axis+in+type+2+diabetes%E2%80%94incretins+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreutzfeldt%26aufirst%3DW.%26atitle%3DThe%2520entero-insular%2520axis%2520in%2520type%25202%2520diabetes%25E2%2580%2594incretins%2520as%2520therapeutic%2520agents%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2001%26volume%3D109%26issue%3DSuppl.%25202%26spage%3DS288%26epage%3DS303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Plaisanciė, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumoulin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chayvialle, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuber, J.-C.</span><span> </span><span class="NLM_article-title">Luminal glucagon-like peptide-1(7–36) amide-releasing factors in the isolated vascularly perfused rat colon</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1677%2Fjoe.0.1450521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=7636436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADyaK2MXmtV2gtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1995&pages=521-526&issue=3&author=P.+Plaisanci%C4%97author=V.+Dumoulinauthor=J.-A.+Chayvialleauthor=J.-C.+Cuber&title=Luminal+glucagon-like+peptide-1%287%E2%80%9336%29+amide-releasing+factors+in+the+isolated+vascularly+perfused+rat+colon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon</span></div><div class="casAuthors">Plaisancie, P.; Dumoulin, V.; Chayvialle, J.-A.; Cuber, J.-C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-6</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Journal of Endocrinology</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is released from endocrine cells of the distal part of the gut after ingestion of a meal.  GLP-1 secretion is, in part, under the control of hormonal and/or neural mechanisms.  However, stimulation of the colonic L cells may also occur directly by the luminal contents.  This was examd. in the present study, using an isolated vascularly perfused rat colon.  GLP-1 immunoreactivity was measured in the portal effluent after luminal infusion of a variety of compds. which are found in colonic contents (nutrients, fibers, bile acids, short-chain fatty acids (SCFAs)).  Oleic acid (100 mM) or a mixt. of amino acids (total concn. 250 mM), or starch (0.5%, w/v) did not increase GLP-1 secretion over basal value.  A pharmacol. concn. of glucose (250 mM) elicited a marked release of GLP-1 which was maximal at the end of infusion (400% of basal), while 5 mM glucose was without effect on secretion.  Pectin evoked a dose-dependent release of GLP-1 over the range 0.1-0.5% (w/v) with a maximal response at 360% of basal when 0.5% pectin was infused.  Cellulose or gum arabic (0.5%) did not modify GLP-1 secretion.  The SCFAs acetate, propionate or butyrate (5, 20 and 100 mM) did not induce a significant release of GLP-1.  Among the four bile acids tested, namely taurocholate, cholate, deoxycholate and hyodeoxycholate, the last one was the most potent at eliciting a GLP-1 response with a maximal release at 300% and 400% of the basal value when 2 and 20 mM bile acid were administered resp.  In conclusion, some fibers and bile acids are capable of releasing colonic GLP-1 in rats and may contribute to the secretory activity of colonic L cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqon6gR_1sVobVg90H21EOLACvtfcHk0ljSRhBMcpvCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtV2gtr4%253D&md5=f9a4233cd24017cbdb7bf72ffffba309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1450521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1450521%26sid%3Dliteratum%253Aachs%26aulast%3DPlaisanci%25C4%2597%26aufirst%3DP.%26aulast%3DDumoulin%26aufirst%3DV.%26aulast%3DChayvialle%26aufirst%3DJ.-A.%26aulast%3DCuber%26aufirst%3DJ.-C.%26atitle%3DLuminal%2520glucagon-like%2520peptide-1%25287%25E2%2580%259336%2529%2520amide-releasing%2520factors%2520in%2520the%2520isolated%2520vascularly%2520perfused%2520rat%2520colon%26jtitle%3DJ.%2520Endocrinol.%26date%3D1995%26volume%3D145%26issue%3D3%26spage%3D521%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dumoulin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barcelo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuber, J.-C.</span><span> </span><span class="NLM_article-title">Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3780</span><span class="NLM_x">–</span> <span class="NLM_lpage">3786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=3780-3786&issue=9&author=V.+Dumoulinauthor=F.+Moroauthor=A.+Barceloauthor=T.+Dakkaauthor=J.-C.+Cuber&title=Peptide+YY%2C+glucagon-like+peptide-1%2C+and+neurotensin+responses+to+luminal+factors+in+the+isolated+vascularly+perfused+rat+ileum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumoulin%26aufirst%3DV.%26aulast%3DMoro%26aufirst%3DF.%26aulast%3DBarcelo%26aufirst%3DA.%26aulast%3DDakka%26aufirst%3DT.%26aulast%3DCuber%26aufirst%3DJ.-C.%26atitle%3DPeptide%2520YY%252C%2520glucagon-like%2520peptide-1%252C%2520and%2520neurotensin%2520responses%2520to%2520luminal%2520factors%2520in%2520the%2520isolated%2520vascularly%2520perfused%2520rat%2520ileum%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26issue%3D9%26spage%3D3780%26epage%3D3786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Adrian, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantyne, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilchik, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tierney, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlin, I. M.</span><span> </span><span class="NLM_article-title">Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=1219-1224&issue=9&author=T.+E.+Adrianauthor=G.+H.+Ballantyneauthor=W.+E.+Longoauthor=A.+J.+Bilchikauthor=S.+Grahamauthor=M.+D.+Bassonauthor=R.+P.+Tierneyauthor=I.+M.+Modlin&title=Deoxycholate+is+an+important+releaser+of+peptide+YY+and+enteroglucagon+from+the+human+colon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdrian%26aufirst%3DT.%2BE.%26aulast%3DBallantyne%26aufirst%3DG.%2BH.%26aulast%3DLongo%26aufirst%3DW.%2BE.%26aulast%3DBilchik%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DBasson%26aufirst%3DM.%2BD.%26aulast%3DTierney%26aufirst%3DR.%2BP.%26aulast%3DModlin%26aufirst%3DI.%2BM.%26atitle%3DDeoxycholate%2520is%2520an%2520important%2520releaser%2520of%2520peptide%2520YY%2520and%2520enteroglucagon%2520from%2520the%2520human%2520colon%26jtitle%3DGut%26date%3D1993%26volume%3D34%26issue%3D9%26spage%3D1219%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hofmann, A. F.</span><span> </span><span class="NLM_article-title">The enterohepatic circulation of bile acids in mammals: form and functionas</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2741%2F3399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=19273221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2nsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=2584-2598&author=A.+F.+Hofmann&title=The+enterohepatic+circulation+of+bile+acids+in+mammals%3A+form+and+functionas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The enterohepatic circulation of bile acids in mammals: form and functions</span></div><div class="casAuthors">Hofmann, Alan F.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2584-2598</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The features of the enterohepatic circulation of bile acids in mammals are reviewed.  Inputs into the circulating bile acids are primary bile acids synthesized from cholesterol in the hepatocyte and secondary bile acids formed by bacterial modification of primary bile acids in the distal intestine.  Intestinal conservation of bile acids generates pools of individual bile acids whose relative sizes det. biliary bile acid compn.  Efficient hepatic clearance results in low plasma bile acid levels, and virtually no renal excretion.  Methods for characterizing the enterohepatic circulation are summarized.  Bile acids have numerous physiol. functions in the liver, biliary tract, and intestine resulting from their signaling and physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcytQeFu5q7rVg90H21EOLACvtfcHk0lgTOEm3dVthRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2nsbc%253D&md5=79908d57e756691f0c5c2daa7c7c9db3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2741%2F3399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3399%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DA.%2BF.%26atitle%3DThe%2520enterohepatic%2520circulation%2520of%2520bile%2520acids%2520in%2520mammals%253A%2520form%2520and%2520functionas%26jtitle%3DFront.%2520Biosci.%26date%3D2009%26volume%3D14%26spage%3D2584%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Roberts, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burczynski, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span> </span><span class="NLM_article-title">Enterohepatic circulation: physiological, pharmacokinetic and clinical implications</span> <span class="citation_source-journal">Clin. Pharmacokinetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2165%2F00003088-200241100-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=12162761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFyru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=751-790&issue=10&author=M.+S.+Robertsauthor=B.+M.+Magnussonauthor=F.+J.+Burczynskiauthor=M.+Weiss&title=Enterohepatic+circulation%3A+physiological%2C+pharmacokinetic+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enterohepatic circulation: physiological, pharmacokinetic and clinical implications</span></div><div class="casAuthors">Roberts, Michael S.; Magnusson, Beatrice M.; Burczynski, Frank J.; Weiss, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">751-790</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Enterohepatic recycling occurs by biliary excretion and intestinal reabsorption of a solute, sometimes with hepatic conjugation and intestinal deconjugation.  Cycling is often assocd. with multiple peaks and a longer apparent half-life in a plasma concn.-time profile.  Factors affecting biliary excretion include drug characteristics (chem. structure, polarity and mol. size), transport across sinusoidal plasma membrane and canniculae membranes, biotransformation and possible reabsorption from intrahepatic bile ductules.  Intestinal reabsorption to complete the enterohepatic cycle may depend on hydrolysis of a drug conjugate by gut bacteria.  Bioavailability is also affected by the extent of intestinal absorption, gut-wall P-glycoprotein efflux and gut-wall metab.  Recently, there has been a considerable increase in our understanding of the role of transporters, of gene expression of intestinal and hepatic enzymes, and of hepatic zonation.  Drugs, disease and genetics may result in induced or inhibited activity of transporters and metabolizing enzymes.  Reduced expression of one transporter, for example hepatic canalicular multidrug resistance-assocd. protein (MRP) 2, is often assocd. with enhanced expression of others, for example the usually quiescent basolateral efflux MRP3, to limit hepatic toxicity.  In addn., physiol. relevant pharmacokinetic models, which describe enterohepatic recirculation in terms of its determinants (such as sporadic gall bladder emptying), have been developed.  In general, enterohepatic recirculation may prolong the pharmacol. effect of certain drugs and drug metabolites.  Of particular importance is the potential amplifying effect of enterohepatic variability in defining differences in the bioavailability, apparent vol. of distribution and clearance of a given compd.  Genetic abnormalities, disease states, orally administered adsorbents and certain co-administered drugs all affect enterohepatic recycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmTzuEhf7QLVg90H21EOLACvtfcHk0lgTOEm3dVthRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFyru78%253D&md5=514a6ffb4ee275ccd2a7082fe2fe3d87</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F00003088-200241100-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200241100-00005%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DM.%2BS.%26aulast%3DMagnusson%26aufirst%3DB.%2BM.%26aulast%3DBurczynski%26aufirst%3DF.%2BJ.%26aulast%3DWeiss%26aufirst%3DM.%26atitle%3DEnterohepatic%2520circulation%253A%2520physiological%252C%2520pharmacokinetic%2520and%2520clinical%2520implications%26jtitle%3DClin.%2520Pharmacokinetics%26date%3D2002%26volume%3D41%26issue%3D10%26spage%3D751%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Schneider, B. L.</span><span> </span><span class="NLM_article-title">Intestinal bile acid transport: biology, physiology, and pathophysiology</span> <span class="citation_source-journal">J. Pediatr. Gastroenterol. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1097%2F00005176-200104000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=11396803" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=407-417&author=B.+L.+Schneider&title=Intestinal+bile+acid+transport%3A+biology%2C+physiology%2C+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00005176-200104000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005176-200104000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DB.%2BL.%26atitle%3DIntestinal%2520bile%2520acid%2520transport%253A%2520biology%252C%2520physiology%252C%2520and%2520pathophysiology%26jtitle%3DJ.%2520Pediatr.%2520Gastroenterol.%2520Nutr.%26date%3D2001%26volume%3D32%26spage%3D407%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Root, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundseth, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. C.</span><span> </span><span class="NLM_article-title">Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94</span> <span class="citation_source-journal">J. Lipid. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1320-1330&author=C.+Rootauthor=C.+S.+Smithauthor=S.+S.+Sundsethauthor=H.+M.+Pinkauthor=J.+G.+Wilsonauthor=M.+C.+Lewis&title=Ileal+bile+acid+transporter+inhibition%2C+CYP7A1+induction%2C+and+antilipemic+action+of+264W94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoot%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%2BS.%26aulast%3DSundseth%26aufirst%3DS.%2BS.%26aulast%3DPink%26aufirst%3DH.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26atitle%3DIleal%2520bile%2520acid%2520transporter%2520inhibition%252C%2520CYP7A1%2520induction%252C%2520and%2520antilipemic%2520action%2520of%2520264W94%26jtitle%3DJ.%2520Lipid.%2520Res.%26date%3D2002%26volume%3D43%26spage%3D1320%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kramer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glombik, H.</span><span> </span><span class="NLM_article-title">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.2174%2F092986706776361003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=16611081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=997-1016&author=W.+Kramerauthor=H.+Glombik&title=Bile+acid+reabsorption+inhibitors+%28BARI%29%3A+novel+hypolipidemic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs</span></div><div class="casAuthors">Kramer, Werner; Glombik, Heiner</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1016</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The enterohepatic circulation of bile acids is a major regulator of serum cholesterol homeostasis.  After biosynthesis from cholesterol in the liver, bile acids are secreted with bile into the lumen of the small intestine to aid in the digestion and absorption of fat and fat-sol. vitamins.  The bile acids are nearly quant. reabsorbed in the terminal ileum by a Na+-dependent transport system (IBAT) and are transported with portal blood to the liver and taken up by a second Na+-/bile acid cotransporter (LBAT) to be resecreted into bile.  In the liver bile acids inhibit the rate-limiting enzyme for the conversion of cholesterol into bile acid: cholesterol-7α-hydroxylase; interruption of the enterohepatic circulation of bile acids withdraws this feedback inhibition and leads to an upregulation of hepatic LDL-receptors with a concomitant decrease of serum LDL-levels.  Specific inhibitors of the ileal bile acid transporter belonging to different chemotypes have been developed in recent years for this purpose, some now entering clin. stage.  To exert a profound systemic effect these compds. do not need to be available systemically but can act from the luminal side of the small intestine, which offers the advantage to avoid the well-known adverse side effects of other hypolipidemic drugs like statins due to metab. and drug-drug interactions in the liver.  This implies several aspects in compd. optimization and drug development quite different from std. procedures, for example the concept of low absorption drugs was established to avoid systemic side effects.  This review article covers the mechanistic and therapeutic principles of the approach and presents an overview on the mol. target, the discovery of specific inhibitors and resp. optimization strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXNSDtAqiZbVg90H21EOLACvtfcHk0lhusIxKqkjHWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtLs%253D&md5=8411f5d6f3e3218ad5ba6cb8fe2075c4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986706776361003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DGlombik%26aufirst%3DH.%26atitle%3DBile%2520acid%2520reabsorption%2520inhibitors%2520%2528BARI%2529%253A%2520novel%2520hypolipidemic%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D997%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajpal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamlet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedulin, B.</span><span> </span><span class="NLM_article-title">Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">E68</span><span class="NLM_x">–</span> <span class="NLM_lpage">E76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=E68-E76&author=L.+Chenauthor=X.+Yaoauthor=A.+Youngauthor=J.+McNultyauthor=D.+Andersonauthor=Y.+Liuauthor=C.+Nystromauthor=D.+Croomauthor=S.+Rossauthor=J.+Collinsauthor=D.+Rajpalauthor=K.+Hamletauthor=S.+Smithauthor=B.+Gedulin&title=Inhibition+of+apical+sodium-dependent+bile+acid+transporter+as+a+novel+treatment+for+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMcNulty%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNystrom%26aufirst%3DC.%26aulast%3DCroom%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DRajpal%26aufirst%3DD.%26aulast%3DHamlet%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DGedulin%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520apical%2520sodium-dependent%2520bile%2520acid%2520transporter%2520as%2520a%2520novel%2520treatment%2520for%2520diabetes%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D302%26spage%3DE68%26epage%3DE76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lundåsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Őstlund-Lindqvist, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudling, M.</span><span> </span><span class="NLM_article-title">Inhibition of intestinal bile acid transporter slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1-14&issue=5&author=T.+Lund%C3%A5senauthor=E.-M.+Anderssonauthor=M.+Snaithauthor=H.+Lindmarkauthor=J.+Lundbergauthor=A.-M.+%C5%90stlund-Lindqvistauthor=B.+Angelinauthor=M.+Rudling&title=Inhibition+of+intestinal+bile+acid+transporter+slc10a2+improves+triglyceride+metabolism+and+normalizes+elevated+plasma+glucose+levels+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLund%25C3%25A5sen%26aufirst%3DT.%26aulast%3DAndersson%26aufirst%3DE.-M.%26aulast%3DSnaith%26aufirst%3DM.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DLundberg%26aufirst%3DJ.%26aulast%3D%25C5%2590stlund-Lindqvist%26aufirst%3DA.-M.%26aulast%3DAngelin%26aufirst%3DB.%26aulast%3DRudling%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520intestinal%2520bile%2520acid%2520transporter%2520slc10a2%2520improves%2520triglyceride%2520metabolism%2520and%2520normalizes%2520elevated%2520plasma%2520glucose%2520levels%2520in%2520mice%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26issue%3D5%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span> </span><span class="NLM_article-title">Hypolipidemic 1,4-benzothiazepen-1,1-dioxides</span>. (<span class="NLM_publisher-name">Wellcome Foundation</span>, <span class="NLM_publisher-loc">London</span>). Patent WO9605188, <span class="NLM_month">February</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=L.+E.+Brieaddy&title=Hypolipidemic+1%2C4-benzothiazepen-1%2C1-dioxides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26atitle%3DHypolipidemic%25201%252C4-benzothiazepen-1%252C1-dioxides%26pub%3DWellcome%2520Foundation%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ghosh, M.; Christopher, K.; Zhang, X.; Tarrant, J. G.; Lee, C.-W.; Kaiser, B.; Zablocki, M.-M.; Chenard, B. L.; Doller, D.; Yamaguchi, Y.; Wustrow, D. J.; Li, G.</span><span> </span><span class="NLM_article-title">Aminopiperidines and related compounds a MCH modulators and their preparation, pharmaceutical compositions and use in the treatment of metabolic, feeding and sexual disorders</span>. (<span class="NLM_publisher-name">Neurogen Corporation</span>) Patent WO2008016811, <span class="NLM_month">July</span><span class="NLM_day">25</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Ghosh&author=K.+Christopher&author=X.+Zhang&author=J.+G.+Tarrant&author=C.-W.+Lee&author=B.+Kaiser&author=M.-M.+Zablocki&author=B.+L.+Chenard&author=D.+Doller&author=Y.+Yamaguchi&author=D.+J.+Wustrow&author=G.+Li&title=Aminopiperidines+and+related+compounds+a+MCH+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+metabolic%2C+feeding+and+sexual+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DM.%26atitle%3DAminopiperidines%2520and%2520related%2520compounds%2520a%2520MCH%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520metabolic%252C%2520feeding%2520and%2520sexual%2520disorders%26pub%3DNeurogen%2520Corporation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cornforth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R. H.</span><span> </span><span class="NLM_article-title">A general reagent for <i>O</i>-phosphonomethylation of phenols</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1897-1900&author=J.+Cornforthauthor=J.+R.+H.+Wilson&title=A+general+reagent+for+O-phosphonomethylation+of+phenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornforth%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%2BH.%26atitle%3DA%2520general%2520reagent%2520for%2520O-phosphonomethylation%2520of%2520phenols%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1994%26volume%3D14%26spage%3D1897%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Fields, E. K.</span><span> </span><span class="NLM_article-title">The synthesis of esters of substituted amino phosphonic acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1531</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01126a054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADyaG2cXntl0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1952&pages=1528-1531&author=E.+K.+Fields&title=The+synthesis+of+esters+of+substituted+amino+phosphonic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of esters of substituted amino phosphonic acids</span></div><div class="casAuthors">Fields, Ellis K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1528-31</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">R2R3NCRR4P(O)(OR1)2 can be synthesized by treating a phosphorus acid diester with (1) an aldehyde or ketone and an imine, (2) an α-alkylol amine, (3) an alkylidene diamine, (4) an N-substituted amino Me ether, or (5) an aldimine or ketimine derived from a primary amine.  Table I; R, R4, R1, R2, R3, Yield (%), B.p.(°C.)/mm.; H, H, Me, Me, Me, 88, 88/2; H, H, Et, Et, Et, 94, 96/3; H, H, Et, iso-Pr, iso-Pr, 91, 112/2; H, H, Et, Bu, Bu, 94, 127/2; H, H, Et, Cyclohexyl, Cyclohexyl, 81, 149/2; H, H, Et, Octyl, Octyl, 86, 175/2; H, H, Et, , Oxydiethylene, 92, 137/3; H, H, Et, , Pentamethylene, 87, 124/3; H, H, Et, Et, Ph, 47, 126/1; H, H, Et, H, Bu, 38, 89, 114/2.5; H, H, Et, H, PhCH2CH2, 32, 91, 109/0.4; H, Me, Et, Et, Et, 81, 94/1; H, Et, Et, Et, Et, 78, 95/0.8; H, Pr, Et, Et, Et, 79, 104-7/1; Me, Me, Et, Et, Et, 64, 103-5/2-5; H, α-Furyl, Et, Et, Et, 84, 140/2; H, Vinyl, Et, Et, Et, 87, 116/4; H, Pr, Et, Bu, Bu, 91, 147/2; H, H, Bu, Et, Et, 93, 131/1; H, H, 2-Ethylhexyl, Et, Et, 90, 162-6/0.7; H, Me, Et, H, Me, 94, 87/2.2; H, Me, Et, H, Et, 91, 84/1; Me, Me, Et, H, Et, 97, 91/2.3; H, Pr, Et, H, Me, 93, 110/1.5; H, Pr, Et, H, Bu, 94, 119/2; H, Et, Et, H, Et, 89, 93/1.5; H, Pr, Bu, H, Me, 84, 118-22/2; H, Ph, Et, H, Ph, 97, m. 92; H, α-Furyl, Et, H, Et, 85, 127/0.75; H, Ph, Et, H, p-MeOC6H4, 89, sirup; H, Ph, Et, H, diethylene, 97, m. 95; H, Pr, Et, H, 1-Diethylamino-4-pentyl, 84, 133-5/2; H, p-MeOC6H4, Et, H, 1-Diethylamino-4-pentyl, 92, decompd.; H, ο-ClC6H4, Et, H, Me, 88, 130-2/1.5; H, H, Et, H, 2,4,4-Trimethyl-2-pentyl, 96, 123/0.74</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfw5zhGvy-LVg90H21EOLACvtfcHk0lhusIxKqkjHWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXntl0%253D&md5=7c65e6ac220540eab3d0ae74aa034183</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja01126a054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01126a054%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DE.%2BK.%26atitle%3DThe%2520synthesis%2520of%2520esters%2520of%2520substituted%2520amino%2520phosphonic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1952%26volume%3D74%26spage%3D1528%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stefely, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palchaudhuri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraski, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title"><i>N</i>-((1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3395</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3389-3395&author=J.+A.+Stefelyauthor=R.+Palchaudhuriauthor=P.+A.+Millerauthor=R.+J.+Petersonauthor=G.+C.+Moraskiauthor=P.+J.+Hergenrotherauthor=M.+J.+Miller&title=N-%28%281-Benzyl-1H-1%2C2%2C3-triazol-4-yl%29methyl%29arylamide+as+a+new+scaffold+that+provides+rapid+access+to+antimicrotubule+agents%3A+synthesis+and+evaluation+of+antiproliferative+activity+against+select+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm1000979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000979%26sid%3Dliteratum%253Aachs%26aulast%3DStefely%26aufirst%3DJ.%2BA.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DPeterson%26aufirst%3DR.%2BJ.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DN-%2528%25281-Benzyl-1H-1%252C2%252C3-triazol-4-yl%2529methyl%2529arylamide%2520as%2520a%2520new%2520scaffold%2520that%2520provides%2520rapid%2520access%2520to%2520antimicrotubule%2520agents%253A%2520synthesis%2520and%2520evaluation%2520of%2520antiproliferative%2520activity%2520against%2520select%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3389%26epage%3D3395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Brown, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, R. D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, N. W.</span><span> </span><span class="NLM_article-title">Adaptation of hydrogen analysis to measure stomach to caecum transit time in the rat</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1987&pages=849-854&author=N.+J.+Brownauthor=R.+D.+E.+Rumseyauthor=N.+W.+Read&title=Adaptation+of+hydrogen+analysis+to+measure+stomach+to+caecum+transit+time+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BJ.%26aulast%3DRumsey%26aufirst%3DR.%2BD.%2BE.%26aulast%3DRead%26aufirst%3DN.%2BW.%26atitle%3DAdaptation%2520of%2520hydrogen%2520analysis%2520to%2520measure%2520stomach%2520to%2520caecum%2520transit%2520time%2520in%2520the%2520rat%26jtitle%3DGut%26date%3D1987%26volume%3D28%26spage%3D849%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Thomas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioiello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noriega, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mataki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruzanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonjans, K.</span><span> </span><span class="NLM_article-title">TGR5-mediated bile acid sensing controls glucose homeostasis</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400459m&amp;key=10.1016%2Fj.cmet.2009.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400459m&amp;key=19723493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400459m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=167-177&author=C.+Thomasauthor=A.+Gioielloauthor=L.+Noriegaauthor=A.+Strehleauthor=J.+Ouryauthor=G.+Rizzoauthor=A.+Macchiaruloauthor=H.+Yamamotoauthor=C.+Matakiauthor=M.+Pruzanskiauthor=R.+Pellicciariauthor=J.+Auwerxauthor=K.+Schoonjans&title=TGR5-mediated+bile+acid+sensing+controls+glucose+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">TGR5-mediated bile acid sensing controls glucose homeostasis</span></div><div class="casAuthors">Thomas, Charles; Gioiello, Antimo; Noriega, Lilia; Strehle, Axelle; Oury, Julien; Rizzo, Giovanni; Macchiarulo, Antonio; Yamamoto, Hiroyasu; Mataki, Chikage; Pruzanski, Mark; Pellicciari, Roberto; Auwerx, Johan; Schoonjans, Kristina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">TGR5 is a G protein-coupled recpetor expressed in brown adipose tissue and muscle, where its activation by bile acids triggers an increase in energy expenditure and attenuates diet-induced obesity.  Using a combination of pharmacol. and genetic gain- and loss-of-function studies in vivo, we show here that TGR5 signaling induces intestinal glucagon-like peptide-1 (GLP-1) release, leading to improved liver and pancreatic function and enhanced glucose tolerance in obese mice.  In addn., we show that the induction of GLP-1 release in enteroendocrine cells by 6α-ethyl-23(S)-methyl-cholic acid (EMCA, INT-777), a specific TGR5 agonist, is linked to an increase of the intracellular ATP/ADP ratio and a subsequent rise in intracellular calcium mobilization.  Altogether, these data show that the TGR5 signaling pathway is crit. in regulating intestinal GLP-1 secretion in vivo, and suggest that pharmacol. targeting of TGR5 may constitute a promising incretin-based strategy for the treatment of diabesity and assocd. metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou5U1cAgVnYbVg90H21EOLACvtfcHk0ljhhyJbvJgFog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChtLnM&md5=05938b6d2028551cc1e7691d42421bf3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2009.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2009.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGioiello%26aufirst%3DA.%26aulast%3DNoriega%26aufirst%3DL.%26aulast%3DStrehle%26aufirst%3DA.%26aulast%3DOury%26aufirst%3DJ.%26aulast%3DRizzo%26aufirst%3DG.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DMataki%26aufirst%3DC.%26aulast%3DPruzanski%26aufirst%3DM.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26atitle%3DTGR5-mediated%2520bile%2520acid%2520sensing%2520controls%2520glucose%2520homeostasis%26jtitle%3DCell%2520Metab.%26date%3D2009%26volume%3D10%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dalmer, O.; Diehl, C.; Pieper, H.</span><span> </span><span class="NLM_article-title">Derivatives of tertiary amino aliphatic acids</span>. (<span class="NLM_publisher-name">Merck & Co., Inc.</span>, <span class="NLM_publisher-loc">Rahway, NJ</span>). U. S. Patent US2,370,015, <span class="NLM_month">February</span><span class="NLM_day">20</span>,<span class="NLM_x"> </span><span class="NLM_year">1945</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1945&author=O.+Dalmer&author=C.+Diehl&author=H.+Pieper&title=Derivatives+of+tertiary+amino+aliphatic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDalmer%26aufirst%3DO.%26atitle%3DDerivatives%2520of%2520tertiary%2520amino%2520aliphatic%2520acids%26pub%3DMerck%2520%2526%2520Co.%252C%2520Inc%26date%3D1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400459m&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400459m%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400459m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996eb06a703db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
